Articles of Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences | Volume , Issue suppl.1 / 2008

Search by Journal

HOME
> Search by Journal
> Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2008

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	We clear the way to the coming times Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2008.

	Dramatic change of peptic ulcer drug treatment : To complete recovery from healing 浅香正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2008.

	Introduction of hospital pharmacist duties in China Pheasant 所迪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2008.

	Professional service and the management of my pharmacy;present role and future contribution in the multi-disciplinary oncology team Susan M. Spivey Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2008.

	Disease prevention ... "to be healthy with a meal", and to learn from - Chinese medicine Kiyoshi Hotta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2008.

	Because is inflected as improvement of school feeding ... "lifelike teaching materials"; ... Keiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2008.

	"A drug administration design of the childhood and the study on drug interactions" Hiroshi Nakamura justice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2008.

	The pharmacokinetics change mechanism of the beta-blocker for the purpose of the individual pharmacotherapy of heart failure and elucidation of racial differences The Tadashi Taguchi up Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2008.

	The 20-S1-1 "expectation to the pharmacotherapy to a pregnant woman and a specialized pharmacist" Kodo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2008.

	Evaluation and risk communication - of the 20-S1-2 "role - teratogenicity information of medication counseling and the pharmacist to a pregnant woman" Shigeo Takamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2008.

	The 20-S1-3 "expectation to pharmacotherapy to nursing mother and a specialized pharmacist" Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2008.

	Evaluation and risk communication - of the 20-S1-4 "role - infants hazardousness information of medication counseling and the pharmacist to nursing mother" Ken Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2008.

	20-S2 "business training by Preceptors" (instruction pharmacist) Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2008.

	20-S2-1.2 A Guide to Precepting Pharmacy Students on Clinical Clerkship Michael A.Oszko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2008.

	Term "You are developing!" of the 20-S2-3 encouragement Atsumi Nishikiori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2008.

	20-S2-4 I learned from the discussion "knowledge + α" 上塚朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2008.

	Is the practical clinical practice of the student who does not have 20-S2-5 pharmacist qualification possible; role - of the clinic teacher, instruction pharmacist in - United States? Rie Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2008.

	Suggestion ... to the ethic education of professionalism - pharmacist in the 20-S3-1 medical care Yasushi Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2008.

	The present conditions of the outlook on ethic of the pharmacist in the 20-S3-2 clinic Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2008.

	Critical comment - to limit - pharmacy education model core curriculum of the cultivation of aesthetic sensitivity named the 20-S3-3 humanism Jun Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2008.

	Law and ethic for the 20-S3-4 pharmacist One Inaba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2008.

	20-S4 opening remark Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2008.

	The thing which 20-S4-1 cancer professional training plan aims at Kazuhiro Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2008.

	Training of the cancer specialist by 20-S4-2 "cancer pro" 鳥本悦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2008.

	The role of the nurse in the 20-S4-3 cancer medical care team and upbringing of the specialist Kawamura three rare child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2008.

	Training and postgraduate education of the specialized pharmacist supporting 20-S4-4 altitude cancer medical care Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2008.

	About the training of the pharmacist specialized in 20-S4-5 cancer action - of - National Cancer Center Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2008.

	20-S5-1 Approach to ensuring medication safety in pregnancy and breastfeeding-The activities of the Hospital for Sick Children in Toronto- Mikio Kakumoto1, Midori Hirai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2008.

	20-S5-2 The role of Hospital Pharmacists on the Pharmacy Education Systems in University of Mississippi Takehiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2008.

	20-S5-3 International Cooperation How should we think about "International Cooperation" to improve problems in developing countries? Watanabe Shiomi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2008.

	Is it 20-S5-4 What expectation on pharmacists from community? Zhu Zhu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2008.

	20-S5-5 The roles of Clinical Pharmacy Specialists in Japan Sari Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2008.

	20-S5-6 The Roles of Korean Pharmacists in Changing Medical Circumstances and the Need for Cooperation between Pharmacists in China, Japan and Korea Bon-Ki Koo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2008.

	20-S5-7 How to satisfy expectation of patients? Zhao Limei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2008.

	20-S5-8 "Disaster Relief Pharmacist" has what it takes to be a proactive disaster responder Eiko KOBAYASHI Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2008.

	The present conditions (than questionnaire findings) of the 20-S6-1 businessman teacher Ikuko Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2008.

	The thing which the businessman teacher in the 20-S6-2 pharmacy school aims at Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2008.

	The present conditions and problems of the businessman teacher and drugstore pharmacist of 20-S6-3 drugstore origin Kamimachi Akiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2008.

	Clinical medicine education by the 20-S6-4 medicine cooperation and construction of the clinical on-site pharmacy education Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2008.

	From a situation of thing - university hospital to expect of 20-S6-5 businessman teacher - Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2008.

	20-S6-6 "thing to expect of a businessman teacher" Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2008.

	Thing to expect of 20-S6-7 businessman teacher 渡部廉弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2008.

	Coexistence - of thing - education and the business to expect of 20-S6-8 businessman teacher Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2008.

	20-S7-1 "role of the local Pharmacist Association in the insurance pharmacist education" Michiko Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2008.

	The actual situation and problems of the training of the 20-S7-2 chain drugstore Tokiko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2008.

	The 20-S7-3 "pharmacist education in the small drugstore" Masatoshi Katsura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2008.

	20-S7-4 "cooperation of a pharmacist practice private supplementary school and the training in the company" Takashi Michigami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2008.

	20-S7-5 [Carrier creation of pharmacist sought to diversity era: To the future in a strategic and logical thinking have their own axes] 飯野直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2008.

	Meaning of a presentation at the meeting and the article in the pharmacist authorization specialized in 20-S8-1 psychiatry Takashi Yoshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2008.

	20-S8-2 "announces the practice of the clinical psychiatry pharmacy in a society" 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2008.

	How to write 20-S8-3 case report Junichi Senba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2008.

	20-S8-4 "the situation - of article contribution capture law 1 - clinic" Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2008.

	20-S8-5 "the situation - of article contribution capture law 2 - university" Yasuhiko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2008.

	The 21-S9-1 "development of products in consideration of convenience of the patients" Yasushi Ochiai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2008.

	Information retrieval about the oral medicine suspension for 21-S9-2 medication support and experimental evaluation Shiro Ishida 1, Yoshiro Okano 1, Katsuaki Arai 2, 賀勢泰子 3, Tetsu Ando sincerity 4, Is Kurata; see it; 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2008.

	The medication support that was made in a viewpoint to protect ADL, the quality of life of the 21-S9-3 patients Tetsuji Kawazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2008.

	Do you not forget patient compliance instruction of the 21-S9-4 external preparation? 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2008.

	Induction of safety management and the simple suspension method of medication, the nutrient support tube feeding by 21-S9-5 NST(nutrition support team) Hirohiko Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2008.

	Patient compliance instruction until 21-S9-6 now, medication support in the future Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2008.

	- close as a result of 21-S10-1 "present conditions - questionary survey of the pharmacist duties in critical care centers of the whole country" Kenji Nishizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2008.

	Expectation to 21-S10-2 "extensive critical care center pharmacist involved in the clinical condition diagnosis of the emergency patient" 岩崎泰昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2008.

	From pharmacist duties - patients import in the 21-S10-3 emergency care to a discharge - Norikazu Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2008.

	Relation of the pharmacist to a renal function evaluation and the antimicrobial agent administration plan in 21-S10-4 ICU inpatients Akio Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2008.

	Role of the exclusive duty pharmacist in the 21-S10-5 this hospital intensive care unit Tamaki Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2008.

	Practice of PBL in 21-S11-1 Gifu College of Pharmacy and the result Teramachi eyes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2008.

	Towards practice - pharmacy education's original PBL of the PBL induction in 21-S11-2 Hokkaido College of Pharmacy - Noro shallows Takahiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2008.

	Action - of PBL- Meijo University in the 21-S11-3 pharmacy education Kazuhisa Matsuba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2008.

	21-S11-4 The rffective PBL- Tutorial education : Introduction and its point of large classroom-type model 津田司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2008.

	For the treatment of depression that 21-S12-1 is appropriate including antidepressants and a suicide-related problem: Atsuo Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2008.

	The 21-S12-2 "mood disorders and correspondence that we saw from a pharmacist" Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2008.

	It is ... with the information that you should tell to the drug information ... patients of antidepressants helping 21-S12-3 practice Naoko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2008.

	The truth of "depression" that there seems to be 21-S12-4 intellect and does not know Ritsuko Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2008.

	How do practice 21-S13-1 business training; including / questionnaire findings report? Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2008.

	It is ... for acceptance of ... business training about the induction promotion business of TDM duties under 21-S13-2 Kanagawa Toishima study Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2008.

	21-S13-3 "business training to work on in an area" 鹿村恵明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2008.

	21-S13-4 "thinks about a core curriculum from the actual situation of the drugstore" Choichiro Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2008.

	About "we eat it for teaching collection of for action authorization instruction pharmacists of the Tokyo Pharmacist Association for the 21-S13-5 core Cali LS problems" Naoki Uemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2008.

	See hospital pharmacist activity of business training - United States for pharmacist upbringing in the 21-S13-6 next generation; and ... Yoshihiko Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2008.

	Knowledge - of the appropriate pharmacotherapy -TUE application in 21-S2-F1 sports 山澤文裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2008.

	21-S2-F2 "sports fur better strike authorization system" This node child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2008.

	21-S2-F3 "participation in planning to prevention of doping activity as the hospital pharmacist" Kumiko Kasashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2008.

	Cooperation of 21-S2-F4 sportsdom and the pharmacist Seiko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2008.

	Gene delivery ... due to contribution ... multifunctional envelope form nano structure body to Part 1 Nanomedicine Hideyoshi Harashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2008.

	Part 2 "action to the present conditions and therapeutic drug development of the gastrointestinal disease practice" Hiroshi Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2008.

	Part 3 For the promotion of the translational research of the second 福原俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2008.

	From the situation of the Part 4 pharmacy Net Katsuo Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2008.

	Study policies from Part 5 fundamental researches to the hand of the patients Daisaku Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2008.

	Evaluation of 20 C-01 anticancer drugs regimen function induction Kenji Kimura, Akiko Yamagata, Kunio Ukon, Yoko Haga, Takahashi Setsuko, Akemi Nanun, Tatsuo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	Chemotherapy protocol management in 20 C-02 injection order ring systems non-induction medical institution Naoko Kitamura 1, Nobutaka Sugano 1, Hiroshi Moriya 2, Tomoko Endo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	20 C-03 Establishment of setting the inspection method of cancer chemotherapy discontinuation criteria by the inspection data 渡邊裕之1, 星育子1, 中井由佳1, 亀山雅男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	Side effect of 20 C-04 cancer Japan Society of Chemotherapy systems of administration monitoring 當真房子 2, Saori Yamamoto 1, Terumi Nagahama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	Examination about the safety of the cisplatin /S-1 combination therapy at 20 C-05 renal function degeneracy 櫻井洋臣, Yasuhiko Ichida, 加藤裕芳, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	Action to cancer chemotherapy in 20 C-06 this hospital 眞田真樹, Yuji Funada, Yoko Tsutsui, Jin Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2008.

	About the utility of 20 C-07 anticancer drug preparations, inspection system Hiroyuki Ueno 1, Naoki Hayakawa 1, Makoto Saito 1, Kazuyo Matsuyama 1, Ayako Ono 1, 山内一恭 1, Yoshihisa Honda 1, Next Takeshi Hara 2, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

Radiation exposure situation investigation (1) of pollution and the person of the preparation environment with 20 C-08 anticancer drugs of preparation
Toshihiro Hama, Tsuyoshi Aoyama, Hidetaro Higuchi, Kondo many children, Kakuda still, Wataru Toya, Former Taro Isami, Yasushi Nakamura life
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

	About anticancer drug sterility preparation duties in 20 C-09 Fukui Prefectural hospital Mitsue Uno, 中村尚未, Shoichi Hotta, Takashi Hiraga, Yaeko Hondo, Toshiharu Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

	An action and team approach in medical care to the appropriate cancer chemotherapy enforcement in 20 C-10 district hospitals Kazuyuki Sunada 1, 三阪高春 2, Fumiko Matsueda 3, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Hirofumi Wakamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

	Consumption decrease and resistance ratio decrease of the carbapenem-based antimicrobial agent by the use of 20 C-11 antimicrobial agents report system induction Tetsuya Ueki 1, 4, Keiko Nagai 1, Shigehiko Ito 2, Kotaro Ichikawa 3, Miho Nakajima child 4, Mikiro Nakajima 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

	Pyocyanic chemosensitive change by 20 C-12 carbapenem system antimicrobial agent report system induction 石田茂伸 1, Kayo Maeda 1, Hiroyuki Watanabe 1, Yuka Nakai 1, Junpei Sasaya 2, 山崎多江子 2, Toshio Oshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2008.

	A use of antimicrobial agent trend in 20 C-13 this hospital and chemosensitive surveillance Hiroko Ota 1, Kazumi Shirai 2, Original field Kazumi 1, Yasuji Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

	Examination of the use of antimicrobial agent situation and resistant bacteria measures in 20 C-14 this hospital Kenichi Manabe 1, Makoto Tanaka 1, Teruyuki Otsubo 1, Small thicket Makiko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

	The use of injectable antimicrobial agent situation of methicillin-resistant staphylococcus aureus-positive negative patients in 20 C-15 Matsuyo Nagano General Hospital Long Tawa person 1, 藤井宏亮 1, Tatsuya Arai 1, 金田武敬 2, Masato Takamori 1, 瀧澤好廣 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

	We think about the use of the vancomycin hydrochloride (VCM) note in 20 C-16 this hospital Hiroshi Hara person, Hidetaka Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

	Examination about the initial administration plan of vancomycin hydrochloride note (VCM) in 20 C-17 elderly people Kazushige Sakano, Yu Yamauchi levator, Cresset Tadahiro, Yasuhiro Miki, Shunsuke Nakanishi, Maho Nojiri, Akiko Matsunami, 辻岡利都 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

	20 C-18 A use situation investigation of linezolid and the effectiveness, investigation about the side effect 山崎浩二郎1, 西村あや子1, 宮本剛典1, 武隈洋2, 菅原満1, 井関健1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2008.

About the development of catheter-associated blood flow infection situation in 20 C-19 this hospital
門脇督, Takayuki Tani, History of Takashi Yamada, Nagai Shoichiro, Junichi Kubo, 藪芳, Shunichiro Saito, Naoya Yoshida, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

	It is an action for no responder hepatitis B vaccine low responder in 20 C-20 this hospital Takeki Yamamoto, Keizo Morimoto, 北村諭思, 古川壮彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

	The change of alcohol hand disinfectants for prevention of hand rough weather in 20 C-21 healthcare settings and the evaluation 波能満理惠 1, Masayuki Wakita 1, Tomomi Hoshino 1, Hiromi Fujioka 1, Risa Imamura 2, Hiromi Ito 3, Junko Satake 3, Koichi Nobata 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

Present conditions and problem ... about the hand hygiene of the hospital pharmacist in action ... Tokai district of 20 C-22 Tokai district infection control meetings for the study
Takayuki Inagaki 1, 2, Waterfall Hisashi 2, Mariko Aota 3, Yoshiaki Ikeda 4, Yuki Ito 5, Hiroki Inoue 2, 片山歳也 6, Tadao Kimura 7, Yoshikazu Kobayashi 8, Izumi Shimada 9, Shinichi Tamiya 5, Shigeki Nakane 10, Masashi Sakano 3, Hiroki Mase 9, Yuichi Muraki 11, Ken Mori 1, 7, 二改俊章 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

	The action that the disinfection introduces instruction to eliminate the need for for the patients of 20 C-23 insulin self-administration Star Hatsumi 1, 古川恒昭 2, Hideko Kenmochi 3, Yoshiyuki Suzuki 4, Katsuya Fuse 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

	Suspension fungus investigation in 20 C-24 University of Tokushima Hospital ward 柴田高洋 1, Hirofumi Shibata 4, Fushidani Hideji 3, Kazuyoshi Kawazoe 4, Masahiro Abe 4, Tomihiko Higuchi 4, Kazuo Mizuguchi 4, Shono sentence 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2008.

	Investigation of the hygienic hand-washing procedure acquisition degree of 20 C-25 pharmacy students 森茂彰 1, Masashi Sakano 2, 3, Mariko Aota 2, 3, 寺井文廣 2, Yuki Ito 3, Waterfall Hisashi 3, Izumi Shimada 3, Hiroki Mase 3, Ken Mori 3, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

Utility of the optimal trough blood level decision method in consideration of MIC and a tissue extraction rate of vancomycin hydrochloride in patients with 20 C-26 MRSA pneumonia
Three branch families of the Tokugawa house Naoki 1, Takuya Suzuki 1, Kunio Tomita 1, 樹下成徳 1, 木田兼以 2, Kana Matsumoto 3, Kunihiko Morita 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

	Investigation about the relation of the antiuse of MRSA medicine situation and pharmacist in 20 C-27 this hospital Tomoko Yoshida 1, Chizuru Inoue 1, Many Luo tail love 1, Katsushi Miyake 2, Ochi accounting office 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

	Examination about the vancomycin administration for the CAPD patients whom 20 C-28 peritonitis developed in 浦嶋和也 1, Tomoyuki Yamada 1, Kaoru Suzuki 1, Masami Nishihara 1, Tsuyoshi Nishida 2, Italy husband your Naokazu 2, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

	Pharmacokinetics study of 20 C-29 bepridil 星聡 1, Kamakura Shiro 2, Kyoko Fukumoto 1, Kazuyuki Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

	Pharmacokinetics study of the ceftriaxone sodium in 20 C-30 children Shiori Aida 1, Kyoko Fukumoto 1, Tomohiro Oishi 2, Kazuyuki Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2008.

	Comparison of the blood tacrolimus levels measurement using 20 C-31 MEIA method, CLIA method and ACMIA method Takashi Kitahara, Hiroo Nakagawa, Chieko Shimizu, 兒玉幸修, Tomoyuki Hamamoto, wisteria Hideto, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

Contribution (action of the drug control instruction) of the pharmacist in the patients who presented with anaphylaxis thought about according to 20 D-01 vancomycin
Hisao Ikeda 1, Obayashi fair name child 1, Hiroshi Nomura British 1, Noriko Ono 2, Hisashi Tanaka line 3, Koshin Yoshikawa 3, Katsuyoshi Hatanaka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

	Practice and evaluation of the pharmacotherapy support in 20 D-02 first aids, intensive care unit Chie Goto, Atsushi Watanabe, Yoshimasa Naomi, Yasuo Ogasawara, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

	Role of the pharmacist carrying it out for the quality of life maintenance of patients with 20 D-03 coronary artery disease Yuji Hattori 1, Makoto Saito 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Yoshio Yasumura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

	It is ... including an induction evaluation of the relation ... fondaparinux sodium preparation of the pharmacist to DVT precaution in 20 D-04 this hospital 舟越亮寛 1, Tsuyoshi Washiyama 1, Yoshiko Matsumoto 1, Tatsuya Oyama 2, Sanmatsu interest way 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

20 D-05 pharmacist ward permanent residence for improvement of pharmaceutical management in becoming it
Hiromi Sekimoto 1, Asako Kimura 1, Middle storehouse Ichiro 1, Bank of a moat Yayoi 1, Eri Nishiguchi 1, Hideki Morishita 1, 2 which is related to Kinugasa, Description of Noda world 2, Keiko Fujiwara 2, Jun Kobayashi Jiro 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2008.

Trial of fact-finding and the standard bread fret making of the inhalational instruction in 20 D-06 health insurance pharmacy
Akira Maruyama 1, Kazuaki Kojima 1, Shinobu Araya 1, North side Tomoyuki 2, Daisuke Toko 2, Koshiyama Setsuko 3, Noriko Miyawaki 4, Cheap place wide high 5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

20 D-07 pharmacists, construction of the right insulin injection procedure instruction by the cooperation between nurses
神原康佑 1, Junko Onishi 1, Kazuki Ochi 1, Jun Fujii charges 1, Mieko Miyake 1, Toshi Hara child 1, Sachiko Okano 1, 増田憲俊 1, Mika Wakimoto 2, Lower Kanako Suga 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

As a result of induction recommendation model choice to an usability evaluation and the patients of the insulin injector by the short time type procedure experience workshop for 20 D-08 pharmacists with body function disorder
Eiko Hara 1, 7, Toru Yamada 2, 7, Kazuhiko Nagai 3, 7, Ayumu Katagiri 4, 7, Manabu Abe 5, 7, Toshinari Asakura 6, 7, Miho Kageyama 6, 7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

Side effect investigation in the hematopoietic stem cell transplantation protocol using 20 D-09 mycophenolate mofetil
It is Naho 1 in a circle, Temple former Mayumi 1, Masumi Hasegawa 1, Mountain Hiroshi Morimoto 1, Akiko Tanifuji 1, Kadoyama Kaori 1, Makimoto Hiroo 1, 西口工司 1, Atsushi Okamura husband 2, 松井利充 2, Hirai green 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

	The enforcement of bringing medicine confirmation duties by 20 D-10 ward pharmacists and contents investigation of the bringing medicine Inou Kanako, Winnow music Mayumi, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

Relation as Infusion reaction incidence investigation in the trastuzumab adjuvant postoperative treatment in 20 D-11 outpatient department and the medical person
葉田昌生 1, Toshiko Oda 2, Tadashi Mikami 1, Yoichi Nakajima 1, Yoshiko Murakami 1, Mountainous district will 1 old, Wataru Shiraishi 1, Ikuhiro Nose 1, 田中眞紀 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2008.

	Analysis of inquiry duties in 20 D-12 outpatient department chemotherapy Akira Takagi Kei 1, 2, 吉田睦浩 1, 2, 山之内恒昭 1, Yasuhiko Mimura 1, Cake well Tatsuhiko 3, Atsushi Kato 1, Isao Adachi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

	Action about the proper use promotion of antiemetics used by 20 D-13 outpatient department chemotherapy Maki Takimoto 1, Yuko Taguchi 2, Virtue comfort Masato 3, Satoshi Ushijima 3, Kenji Horii 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

Fact-finding about the pain control for the cancer outpatient department chemotherapy application patients of 20 D-14 this hospital
Shunichiro Saito, An original collar, Takeru Kawai, Takayuki Tani, Yukiko Honda, Mayumi Iwahori, 門脇督, 鈴木悠加, Nagai Shoichiro, Junichi Kubo, 鶴見里佐, 小原郁司, Takahiro Sakuma
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

	An investigation and measures about the anticancer drug exposure at the cancer pharmacotherapy in 20 D-15 whirlpools Hospital Mari Mizuki 1, Kirai Hiromi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

Application to the establishment of the rating system that assumed doxorubicin an index drug nosocomial pollution and healthcare worker radiation exposure with 20 D-16 antineoplastic and the investigation of the pollution status
Keiji Matsumoto 1, 2, Takafumi Naito 1, 宮本康敬 1, History of moat male 3, Takashina Yoshiaki 1, Naoko Yoshida 1, Hiroshi Yamada 2, Junichi Kawakami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

	Physicochemical characteristic examination of the vinca alkaloid-based anticancer drug for 20 D-17 temperature changes Kazuaki Kojima 1, 寺田智祐 2, Shinko Tsuda 2, Toru Hashida 2, Ikuko Yano 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2008.

	About the Error of measurement with the syringe in 20 D-18 anticancer drug preparations Eri Tada, Utsubo Yuko, Megumi Fujita, It is Naho in a circle, Toshihiko Yamaji, Mao Yamamoto, Shinto priest Mari, Atsushi Wada, Kadoyama Kaori, Makimoto Hiroo, 西口工司, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

	20 D-19 Examination of the factor affecting the dose of imatinib 岸三重子1, 2, 河原昌美2, 高田直子3, 春木一伸4, 荒川雅美1, 宮本謙一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

	The making of 20 D-20 cancer chemotherapy enforcement planned calendar and examination of the utility Kazuyo Aoyagi 1, Mayumi Kaise 2, Gutter bear Kinji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

	20 D-21 The combination of zoledronic acid hydrate and chemotherapy : Patients who obtained a therapeutic effect in the renal pelvis cancer 佐藤利之1, 泉浩司2, 滝沢明利2, 宇田川幸一2, 依田啓司1, 村井哲夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

	Relation of the pharmacist in 20 D-22 team bell Quaid Takashi Sugizaki person, Takahashi volost, Description of basic truth, Hidetaro Higuchi, Chieko Kondo, Cheap Fujihana clip, Tomoko Hiraoka, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

Observe ... M.D.Anderson Cancer Center thinking about the role of the pharmacist in 20 D-23 team approach in medical care; and ...
橋本浩伸 1, Yoichi Osato 2, Jun Takashima straight 3, Sugiyama (Yoshimura) Naoko 4, Hitomi Sato 5, Kitayama Sayuri 6, Hillary A.Prescott7, Jeffrey Bryan7, Naoto Ueno 8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2008.

	Comparison of the use of cancer pain therapeutic drug situation in this hospital before and after 20 D-24 psychological care team starts Hiroko Takahashi 1, Advancement in the world static 2, Setsuo Tsuchiya 1, 丹田滋 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	20 D-25 Supportive care of cancer: Mainly stomatitis 新井律子, 森田智子, 丹原敏男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	Action to an adverse event collection of process and patients feedback in 20 D-26 breast cancer chemotherapy Nabeta Izumi 1, Kazuyo Nakamura 1, Kimiko Asakura 1, Midori Kimura 1, Tsuneizumi Michiko 2, Kazuhiko Nakagami 2, 河原崎貴伯 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	Example that showed INR increase thought to be the interaction with the Gefitinib in 20 D-27 warfarin remedy patients Aihara Hideaki, Tomomi Omori, Kohei Ichikawa, Haruka Fujise, Masami Onishi, 前彰, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	Pro-evaluation of the oral mucosa disorder with 20 D-28 radiotherapy establishment Chie Nakata 1, Tsuyoshi Hirano 2, Rumi Takano 3, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	Investigation about the onset of stomatitis in patients with head and neck cancer given 20 D-29 cancer chemotherapy Shinya Suzuki, Kenji Kawazumi, Genei Shinya, Sonoko Furubayashi, 加藤裕芳, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2008.

	Application of the antioxidant material for the prevention of stomatitis in 20 D-30 cancer chemotherapy Rumi Takano 1, Tsuyoshi Hirano 2, Chie Nakata 2, Kumiko Kasashi 3, Mitsuru Sugawara 3, Masanori Kobayashi 2, Shiro Itagaki 2, It is 3 Takeshi Iseki 2, Toshiji Oe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

Examination of the angiogenesis factor gene expression in 20 D-31 hepatocellular carcinoma biopsy preparation
Tamotsu Suzuki season 1, Chisato Kitayama 1, Osamu Ito greens 1, Daiya Sakurada 1, Masahiko Sunaga 2, Shoji Yoshikawa 3, 横須賀收 3, Fumio Nomura 4, Noboru Sato example 1, Shiro Ueda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

	Innovator drug of 20 E-01 cefazolin sodium (CEZNa) notes, examination of the equivalency of the generic drug Your Orihara wide 1, Miwako Kamei 1, 櫻井康亮 2, Tomioka Mitsugu 2, Junichiro Murayama 2, Makoto Otsuka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

Effect on neutropenic frequency with the forerunner and the generic medicine of 20 E-02 hydrochloric acid epirubicin preparation
Tomoko Suzuki 1, Kimura なつほ 3, Yuko Fukuda 1, Ayako Kato 1, Sei Suzuki Nako 1, Kadomura Shota 1, Mina Takeuchi 1, It is still 1 Asano, Takahiro Shiga 1, Tatsuya Ito 1, Law of nature authority 2, Prince Takashi Nakagawa 2, Shinichi Matsuoka 2, Koji Saito 3, Takemoto success 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

	Pharmaceutics-like comparison between starting medical supplies and generic medicine of 20 E-03 micro emulsion-type cyclosporine preparation Ueda Kosuke 1, 武隈洋 2, 沖洋充 1, Suda example line 1, Mitsuru Sugawara 1, Takeshi Iseki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

Stability evaluation after the last packing opening a letter of a lot of 20 E-04 limaprost alfadex marketing preparation
Tamami Hirayama 1, Hidetoshi Arima 2, Ichiro Inaba 1, Keiko Kinoshita 1, Quantity of Seo 3, Kenichiro Fujii 1, Shunei Maeda 1, Yuko Matsunami 1, Shigeyuki Miyamura 1, Aphananthe aspera Takayuki 1, Masato Yamamura 1, Tadashi Nomura 1, Junichi Saeki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2008.

	Examination about the quality in an innovator drug and the generic drug of 20 E-05 limaprost preparation and the stability Helmet slope Masashi 1, Kiyoto Edo 1, Fumiko Negishi 1, Keiji Maruyama 1, 河野博充 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Inquiry, inquiry investigation from 20 E-06 patients, staff Masato Shindo 1, Yoko Shimada 1, Keiko Fujisawa 1, Tomoko Kawahara 1, Yoshizawa peak blue 1, Najima reason slop-bowl 1, Mitsue Shindo 2, Seigo Iwakawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Information inflection of adverse event database AERS by the synonym solution to 20 E-07 medical supplies names Shuji Kaneko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Construction of the additive search system in 20 E-08 ethical drugs Satoko Suzuki 1, Noriko Nakamura 5, Daiya Sakurada 1, 鈴木弘誉 4, Shigeyuki Yamada 4, Masahiro Fukushima 4, Net Katsuo Oka 3, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Development of poisoning information database by 20 E-09 Adobe Flex 2+ XML and diagnostic aid system (SPIA) Akira Inoue 1, Yuta Inoue 1, Yasuko Nakano 1, 戸部敞 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Drop capacity and change factor of a lot of 20 E-10 infusion 橋本大佑, Junji Kaga, Kayoko Fujita, Tetsushi Iwamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2008.

	Fact-finding of the diabetes patient education in 20 E-11 opening of an office drugstores Hiroaki Nagata, Manabu Tanimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

	The medicine medicine cooperation that utilized 20 E-12 side effect conjugation monitor systems 本樫寿裕 1, Yuko Okamura 2, Yagi Nobuhiko 1, Tatsuya Yokoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

The construction of the internal use anticancer drug checking prescription system using 20 E-13 treatment planning form and trial to the patients information bank attendant to the out of the hospital drugstore
Toshiya Goto, Kazuaki Hirose, Kazuhide Tanaka, Masaki silver three, Akira Takada
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

	Recognition degree investigation about 20 E-14 cancer pain control Takeshi Miyake sentence, 須山奈見子, Saori Okamoto, Yoko Nakano, Kana Akahori, Otake A tree, Shizuka Takaoka, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

	Examination of the oral anticancer drug orientation induction by 20 E-15 hospital pharmacists Yoichi Nakajima, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, 葉田昌生, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

	Present conditions report of the pharmacist training specialized in a cancer in 20 E-16 Tokyo Medical College Hospital Tomomi Omori, Hiroshi Soeda, Kanako Azuma, Yoichi Osato, Aihara Hideaki, Yasushi Naito period, 冨樫英晶, 前彰, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2008.

	Action for antimicrobial agent proper use based on 20 G-01 De-escalation enforcement investigations Nobuko Umemura 1, Masashi Sakano 2, 森茂彰 1, 豊田行康 1, Mariko Aota 2, 寺井文廣 2, Yuki Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

	Effect on residual quantity in the vial of 20 G-02 vancomycin hydrochloride notes and AUC and time above MIC Hiroshi Yamazaki 1, Shigeharu Oie 3, 園山裕靖 2, Hiroko Tanaka 2, Yasuhiko Sato 2, Naoyuki Miyano 1, Akira Kamiya 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

	Contribution to proper use of the medicine by 20 G-03 ward permanent residence pharmacists Kazuya Fujita, 郡妙恵, Sumiko Inamura, Toru Shinohara, 並木路広, 大谷道輝, Kiichi Yamamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

	It is a change of the dissolution by the heat denaturation the denaturation (the second report) due to the fever of 20 G-04 clarithromycin dry syrup Yasuhiro Matsumoto 1, Rie Kai 2, Kyuju U.S. tree Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

It is ... from the settings of role - thrombolytic therapy (rt-PA therapy) of the pharmacist in the medical care for 20 G-05 stroke hyperacuteness period
Aku Masami Sawa 1, Takeharu Nakane 1, Hiroyuki Sekiguchi 1, Tomoko Itano 1, Tomoyo Harada 1, Tomoharu Morita 1, Hiroyuki Tajima 1, Akiko Miura 1, God Takao Sawa 2, Beautiful master 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

	Examination of the utility about 20 G-06 pioglitazone 7.5mg/day administration Mayuko Yamashita 1, Yasuko Ichikawa 1, Yasushi Fujii 1, Kenichiro Fujii 1, Katsutoshi Miyakawa 2, It is Taiji 2 in Seki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2008.

Water absorptive examination of hydrochloric acid Seve Lamar and the carmellose by 20 G-07 healthy subjects
Esaki hsiang tsai child 1, Kanai A Kei 1, Mika Kano 1, 濟川聡美 1, Kei Sato wound 2, Yoichi Ishizuka 3, Mitsuru Irikura 3, Toru Irie beauty 3, Daisuke Kadowaki 1, Sumio Hirata 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

	Effect on laboratory values in front and back where we made change of prescription from 20 G-08 ticlopidine to clopidogrel Aya Kajita 1, Yuji Hattori 1, Makoto Saito 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1, Yoshio Yasumura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

	*Examination of the simple genetic polymorphism diagnostic procedure of UGT1A1 28 which is necessary for Serious ADR prediction of 20 G-09 irinotecan** Ayako Morita 1, Amount of Ariyoshi example 2, Koichi Kitada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

	Analysis - in examination - sun stage and the small positive stage of the utility of the Chinese medicine extract preparation for 20 G-10 common colds Yasuhiro Sugiyama 1, Miyashita quiet 2, 齋藤幹央 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

	Induction and evaluation of the clinical pharmacy experience team type training in 20 H-01 Sino-Japanese traditional medicine basic education 日置智津子, Katsuhiko Arai, Takashi Masanori, Makoto Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

	Examination of the learning result evaluation analytical procedure in the arrival target of 20 H-02 business training model core curricula Hidenori Sagara 1, Yoshihisa Kitamura 2, Hiromi Okazaki 3, Atsumi Nishikiori 3, Satoko Fujiwara 3, Sendo Toshiaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2008.

For improvement of the quality of 20 H-03 hospital pharmacists trial - of the - Nagano Hospital Pharmacist Association
Masaru Nakajima 1, Okazawa incense Tsu child 1, Katsuo Tanaka 1, Kenji Kiyohara 1, 1, Kyoshi, Nakayama, Hatsutani University child 1, Mitsue Mizutani 1, Osamu Atobe 1, 六波羅孝 1, Akihiro Tada 2, 白澤吉哲 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

	The evaluation of the postgraduate training pharmacist system in the hospital attached to 20 H-04 Osaka Medical College and the future prospects Masami Nishihara, Nishimura ankle purely, Toyofusa, Kobayashi, Tomoko Ueda, Osamu Kiyama, Noriko Suzuki, Kaoru Suzuki, Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

The situation of the trial education judging from questionnaire results in 20 H-05 Hospital training for 9 years and future problem
Yoko Iguma 1, Old real name Tsu child 1, Spring fortune Manami 1, Tomoko Matsuyama 1, Ayumi Shida 1, Eriko Sato 2, Taeko Hashida 2, Matsui あや 2, Yoshiko Ishizuka 1, Ikuko Yano 1, Kenichi Inui 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

	Conduct 20 H-06 visit drug control instruction Isurugi Ikuko, Miki Sato, 曽我師賢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

	The way of promotion and the discharge plan of 20 H-07 treatment at home Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

	Action of DCST in 20 H-08 Saitama Red Cross Hospital Naoto Sugawara 1, Yoko Kamei 1, Kana Fukuda beauty 2, Hitomi Matsui 3, Hashizume English sentence 4, Yoshio Fujikake 1, Kazuyuki Ikui 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2008.

	Action to the smoking cessation support in 20 H-09 coronary stenting patients Nishiyama non-lawn 1, Yuri Ino 1, Yuka Tsutsui 1, 窪川渉一 2, Kazuya Kawai 2, Fumi Yoshinaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

It is ... from insulin preparation in 20 H-10 health insurance pharmacy and relation one - area, a hospital to the disposal of used needle, the present conditions of the drugstore
Kenji Kobayashi 1, 2, Manabu Kumakura 1, 2, 林忍 1, 2, Toshinari Asakura 3, Yoshizo Kaneko enthusiast 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

	The change and the present conditions (2007) of the pharmacist duties in 20 H-11 capital municipal hospitals Mikio Hayashi 1, 梶谷文裕文裕 2, Tatsuo Tanaka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

	Fact-finding of the use of medical supplies about the infectious gastroenteritis of 20 H-12 children Fumiyo Kita 1, Yu Shibata joy 2, 依藤亨 3, Junichi Kawakami 2, Koji Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

	Questionary survey about the dosage form design of the oral antimicrobial agent for 20 H-13 children Tomoyuki Ikehata 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Mitsuru Santo 2, 佐藤吉壮 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

	About the number of the use and the use fact-finding of 20 H-14 antiinfluenza agent (Tamiflu (R), Relenza (R)) Akifumi Hayashi 1, Yuko Yoshioka 3, Go Kato 2, Kiyoshi Kuromiya 4, Hiroshi Yabe 5, Teru Yamamoto person 6, Tomoji Saito 7, Hajime Kikima 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2008.

	20 H-15 The effectiveness and problem judging from the use situation of linezolid 北村正樹, 加文字理江, 中島清江, 奥津利晃, 加藤潤一郎, 赤石和久, 菊野史豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

	20 H-16 Efficacy of Insulin detemir in Basal-Bolus therapy 西村博之1, 江口朝子1, 魚住多佳子1, 吉田陽1, 梶原敬三2, 陣内冨男2, 陣内秀昭2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

	Image investigation of the insulin device for the self-administration that 20 H-17 insulin self-administration inexperienced patients hold Hiroyuki Deguchi 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

The acceptance of the patients for 31 gauge 6mm needles for 20 H-18 insulin injectors and 32 gauge taper type 6mm needle and examination about a feeling of pain
Miho Kageyama 1, Toshinari Asakura 1, Hiroaki Seino 2, Matsui A flower 3, Kazuhiko Sugiyama 4, Yoko Yoshida 5, Juichi Yamamoto 6, Makoto Nomura 7, Uchida University 8, Takashi Tanaka 9, Tsuyoshi Tanaka 9, Kazushi Ishida 10, Ryuzo Kawamori 11, Kohei Kaku 12, Noriaki Yokou 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

	Fact-finding - for the adherence of adherence - once a week preparation of 20 H-19 bisphosphonate preparation Izumi Shimada 1, Ikuko Tanaka 2, 玉置繁憲 3, Kazuko Koyama 1, Hiroki Mase 1, Koike former 1, Suzuki Suehiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

About the clinical condition change in 20 H-20 chronic kidney disease (CKD) patients and a use drug investigation
Shigeru Yamada tree 1, Kana Kato 1, Koki Kasuga 2, 鳥山高伸 2, Hiromi Sakai 1, Shinji Takahashi 1, Ayumu Ichimura 1, Takako Nakajima 1, 1 which is related to Nomura
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2008.

	Follow-up of the use of 20 H-21 amiodarone injection case Emi Momiyama, Yoshie Araki, Yoshie Nishiyama, Tomoko Shibata, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

	Comparison of intermittent administration of furosemide in 20 H-22 heart failure patients and the effect of the continuous medication Hatamoto Keita 1, Yasuko Ichikawa 1, Yasushi Fujii 1, Kenichiro Fujii 1, Tsuneaki Sadanaga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

Examination of change effects from hydrochloric acid cevimeline in 20 H-23 Sjogren's syndrome to pilocarpine hydrochloric acid
Hiroki Mase 1, Izumi Shimada 1, Kazuko Koide 1, Masako Watanabe 1, Takako Yamauchi 1, Shoji Hattori 1, Takeshi Noro 1, Ikuko Tanaka 3, 玉置繁憲 2, Suzuki Suehiro 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

	Examination about efficacy of 20 H-24 liposome amphotericin B and the safety Yukihiro Hamada 1, 小松敏彰 1, Rumiko Kondo 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

	Through a role of the significance -NST public information of the publication of the NST newspaper by 20 I-01 pharmacists - Masahiro Okuno, Junko Miyazaki, Mai Fujimoto, Nobuko Takayanagi, Tomoko Sato, Manabu Nakata, Koichi Hosomi, Yoshiharu Umetani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

	It is ... through two cases of role - short bowel syndrome of the pharmacist in NST rounds in 20 I-02 surgery Junko Miyazaki, Masahiro Okuno, Mai Fujimoto, Tomoko Sato, Manabu Nakata, Koichi Hosomi, Yoshiharu Umetani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2008.

	The pharmaceutical intervention in 20 I-03 NST duties and the effect Wataru Goto 1, Mountain Rieko Sawa 1, Umizuka Yasuro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

	The way of the NST pharmacist in the nutritional management of 20 I-04 advanced age patients on dialysis Mami Kiyokawa 1, Asahi Ueno 2, Yoko Ikeda 2, Suda example line 1, Masaya Watanabe 3, 石川康暢 4, Mitsuru Sugawara 1, Hiroshi Takeda 5, Takeshi Iseki 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

	To obtain induction - understanding of 20 I-05 simple suspension method; - Prince Taniguchi chapter, Tatsuya Sasaki, Kaifu Masayo, Noriko Fukuda, The Ishikawa immensity, Akihiro Kai, The Era right track, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

It is effect on immunocompetence with the slow administration of lipid microsphere in the nutrition care and nutritional status after 20 I-06 altitude invasive surgeries
Ueda clothes texture 1, 加藤安宏 1, Satoru Minami 3, Tatsu Sakamoto Ichiro 3, Midori Kimura 3, 河原崎貴伯 3, Toshio Maeda 1, Hiroshi Yamada 2, Masakazu Takagi 4, Yoshiyuki Kagawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

	Stable examination of aspirin at magnesium oxide combination in 20 I-07 intubation administration Yukio Shimizu 1, 2, Yunohara Ami 1, Junichi Iida 1, Igarashi sincerity intellect 1, Kiyomi Ito 1, Katsuko Yano 2, Takao Orii 2, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

	Examination of the base recover rate in the transluminal administration of 20 I-08 grammar reel (R) infinitesimal grains Junichi Iida 1, 2, Katsuko Yano 3, Igarashi sincerity intellect 2, Kiyomi Ito 2, Takao Orii 3, Kiyoshi Sugiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2008.

It "is demanded 20 I-11 from pharmacist and supplement ... us!"
Yasushi Amano 1, Yukiko Arakawa 1, Keiko Anzai 1, Noriko Azuma 1, Yukinori Oshima 1, Keiko Kawasaki 1, Koji Shibata 1, Takeshi Sugasawa 1, Awara Tomohito 1, Satoshi Mizuno 2, Toshihiro Noda 2, 3, Hirai green 2, 4, Takeshi Iseki 2, 5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	Inhibitory effect for the onset of ischemic neuropathy of 20 I-12 Morinda citrifolia fruit juice from Okinawa Shinichi Harada 1, 濱邊和歌子 1, Will Tomoka Nako 1, Kohei Kamiya 2, Noriko Satake 2, It is still I 1 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	Elucidation - of the decoloration mechanism of the carminic acid using the mechanism elucidation (the second report) - molecular orbital method of the photobleaching response in 20 I-13 five mini-(R) Tadashi Okubo 1, Mariko Tanaka 3, 7, Okubo branch 2, Miho Okubo 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	Effect of the light to give to stability of 20 I-14 trichlormethiazide preparation Yuki Matsushima 1, Reiko Teraoka 1, Tomomi Akita 1, Kana Mizoguchi 1, Isao Sugimoto 2, Fumie Kato 1, Kana Inoue 1, Shinya Morita 1, Shuji Kitagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	Denaturization of the suspension insulin preparation which we left under 20 I-15 thermophile Toshinari Asakura 1, 神田循吉 2, Miho Kageyama 1, Noriaki Yokou 1, Hiroaki Seino 3, Hiroyuki Wakabayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	20 I-16 1 patients who use the hospital formulation Azunol Futhan ointment to the buttocks erosion formed by diarrhea to continue 竹本雄一1, 中島貴子1, 市村歩1, 山田成樹1, 澤田真紀2, 薗田信広2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2008.

	Quality evaluation of 20 I-17 hospital preparation rifampicin suppositories Seki Yuka village 1, Yu Yokoyama law of nature 1, Yu Haruki person 1, Sachiyo Kondo 1, 毎熊隆誉 2, Daisuke Teshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

Preparation and evaluation (2) of the patch in the catechin component oral cavity for the patients with 20 I-18 xerostomia
Jewel bug Kasumi 1, Willow Shinji sail 1, Isao Murakami 1, Hiroyuki Hosono 1, Sanae Shino 1, Hiroki Fukushima 1, Ichinokawa Yoshimi 2, Keiko Yamaoka 3, Machiko Watanabe 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

Development of 20 I-19 hydroquinone stabilization conditions and new hydroquinone component pigmentation therapeutic drug, utility to the hospital preparation
Naoko Iimura, Yoko Ono, 柴澤京子, Description of Okubo sand, Takahiro Iida, Koichi Shinohara, Kazuhito Saiki, Kazuyuki Ueno
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

About likelihood of the hospital preparation for the financial burden reduction of patients with 20 I-20 recurrence acute promyelocytic leukemia
Mannen Takuya 1, Hiroki Ono 1, Masayuki Yuki 1, 富樫修弘 1, Toshiko Hosoya 1, Mountain Masayuki Sawa 2, 丘龍祥 3, 小嶋文良 3, Tadashi Shiraishi 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

	Change of 20 I-21 LPS and digoxin pharmacokinetics in the CpG-DNA administration rat Takashi Kato children 1, Takako Irie 2, 楠川侑吾 2, 2, Asuka, Iwamoto, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

	The effect that capsaicin gives to digoxin pharmacokinetics in 20 I-22 Lipopolysaccharide administration rat 楠川侑吾 1, Takako Irie 1, 1, Asuka, Iwamoto, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2008.

	The effect that capsaicin in 20 I-23 LPS administration rat gives to CYP3A2 and total CYP expression 1, Asuka, Iwamoto, Takako Irie 1, 楠川侑吾 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

	Change of small intestine absorption dynamics at 20 I-24 small intestine ischemia reperfusion injury So Maruyama 1, Jiro Ogura 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

	The organic anionic transporter expression change by 20 I-25 hepatectomies and effect on remote organ Tatsuro Fujii 1, Shiro Itagaki 2, Masanori Kobayashi 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

Change of a blood coagulation system, inflammatory reaction in the perioperative period of 20 I-26 dissecting aneurysm and abdominal aneurysms and the platelet function
Your Nakamura existence 1, Harunobu Iwase 1, Kaya Hiroko Sono 2, Ryuji Ikeda 3, Junko Arima 3, Katsushi Yamada 3, 4, Ryuji Sakata 4, Kazuo Nakamura 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

	Change of the delayed-action nausea, vomiting measures prescription at the breast cancer chemotherapy by 21 C-01 pharmacist intervention Junichi Takano 1, Yuka Ito 1, Upper mound Tomoko 1, Yuko Shinmyo 2, Ogata fine weather tree 2, Hisahiro Yoshida 3, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

	The expression situation of nausea, vomiting at the chemotherapy in 21 C-02 patients with nonsmall cell lung cancer and future problem 宅和真由美 1, Yoko Imoto 1, Keiko Sano 1, Noriko Otomo 1, Yoshishige Fujio 1, 笠松美宏 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2008.

	Side effect investigation in the cisplatin super selective intraarterial injection for 21 C-03 head and neck cancer Masaki Kumai 1, Asano order next 2, Kumiko Kasashi 1, Mitsuru Sugawara 1, Takeshi Iseki 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

	Examination about the risk factor of the hiccup development in 21 C-04 cisplatin chemotherapy Makoto Hayashi 1, Hayato Sugimura 1, Kan Yukio 2, Masami Kawahara 2, Koji Abe 1, Aspect shrine Koji 1, Kenichi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

Nausea, vomiting, the anorectic expression situation at gemcitabine monotherapy enforcement in 21 C-05 abdomen regions
野村充俊 1, Small Ido Keiichi 1, Toru Akagi 1, 牧野好倫 1, Koji Murakoshi 1, Nobuaki Yokote 1, Minoru Mori 1,000 kinds 2, Hideki Ueno 2, 奥坂拓志 2, Hiroshi Yamamoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

	One case that treatment was able to continue safely by measuring blood platinum concentrations at the mFOLFOX6 enforcement of 21 C-06 patients on dialysis Tadashi Fujita will 1, Tetsuro Koide 2, Hiroaki Matsuda 4, 片山歳也 3, Yasushi Kataoka 1, Shinko Okuda 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

	Fact-finding of the side effect expression in the mFOLFOX6 therapy in 21 C-07 this hospital Mayumi Iwahori, Bridge Ryosuke, Junichi Kubo, Shunichiro Saito, 鶴見里佐, Naoya Yoshida, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

	It is ... from the situation of real - pharmacist of the colorectal cancer chemotherapy in 21 C-08 this hospital Yasushi Nishiyama 1, Takeshi Abe reason 1, Minoru Oshima 2, Jun Teramoto 2, Seiji Mori 2, 因藤春秋 2, Morning market Takashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2008.

	Examination of the background factor which has an influence on carboplatin hypersensitivity in patients with 21 C-09 gynecologic cancer Yu Murashima oneself child 1, Hiroko Sugimoto 1, Takuya Iwamoto 1, Tsutomu Tabata 2, Norimasa Sagawa 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

	Evaluation of the carboplatin doses setting by the revision of 21 C-10 serum creatinine levels Katsuya Makihara 1, Hiroshi Okada 2, Hiroto Kishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

	Bioequivalence in healthy adults of 5 mg of 21 C-11 meloxicam tablets "Towa" and 10 mg of meloxicam tablets "Towa" Yoshiaki Itano, Hiroshi Morimoto, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

Pharmaceutic equivalency evaluation (1) of the generic medicine using 21 C-12 gastrointestinal absorption prediction systems
Descent from a mountain Tetsuya 1, Yuko Watanabe 1, Chiaki Yamamoto 1, Masanori Kobayashi 2, Shiro Itagaki 2, Mitsuru Sugawara 3, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

Evaluation - of the product made in by international guarantee of quality - dissolution test of 21 C-13 generic drugs Japan and the carbamazepine lock made in the United States
Mari Fujimoto 1, 2, Kiyoshi Mihara 1, Jorgenson James A.3, Kuniko Otsuka 4, Tomi Kawata branch 1, Oil field Masaki 1, Junko Ishizaki 2, Kenichi Miyamoto 2, Makoto Otsuka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

	21 C-14 "attitude surveys about the generic drug of the patients and the health insurance pharmacy pharmacist" Yano reason Rika 1, Bamboo blind Takashi 1, Yasushi Morimoto intellect 1, Kudo sheath or 1, Daiya Sakurada 1, Net Katsuo Oka 2, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2008.

	The present conditions of the change to the generic medicine in 21 C-15 out of the hospital prescriptions Yuki Meishin, Risa Oda, Etsuko Endo, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

Medical economic discussion by the difference in preparing compound of 21 C-16 antibiotics
Yutaka Hasegawa 1, Ota friend Rie 1, Minako Hino 1, Hiroaki Kishida 1, Takahashi sub-Mana 1, Riyusuke Rokusha 1, It is still 1 Tatsu Sada, Kenichi Hasuike 1, Hiroko Urushihara 1, Yukiko Uchiyama 1, Keigo Ezaki 1, Takahiro Uchida 2, Miki Chihiro 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

	Can apply the effective improvement of drugstore duties in 21 C-17 this hospital and the management technique of consciousness reform - company in the drugstore; or - Yuki Mikami, Masako Yoshimura, Ito greens wave, 日置三紀, Ayumu Nozaki, Satoru Ueda, Hirokazu Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

	21 D-01 How we should deal with the rapidly disintegrating tablet? : From questionnaire survey of fast disintegrating tablet that target pharmacist 内田享弘1, 奥原有希子2, 徳山絵生1, 吉田都1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

	Remedy-related evaluation of a generic drug, the innovator drug using 21 D-02 taste sensors Tokuyama picture life, Haji River dance, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

	Quality evaluation - content uniformity of 21 D-03 clarithromycin dry syrup 12 preparations and remedy-related evaluation - Haji River dance 1, Miyako Yoshida 1, Tokuyama picture straight 1, Toshihiko Ishizaka 2, Junji Mukai 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2008.

	Remedy-related improvement effect with 21 D-04 Chinese medicine remedy jelly Miyako Yoshida 1, Tokuyama picture straight 1, Haji River dance 1, Takahiro Uchida 1, Fukui Atsuko 2, Takahiro Fujii 2, Kyuichi Sunada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

	About an advantage and problems in 21 D-05 simple suspension method induction and the measures Yuichiro Wada, Takako Nakajima, Nomura connection, Hiromi Sakai, Kana Kato, Shigeru Yamada tree, Yoichi Sakakibara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

	We administer it for a day in construction - pharmacy of the administration system of administration of 21 D-06 inpatients and set it and pay it and work 鈴木敬秀, Yuka Kato, Masashi Toyama, Shinji Sasaki, Seki Mihoko, 近藤覚也, 貞川俊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

Action for the safety management of 21 D-07 on admission bringing medicine
Sambommatsu Yasutaka 1, Aya Fujii 1, Takuya Maruyama 1, Keiko Saito 1, Satoru Yamane 1, Yuki Tezuka 1, Tanaya Mitsugu 1, Yu Tanaka season 2, Kensho Sada 1, 森田眞樹子 1, Toshihito Komiyama 2, Hitoshi Komori 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

	Improvement of the bringing medicine for 21 D-08 duties investigation for the purpose of the improvement of efficiency and the medical security Yoshiaki Hattori, Toshiro Sawada, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

	About screening of the preoperative cancellation medicine at the foreign consultation which considered the off-period of 21 D-09 surgery planned inpatients Hiroshi Hatano, Maki Nakabayashi, Shiho Enami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2008.

	The present conditions and problems of the bringing medicine management in 21 D-10 this hospital orthopedics inpatients Aya Ido Keiko 1, Fumio Yoshimoto 1, Hidehiko Suzuki 2, 笹哲彰 2, Kitasato spirit Ichiro 2, Hashimoto court official 2, Hiromi Kajiwara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

	Examination of the interaction of 21 D-11 Yokukansan and donepezil 一澤砂央里 1, Igarashi sincerity intellect 1, Kiyomi Ito 1, Junko Watanabe 2, Toshimi Morita 2, Kiyoshi Sugiyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

	Examination of the drug interaction with 21 D-12 compound oxycodone injection component hydrocotarnine Satoshi Sudo, Kobayashi hsiang tsai, Fumika Takasaki, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

	Examination of the effect degree of the combined medicine which gives it to digoxin clearance based on 21 D-13 population analysis Yuko Honma, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

3 cases in acknowledgment of peripheral neuropathy and thrombocytopenia that were remarkable by combination of 21 D-14 proteasome inhibitor bortezomib and itraconazole
Miki Ishibashi 1, Takuya Iwamoto 1, Okamoto Meiji University 1, 奥村悟司 1, Yuka Sugimoto 2, Atsushi Fujieda 2, Kazuhiro Nishii 2, Naoyuki Katayama 2, Shinko Okuda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

	Construction of the management information support system of 21 D-15 drug interaction Yoshiyuki Ono 1, Stave Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2008.

	The investigational present conditions in the Marunouchi Hospital attached to 21 D-16 Inst. for Adult Diseases Asahi Life Foundation 熊澤良祐 1, 2, Yukiko Onishi 2, Spring Kyoko Sawa 3, 豊田行康 1, Ichitomo Miwa 1, Masatoshi Kikuchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	Examination (1) about the clinical activity that a pharmacist is involved in in 21 D-17 trials Mariko Ono 1, Masakazu Yamaguchi 2, Tetsuo Shinba 2, Toshi Iwata 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	Examination (2) about the clinical activity that a pharmacist is involved in in 21 D-18 trials Masakazu Yamaguchi 1, Mariko Ono 2, Junko Kitsu 2, Tetsuo Shinba 1, Toshi Iwata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	Enforcement experience of 21 D-19 MILES Trial (physician-led country conjugation trial) and the problem 廣畑和弘 1, Morizu Hiroki 1, Depths water Yoshie 1, Yumi Inoue 1, Akito Kubo 1, Tabuse course 2, Zenji Okada 1, Yoshikazu Inoue 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	About the introduction of IT of 21 D-20 trial secretariat duties Morihiro Nomura 1, 2, Miyoko Takara 1, 2, Yutaka Kuwano line 2, Kenzo Moriyama 2, Kazuhiko Nakagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	Examination of the utility of the leukocyte migration test in 21 E-01 drug shock Katsuji Uno 1, Yagi Motohiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2008.

	Examination of 21 E-02 beta-lactam antibiotic hypersensitivity Manabu Abe 1, 齊藤幹央 2, Yagi Motohiro 3, Katsuji Uno 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

	Examination of hypersensitivity in 21 E-03 alleviation of fever analgesia antiphlogistic 齊藤幹央 1, Manabu Abe 2, Tomoyasu Furukawa 3, Yagi Motohiro 3, Koike reason Expo 4, Katsuji Uno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

	2 cases of chemical thrombocytopenia with 21 E-04 sodium valproate 篠永浩 1, Tsutomu Kachi 1, 南木伸基 2, Eiji Mukai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

	Relation of the pharmacist for 21 E-05 drug-induced hepatic injury Hashimoto positive 1, Makoto Matsuda left child 1, Tetsuro Koide 2, Swamp part Kimiko 1, Shigeru Omori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

	Use experience of the magnesium oxide to 21 E-06 patients on dialysis 秋山和映 1, 3, Chinatsu Kaneshige 1, Daiya Sakurada 3, Noboru Sato example 4, Yasufumi Irie 2, Shiro Ueda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

	Examination of the tolerability of clopidogrel in patients in 21 E-07 this hospital sulfate Naoya Ashikawa, Hideaki Yanagisawa, Yuko Tanaka, Hideyuki Ishiguro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2008.

Action to a risk of developing investigation and development evasion of the necrosis of the jaw bone with the oral BP agent in 21 E-08 ethical pharmacy
Yamamoto High School size 1, Takayuki Shimahara 2, Daisuke Matsubara 1, Masaru Kawabe inquiry 1, 高松諭志 1, Yutaka Oda 1, Paulownia forest Ichiro Azuma 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

	Examination about the skin reaction with 21 E-09 molecular target drug Gefitinib Naoko Takada 1, 2, Naho Yamamoto 2, Masami Kawahara 2, 春木一伸 3, Mieko Kishi 4, Katsuyo Fujii 1, Kenichi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

	The case that produced hearing loss by 21 E-10 furosemide IV infusion Reiko Osanami, Minako Taguchi, Yuko Notoya, Tomoko Baba, Owada existence, Takehisa Hama Yoshiko, 蛭田千昭, Akihiro Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

	To handle 21 G-01 Hazardous Drugs (critical drug) safely; comparison - of - international guidelines Setsuko Anan 1, 2, 3, 4, Yukako Yasui 1, Miyuki Sakurai 2, Emiko Kawano 4, Yuko Tokushima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

	- to send safety management to 21 G-02 high risk drug workshop - areas Keiko Kitajima 1, Tatsuya Sasaki 1, Kaifu Masayo 1, Noriko Fukuda 1, Ishikawa immensity 1, Akihiro Kai 1, Era right track 1, Prince Taniguchi chapter 1, Tomiko Sato 2, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

	Evaluation of preventive measures against dispensing errors judging from 21 G-03 compounding of medicines incident development situation Kazuhiko Teraoka, Toshi Nakamura oneself, Takafumi Umeda, Hisatsugi U.S. Toshihide, Kazuyoshi Kawazoe, Kazuo Mizuguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2008.

Trial - in effect (the second report) - hospital business training of preventive measures against dispensing errors which are main by 21 G-04 ID number checks
片倉道啓, Ayako Ito, Atsuko Kikuchi, Katsuya Omori, Akiko Sasaki, Job field Takashi, Country book Yusuke, Kazuya Takahashi, Masumi Kageyama, Naomi Sasaki, Toshie Yamazaki child, Noriko Araya, Michiko Fujimori, Keiichi Okahara, 舩山幹男, Hiroshi Nakata is elegant, Rev. Noda plus, Atsushi Miyamoto
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	Example analysis with the dispensing error report system which intended 21 G-05 factor analysis Kazuyuki Yoshida 1, Koji Hayashi 1, Doi reason Yuko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	21 G-06 About a method of the Distribution of medicine car SET of the oral medicine by pharmacists 榊原洋一, 中島貴子, 竹本雄一, 坂井裕美, 加藤香奈, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	Risk management after 21 G-07 electronic chart induction Toshiyuki Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	Because 21 G-08 pre-Abo id exhibits a utility of classification and evaluation - drug control instruction of the disadvantageous evasion example; ... Makoto Nakajima, Takuya Goto, Akira Takahashi, Yoshie Nomura, Yumi Suzuki, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	It is inventory survey in Takatsuki-shi, Osaka recognition to participation awareness and accident avoidance behavior to the medical treatment of 21 G-09 outpatients Sachiko Nakamura 1, 2, 漆原尚巳 3, Kikuko Miyazaki 1, Takeo Nakayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2008.

	Action of "the medical supplies safety management round" in 21 G-10 Kyushu welfare annuity hospitals Masayo Maeda 1, 2, Hidemi Ogura 1, Yoshikuni Kenji 1, Yoshiko Goto 2, Nobuyuki Yamashita 2, 3, Castle tail Kunitaka 2, 4, 峯本正夫 5, Takashi Akamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

	21 H-01 Development of the comprehensive community medical care training by studying together with medical students 荒木良介1, 中嶋弥穂子1, 中里未央1, 2, 前田隆浩1, 2, 大園恵幸1, 青柳潔1, 塚元和弘1, 畑山範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

It is the comparison with the medical student a change of the consciousness for the remote island medical care of the pharmacy student by 21 H-02 remote island medical care, welfare, health training
Miho Nakajima child 1, Ryosuke Araki 1, Mio Nakazato 1, 2, Takahiro Maeda 1, 2, Megumi Osono good luck 1, Kiyoshi Aoyagi 1, Mound former Kazuhiro 1, Hatayama example 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

	To fill School of Medicine in Chinese medicine attitude survey - Chinese medicine education for 21 H-03 active play pharmacists and the gap of the pharmacy school; - Kazuyoshi Kawazoe 1, 2, Kumiko Sakamoto 2, Fushidani Hideji 2, Kazuo Mizuguchi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

	Relation of the pharmacist for the pharmacy education in 21 H-04 nursing technical schools Koichi Hasegawa, Teruhiro Kusumi, Nobuyuki Mamiya, Kaoru Wakabayashi, Takeshi Minami husband Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

	Examination about the end-point in the patients reception problem in 21 H-05 pharmacy OSCE 窪田愛恵 1, Yoshitaka Yano 1, Tsuyoshi Morimoto 2, Kaori Takada 2, Susumu Seki 2, Yuko Maeda 3, Akinori Akaike 1, Atsushi Hiraide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2008.

	Trial of the risk management training based on the experience of 21 H-06 students East beauty 1, Hino appearance Harumi 1, Miki Akane 1, Kazuhiko Teraoka 2, Hisatsugi U.S. Toshihide 2, Kazuyoshi Kawazoe 2, Kazuo Mizuguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

Trial of the group training by the interhospital cooperation in 21 H-07 Kitami districts
Mere field Koji 1, Kaoru Chiba 1, Michiya Kobayashi 1, Flat wisteria Masahiko 1, Koji Saito 1, Takao Kurosawa 1, Shigeru Uno 2, Kazuhisa Fujiwara 2, Yukihiro Yoshida 2, Yoshiyuki Okauchi 2, Inside easy Kazuhiko 2, Shun Arai 2, Kazuyuki Takayama 2, Katsuhiko Kizaki 2, Masaki Ohba 2, Michio Kubo 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

- to investigate the cooperation with - businessman teacher for a lot of 21 H-08 University of Shizuoka pharmacy school business training acceptance
Midori Kimura 1, Hideki Hayashi 2, 加藤安宏 3, Nabeta Izumi 1, Satoru Minami 1, Tatsu Sakamoto Ichiro 1, Kunihiko Ito 2, Yoshiyuki Kagawa 3, 河原崎貴伯 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

	Examination of problems of the long-term business training that health insurance pharmacy cooperates with 21 H-09 University, and should be settled Chigusa Kikuchi, Toru Maeda, 木村和哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

Fix the eyes on a business training curriculum in the healthcare setting in 21 H-10 business training and a way of thinking -2.5 month called "the education division of labor" with the educational front; and -
Tadashi Mikami, 小西偉雄, Yoshiharu Nakamura, Takeo Nakata, Tsutomu Mizukami, 野田能成
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

	Relation of the pharmacist in 21 H-11 psychiatry team approach in medical care Naomi Okamoto 1, Chizuru Nakagawa 1, Paths of Yu Ogawa 2, Nobuaki Tomita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2008.

	One case of chronic stage schizophrenia that we boiled switching from 21 H-12 risperidone to aripiprazole, and re-diazepam dependence was relieved Michiko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

	A pharmacist is concerned with the medication support to a person of 21 H-13 law concerning medical observation going to hospital treatment and It is looked at Atsushi Kawashima, Takuya Ishida, Arai just levator, Shigehiro Taira, Kayoko Kikuchi, Emiko Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

	About association of 21 H-14 antipsychotics consumption and QT prolonged Yuko Inoue, Wide pillow Kayoko, Tsutomu Yamashita, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

	Compliance of 21 H-15 inpatient cares and sleep agonist 嘉屋道裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

Fact-finding of the second generation antipsychotics alone high dose therapy for refractory schizophrenia in the hospital attached to 21 H-16 Chiba University School of Medicine
Tsukiji jasmin child 1, Tomoki Tanabe 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, Koichi Kitada 1, Hiroyuki Watanabe 2, 伊豫雅臣 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

	Change of the prescription situation in the inpatient with 21 H-17 schizophrenia Junji Uno, Miho Nakata, Shinichi Tojo, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2008.

	A use situation investigation (from 2003 to 19) of the antipsychotics in 21 H-18 this hospital and change of prescription contents Reiko Saito, 新美詠彦, Yumiko Yada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

	Prescription fact-finding of the schizophrenia patient in 21 H-19 Sapporo suburbs 9 institutions Willow Tomoyuki 1, Takako Toi 2, Kazue Sugimura 3, Mitsuru Takahashi village 4, Hiroshi Nishibe 5, Chiaki Tanaka 6, Isurugi Ikuko 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

	About quantity of prescription and laxative of 21 H-20 antipsychotics Mitsuru Takahashi village, Kuzuba Rina, Tooru Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

	About 21 I-01 powdered milk and phthalate di-2-ethyl hexyl (DEHP) elution Harunobu Iwase 1, Your Nakamura existence 2, Kaya Hiroko Sono 3, 大磯茂 3, Nishizawa reason Norihiko 1, 5, Ken Sakurai 1, 4, Kazuo Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

It is the evaluation after three hours after the cerebral infarction onset the comparison between alteplase and plasmin derivative in stroke treatment for 21 I-02 hyperacuteness period
Yasuhiro Suzuki 1, Nobuo Nagai 2, Yamakawa flower Akemi 3, Harada Kosuke 1, 3, Desire Collen4, Junichi Kawakami 3, Kazuo Umemura 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

	Examination of the importance of the HbA1c level in 21 I-03 diabetic peripheral neuropathy onset 鈴木悠加, Takeru Kawai, Descent from a mountain Asako, Yu Tanaka season, Kayo Oikawa, Eiji Funaki, 小原郁司, Toshihito Komiyama, Hiroaki Watanabe, Takahiro Sakuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2008.

	Expression of intestinal aquaporin change with 21 I-04 saline laxative magnesium sulfate Fumika Takasaki, 宇敷隆, Toshihide Mochizuki, Yudai Toda, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

	Expression of aquaporin change by 21 I-05 Byakko-ka-ninjin-to Yutaka Ichikawa is flat, 鏡真依, Megumi Sugitani, Yudai Toda, Toshiyuki Kudo, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

	It is development and use experience of pharmacokinetic safety management system (PHACOSAM) the pharmacokinetic check in 21 I-06 drugstore windows Choichiro Miyazaki 1, Naoki Tomiyama 2, Kenji Matsuyama 3, Shun Higuchi 4, Yoshihiko Maehara 5, Shoji Sakamoto 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

	Patient compliance instruction using the figure of 21 I-07 schemas, medication history management Masaji Furusawa 1, It is still 2 Sawamura, Shigeko Yokota 1, 2, Tamura overlapping patch 1, 2, Masayoshi Kimura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

It is making and the utilization example of the medicine notebook seal in the Warfarin patient compliance instruction for improvement of patient compliance instruction in 21 I-08 health insurance pharmacy (the seventh report)
Yoshiaki Kimura, West Hatsue Hama, Kuniko Sugimoto, Mieko Itakura, 塗茂佳世, 廣部美佐子, Satomi Saga, Yoichi Kojima
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

	Role (the first report) of the pharmacist to pharmacotherapy of 21 I-09 dementia Hiroshi Tani child, Hiroko Saito, 上田飛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2008.

	To meet the medical needs by action - sex differences of the health insurance pharmacy in consideration for 21 I-10 sex differences medical care; - Junko Kasahara 1, Mari Satomi 1, Nobutaka Suzuki 1, Hayamizu Yoshio 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	Change of the pharmacokinetics of the basic drug quinidine in 21 I-11 experimental acute renal failure rat 出羽祐基, Junichi Kusaba, Ishikawa Nanase, 合葉哲也, Hiromi Kawasaki, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	Change of the Cyp3a expression level by 21 I-12 birth and aging Tomoyuki Yoshida, Yudai Toda, Toshiyuki Kudo, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	Elucidation of the pulmonary accumulation mechanism with 21 I-13 lutein chronic administrations Shibuya Tomomi 1, Sato evening period 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	Analysis of the interaction mechanism of 21 I-14 carvedilol and amiodarone Yoshiro Hirasaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	*UGT1A1 6 using 21 I-15 real-time PCR device, examination of 28 genetic polymorphism analytical method* Satoshi Yokoyama 1, Fukuoka kernel 2, Yasushi Usui 3, Yuka Shibata 4, Yasuji Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2008.

	Construction of the compounding of medicines system using the 20-P1-001 handheld unit Atsuko Oshio, Chika Matsumoto, Yoji Kyotani, Hitoko Yoshida, Kazuyuki Ikeda, Setsuko Kajii, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

Trial of the compounding of medicines model (we prepare it on every 1st) that intended the 20-P1-002 safety management
Channel Akiko, 志良堂 Arisa, 麻殖生知子, Chie Sato, Tomoko Yoshida, Tomoko Yanagawa, Chika Masumoto, Yumi Saito, Azusa Kishimoto, Junko Torii, Kyoko Wada, Hiroyuki Takahashi, 100 sea Yuji
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

It is effect ... by - electronic chart induction about the analysis of the 20-P1-003 compounding of medicines error (the second report)
右川浩 1, Kanichi Kawasaki 1, Needle ヶ valley Yoshihisa 2, Firewood Yuki 2, Hisashi Horikoshi graciousness 2, River 2, Sakae, Kishira, Yuka Adachi 2, Mieko Tanaka 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

	Efficacy of the powder wrapping paper color printing system using 20-P1-004 Xana-2720EU Mountain Yuji Sawa 1, Kikuchi Shiori 1, Mai Onishi 2, Mami Shimakawa 2, Yoshiharu Yamada 1, Woodcut Nobuko 1, Wakako Honma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

Trial of the packeted error prevention system in the 20-P1-005 abstract automatic division packaging machine
Inohira Kyoko 1, Natsuko Iida 1, Tetsuya Kudo 2, Toshiichi Seino 1, Hidetoshi Honda 1, Ryoji Yanagihara 1, Mt. town 1, Misato, Fumie Iijima 1, Katsuyoshi Nakajima 1, Hiroshi Ogasawara 3, Hiroshi Suzuki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

	Basic examination for a lock, the capsules identification systems construction with the 20-P1-006 CCD camera 廣實清司 1, Keizo Ishimoto 1, Akira Kamiya 1, 大田喜代巳 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2008.

	A utility of the 20-P1-007 image observation equipment and future problem (the first report) Reiko Imaizumi, Yuko Kobayashi, Yoko Suzuki, 新井成俊, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

	For, effectively utilizing it with 20-P1-008 doubt inquiry example collection of Kanda Kosuke, Eiji Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

	Comparison of the circular lock and oval lock from the situation of 20-P1-009 user and the compounder with cleavage Taku Ogiwara man 1, Every field Chieko 2, Kaori Morimoto 1, 叶隆 1, Etsuko Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

	Comparison of the pharmaceutical intervention in 20-P1-010 compounding of medicines duties and drug control instruction duties New Keiko Sako, Hiroko Wakasugi, Ikuyo Kawasaki, Yukiyo Yasuda, Rie Hiratsuka, Naomi Adachi, Ikuko Yano, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

Effect of the particle size distribution to give it to a mixed degree of the 20-P1-011 dry syrup preparation
Yoshihisa Yamamoto 1, Suzuki Toyoshi 2, Mika Matsumoto 3, Shuichi Hayano 4, Kazuo Osaki 4, 深水啓朗 2, Shinji Hidaka 5, Mamoru Kamano 1, 大谷道輝 3, Kazuo Tomono 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

	Utilization ... of "the support book" as action ... common knowledge method for the 20-P1-012 simple suspension method trial Ishiwatari beach 1, Kayo Tsuchiya 2, Hiromi Suzuki 2, Hirofumi Koike 2, 西川能治 2, Ryoichi Ariyama 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2008.

	Examination of a utility and problems by the 20-P1-013 simple suspension method induction Yasushi Suzuki University, Yuko Osuka, Yoko Kobayashi, Sayaka Terui, Seki Rie, Takao Oki, Masami Nishiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

	Induction of the simple suspension method in 20-P1-014 neurosurgery, the oral surgery ward 宍戸紀与, Kaori Doi, Yusuke Sekine, One Fujitsuka, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

	Questionnaire count results ... to attitude survey - whole country virtue bank meeting hospital 23 institution and this hospital nurse, pharmacist about an advantage and problems of the 20-P1-015 "simple suspension method" induction Koto Fujiwara, 敦見真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

Attention - to the materials of the appliance to use for the suspension of other drugs case - drug dissolving polystyrene decomposition in 20-P1-016 Epadel S and an analysis and polystyrene
Yutaka Asakura 1, Three department Masumi 1, Is Kurata; see it; 3, Takashi Ito 4, Michiko Amemiya 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

	Construction of all protocol check systems including 20-P1-017 pre-medication and an oral medicine anticancer drug Masakazu Ozaki, Keizo Ishimoto, 廣實清司, Yasuaki Otsubo, Akira Kamiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

	Role of the pharmacist in the 20-P1-018 anticancer drug proper use Motoi Kurahashi still, Ai Hagiwara, Ayumu Takahashi, Mariko Inoue, Yukiko Tsukamoto, 小川賀偉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2008.

	Examination about the administration of antiHIV medicine method for the patients having difficulty with 20-P1-019 internal use Aya Yoshida 1, Naoko Miyazaki 1, 2, Yosuke Kurokawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	Practice of the injection compounding of medicines for the 20-P1-020 NICU Tomomi Ando, Kenji Nishimura, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	20-P1-021 injectables preparations intended for the NICU : Analysis of prescription inspection-doubt inquiry 西村健二, 安東朋美, 森谷康志, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	Evaluation of sterile preparation duties to see for 20-P1-022 transfusion prescription Wada Noda style 1, Masahiro Otsuka 1, Toshiaki Miura 2, Yutaka Murata 2, Naoko Takeuchi 2, Mitsuru Nozawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	Action for the 20-P1-023 TPN prescribed drug inspection system construction Suyama Akina, Toshiya Takeno, Kurumazuka Chiho, Takashi Yasushi Inoue, Yoshiyuki Goto, Kimito Sato, Hiroshi Tamura, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	A dosing rate of the 20-P1-024 lipid microsphere is examination about liver function and the effect to give to lymphocyte counts Shoji Sakakibara 1, Takashi Niwa 1, Akio Suzuki 1, Katsuhiko Matsuura 1, Yoshinori Ito 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2008.

	20-P1-025 Construction of injection drug dispensing audit system : Drip speed and concentration checks and residual liquid amount calculation 片山文子1, 石渡勝美1, 小林功1, 杉本誠1, 川口文誉1, 山本豊1, 小川智之2, 近藤直也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	Action for the disposal decrease after the 20-P1-026 injection mixed preparation Naoki Shibata, Yoshiharu Mitsunaga, Yukiko Omura, The Furuya Sea beauty, Hiroko Arai, Suguru Kasahara Castle, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	Compatibility investigation of 20-P1-027 injection scattering prevention closed ring system (PhaSeal(R) system) and the anticancer drug vial 中山季昭, Kazuyoshi Hosoya, Fumio Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	Effect - of pH to give content decrease mechanism - content decrease of the diazepam injection at use of 20-P1-028 PVC-TOTM tube Norihiro Watanabe, Yuka Tsukada, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	20-P1-029 Busulfex (R) injection of prefilled reduction and usage 瀬尾誠1, 片山志郎1, 浜田真向2, 土橋保夫2, 土橋朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	Effect on injection by the strength of the 20-P1-030 light (illuminance) Let go through; 幸市朗, Hajime Matsubara, Kazuo Yago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2008.

	Revision - of examination - check seat about the incompatibility of the 20-P1-031 ointment Sakai Naoko 1, Kyoko Kojima 1, Kazue Soda 1, Mai Tanaka 1, Koichiro Iwata 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

	The enforcement situation of the laboratory study for 20-P1-032 information on adverse drug reactions management and side effect monitoring Hiroko Fujisaki, Takashi Oikawa, Osamu Kimura, Iwao life, Yasushi Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

	About a construction of 20-P1-033 safety information retrieval site "relief prescription infobox" Shiro Yamaguchi 1, Toshihiro Hama 2, Mayumi Mochizuki 3, Toshiki Hirai 4, Katsuhisa Goto 1, Aya Furukawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

	Analysis about the safe information to bring the behavior modification of the specialist in 20-P1-034 prescription Aya Furukawa 1, Aya Fukuda 1, Katsuhisa Goto 1, Toshihiro Hama 2, Mayumi Mochizuki 3, Toshiki Hirai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

It is ... through participation in application and medical resources proper use - graduate school ward training of the simple suspension method at use of 20-P1-035 anticancer drug
Kazuko Sugihara 1, 大澄朋香 1, 貝崎明日香 1, Is Kurata; see it; 1, Sugiyama endowment 2, Ishikawa mere beauty 2, Kazuko Kato 2, Jun Murayama Ichiro 3, Miwako Kamei 1, 戸部敞 1, Takemi Yoshida 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

	A study on proper use of the 20-P1-036 non-prescription drug (the first report) about an azelastine hydrochloride preparation: Fumiko Kawaguchi, Toyokichi Eri incense, Hitomi Mizuno, Chika Okajima, Taeyuki Oshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2008.

	Proper use of the drug requiring testing using 20-P1-037 medical business data Jun Wada 1, Tetsuya Tsuji 3, Hideki Inouchi 2, Chieko Ozuku 1, Isao Matsumoto three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	20-P1-038 About use of iron medicine, the human erythropoietin preparation in the pre-operative autologous blood donation 中村真一, 高越梨沙, 高尾豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	Comparison between vancomycin elution behavior and about the vancomycin preparation each cement intensity - brand of the 20-P1-039 vancomycin component bone cement Kuniko Terada 1, Kayoko Iwamoto 1, Mutsumi Kobayashi 1, Masashi Tsujino 1, Fumio Teraoka 2, 前田頼伸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	Stable examination in the simple suspension method of the drug which is unstable for 20-P1-040 light Yuji Fujii 1, Hideki Mori 2, Zamami Yoshito 1, 古林呂之 3, Dongfeng 3, Tetsu Ando sincerity 4, Is Kurata; see it; 5, Sendo Toshiaki 6, Hiromi Kawasaki 1, Izushi Fumio 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	20-P1-041 whole country public welfare consecutive hospital "questionary survey count results about the simple suspension method" and analysis Teruaki Okura 1, Toshio Kosuge 1, Takeshi Moriya 1, Nishizono Kenro 2, 賀勢泰子 2, Tetsu Ando sincerity 2, Is Kurata; see it; 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	Intervention to use of inappropriate drug which assumed Beers Criteria for 20-P1-042 Japan grounds Tomoyasu Watanabe, Megumi Yamazaki, Koichi Takatori, Tetsu Ando sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2008.

	Action for the use situation and the proper use of the on admission bringing medicine in the 20-P1-043 renal function degeneracy patients Junko Morioka, 田中亮裕, Shishino Yuki, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	Characteristics of the physical pharmacy of the 20-P1-044 cartridge type insulin preparation Mami Takigawa 1, Higher Kobayashi male 1, Teruhiro Nakamura 1, Taku Miyakawa 1, Yuri Takahashi 1, Tadashi Yamakawa 2, Masanori Iwata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	Relation between the patients, a pharmacist, nurses in the 20-P1-045 insulin proper use Yuko Shimakura, Yasuko Bell, Hirotsugu Kita, Yukiko Kita, Haruhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	The use of the 20-P1-046 antimicrobial agent of fitness and contribution of the pharmacist for the TDM Kayoko Maezawa 1, Asako Terashima 1, Yukiko Kato 1, Yuko Miyano 1, Moat Seiji 2, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	Examination of the drug targeted for the study in the 20-P1-047 antimicrobial susceptibility test Maki Hanada 1, Description of Nishimura existence 1, 河野博充 1, 風間義顕 2, Yoshiko Kato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	20-P1-048 Examination for the use situation and the proper use of the linezolid 水野理恵子1, 相山めぐみ1, 磯部聖子1, 浅原慶徳1, 大塚昇1, 中坊幸晴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2008.

	20-P1-049 Retrospective study of linezolid use cases in the Ehime Prefectural Central Hospital : Evaluation based on the proper use criteria 稲見有1, 橘貴寛2, 出口順子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

	Change of the antibiotic consumption before and after the use registration system induction of injection antibiotics in the 20-P1-050 this hospital Yoshiko Yamaguchi 1, Takashi Goto 1, Emi Hirakawa 1, Yoshida Nobumasa 1, Ken Yamaji 1, Yoshitaka Shiraki 1, Masashi Hashimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

The change of the antimicrobial agent prescription trend by the participation of the pharmacist in 20-P1-051 Gram stain and evaluation of the patients awareness
Masako Maeda 1, Toshihiko Maeda 1, Kana Matsumoto 2, Megumi Kobayashi 2, Reina Kamioka 2, Ayako 2 out of the reed, Kunihiko Morita 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

About a medication of the opioid analgesic for patients with refractory non-cancer pain that we examined from 20-P1-052 pharmacist
Kumiko Okitsu 1, 岩瀬利康 1, Yoshio Ito 1, Masahiro Ishikawa 1, Keiko Shinozaki 1, Jobu truth Sae 1, Book shallows Yoko 1, Junko Miyakawa 1, Minoru Mori Tomoko 1, Chiaki Koshikawa 1, Shigeki Yamaguchi 2, Toshimitsu Kitajima 2, Shizue Sayama 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

	Research about the utility of the adrenocorticosteroid used together by epidural injections for 20-P1-053 sciatica and the lumbago Nao Yasunaga, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

	Study on color change of the 20-P1-054 oxytetracycline ointment Ryo Kosaka 1, Ryo Murata 2, Mitsuru Kobayashi 1, Keiko Mori 1, Kenro Sasaki 3, Fumihiko Yoshizaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2008.

	Estrangement in "how to catch of 20-P1-055 general public group and the pharmacist group risk to fetuses by the medication at pregnancy" Hiroki Masuda 1, Seiichi Maruyama 2, Satoshi Toyama 2, Hiroshi Sato 2, Akira Kikuchi 3, Koichi Takakuwa 3, Kenichi Tanaka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

It is support to an investigation and the proper use after production sale of first kind medical supplies, azelastine hydrochloride in the 20-P1-056 compounding of medicines juxtaposition type drugstore
Takayanagi Yoshiji fruit, Mikio Sakakibara, Masaki Sato, Satoshi Okada, Keiji Arai, Jun Kuribayashi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

Trial of the in-hospital catalogue of medicine system making aiming at the proper use support of 20-P1-057 high risk medical supplies
Motoki Urata 1, Miyuki Ota 1, Manno good luck 1, Rie Matsubara 1, Maiko Matsumoto 1, Toshiko Matsumoto 1, Is Iguma; see it; 1, Toshiko Takayasu 1, Miyuki Yoshimura 1, Yuko Inoue 1, Yoshiko Kitamura 1, 初田泰敏 2, Masashi Ogawa 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

	Examination of the flushing condition to evade incompatibility of 20-P1-058 hyperalimentation and the injection Yoshiyuki Kobayashi, Soichiro Kimura, Hideo Ueda, Yukihiko Numajiri, Yasunori Morimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

New rating system of the acute corneal problem for the purpose of the formulation study support of the 20-P1-059 medicine for ophthalmology
Kenichiro Shimoda 1, Teshima infinity 1, Agematsu sacred book 2, Mao Kusano 2, Takashi Kitaoka 2, Takashi Kitahara 1, wisteria Hideto 1, Hitoshi Sasaki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

	Invention to conduct a Warfarin lesson in Nishimoto Hospital adding 20-P1-060 old age assistance institution Naoki Hasegawa 1, White pine Takako 1, Takashi Nagata 2, Keiko Yamamura 2, Kazuo Nishimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2008.

	Action about the proper use of the 20-P1-061 albumin preparation Katsuhiko Kitahara, Ogre Toshihide Kubo, Akira Shinohara ability, 白澤吉哲, 荻無里千史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

	Adsorptive examination of the powder wrapping paper in the room temperature storage of the 20-P1-062 disulfiram Satoko Okamura 1, Yasuhiro Nakahara 2, Susumu Tauchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

A clinical response and safety of the immunosuppressive drug tacrolimus in the 20-P1-063 hematopoietic stem cell transplantation
Ryoko Udagawa 1, Small Ido Keiichi 1, 橋本浩伸 1, Koji Murakoshi 1, 牧野好倫 1, Nobuaki Yokote 1, Hirohisa Kato 2, Kanari former 3, Shinichiro Mori 3, Takahiro Fukuda 3, Field Ryuji Nozaki 3, Yoichi Takaue 3, Hiroshi Yamamoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

	Mainly on examination - cardiovascular surgery about the preoperative optimal cancellation time in the 20-P1-064 low-dose aspirin preparation remedy patients - Mikiko Goto 1, Hideki Kobayashi 2, Yusuke Matsumoto 1, Etsuko Shinohara 2, Toru Asayama 2, Kenji Matsuyama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

	Comparison between synthetic Xa coagulation factor inhibitor and danaparoid sodium in the deep vein thrombosis prevention after the 20-P1-065 lower limbs surgery Yukie Nagata 1, Takashi Osawa 2, Yosuke Shiraishi 2, Kenichi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

Decrease in insulin dose in patients with 20-P1-066 end stage renal failure and ... inappropriate in diabetes management HbA1c for an index of the glycemic controls
Masayuki Tanaka, 打谷和記, Nishiyama rich person, Mayumi Inoue, Yukiko Inui, Furunaga Ikumi, Hisayo Kadoi, Yumiko Tsurumi, Yasuhiko Hirota
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2008.

	Evaluation of the incompatibility with a flurbiprofen axetil note and the various transfusion preparation using the 20-P1-067 light masking type automatic particulate measurement device 名徳倫明, Kenji Ikeda, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

	Effect of the storage temperature to be it-releasing, and to give it to of the 20-P1-068 tulobuterol percutaneous absorption type preparation Hiroyuki Yamazaki, Takafumi Nagata, Fumika Ryu, Ikuko Ogata, Quantity of Seo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

	Request to the actual situation and a packing of the abstract opening a letter in 20-P1-069 elderly people Kiyomi Sadamoto 1, Mizuho Takahashi 1, Hikota Emi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

The medical supplies proper use to an outpatient based on 20-P1-070 doubt inquiry record and medical safety measures
1, Kyoshi, Shimizu, Noriko Kuramochi 1, Mariko Kawano 1, 岩冨由江 1, Tomoko Fukuda 1, Kyoko Inoue 1, Koichi Nakamura 1, Kazuyuki Hara 2, Kenichi Tomomatsu 2, Kazuo Nosaka 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

	In-hospital dose criteria setting in 20-P1-071 acyclovir, the rose acyclovir and the action Saeko Matsuno, Masato Yamakawa, Ayako Ito, Hitomi Iwase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

	Relation to the resident education by the pharmacist in the 20-P1-072 Anjo rebirth hospital Masayo Yamashita 1, 三浦崇則 2, Akio Katsumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2008.

	Study on continuation, cancellation of the warfarin in the 20-P1-073 perioperative period and resumption Hideaki Tamaoki, 新美全剛, Megumi Mizuhara, Atsuko Oda, Masaaki Yamato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	Meta analysis for the patients factor about individual difference of 20-P1-074 statin high sensitivity CRP decrease effects Paulownia Mio Hayashi 1, 2, Masahiko Ichikawa 1, Yasunori Sakamoto 1, Hirotoshi Echizen 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	The actual situation of the use of drug in the 20-P1-075 care health center for the elderly Koji Okada 1, Satoshi Taniguchi 1, Jin Misawa 3, Itsuko Shiga 2, Saburo Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	The effect that 20-P1-076 orally disintegrating tablet (OD lock) gives for compliance and effect of treatment Dr. Shimazaki 1, Toru Hirashima 1, Kazuhiko Noro 1, Shoji Izumo 1, Measure Shigenori 1, Ryu Kawai beauty 1, Takahiro Shibata 3, Tokuyuki Namiki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	Incompatibility of 20-P1-077 oxytetracycline hydrochloride hydrocortisone composition ointment and the nadifloxacin ointment 川本庸太 1, 田山剛崇 2, Sawa Akihiro 2, Threshold Takami 1, Hiromi Nishikawa 1, Katsushi Miyake 2, Nobuyuki Morita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	The remedy situation and attitude survey of the 20-P1-078 alendronic acid sodium preparation Yosuke Ito, Hiroko Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2008.

	Proper use of the allopurinol for the tumor lysis syndrome in the 20-P1-079 hematopoietic tumor Shinichi Kitamoto, Yuko Yanagida, Kimiyoshi Kumano, Yasuo Ogasawara, 八島加八, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

	Relation of the pharmacy to Pharmaceutical Affairs Council in the 20-P1-080 Toho University medical center Sakura Hospital Masaka Wataru, Member of Satoshi Doi, Prince Kaga, Ishii Toshihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

	Evaluation of the pharmacist ward permanent residence from 20-P1-081 doubt inquiry contents Ayano Tanzawa, 寺松剛, Fumihiko Kitta, Naomi Daita, Mika Hinohara, Tomoki Matsumura, Wakako Suzuki, Masahiko Suzuki, 花輪剛久, Toshio Oguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

	Effect of ethanol which gives it to S-warfarin 7 - hydroxylated metabolism by 20-P1-082 human CYP2C9 and diclofenac 4' - hydroxylated metabolism 辰見明俊 1, 2, Ikegami friend group 3, Ryoko Morii 3, Masatoshi Sugiyama 1, Hilum Muneo Hayashi 2, Seigo Iwakawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

	Investigation about the effect diminishment of the warfarin by the 20-P1-083 risperidone combination 板井進悟, It is moisture in the west, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

Increase case of PT-INR by a 20-P1-084 fluorouracil system anticancer drug and the warfarin combination
Yamamuro butterbur child, Izumi Tanaka, Kita Hiroki Oka, Wealth garden Haruna, 清水奈味, Masanori Mori, Katsuhisa Zaitsu, Sakae Sueyoshi will, Kondo New Year's Day, Shunei Maeda
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2008.

	Pharmacokinetics, kinetic model analysis about the persistent interaction between 20-P1-085 warfarin and the amiodarone Shingo Tanaka 1, Juichi Otani 1, Masaru Nakajima 2, Hiroki Sato 1, Akiko Miki 1, Moat foster child 1, Yasufumi Sawada 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

	Drug interaction study of pranlukast and the clarithromycin in 20-P1-086 health adults 中出進 1, Akinori Yamauchi 1, Tsuneo Kodama 2, Mikio Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

	It is the meta analysis of dihydropyridine drugs and properties of matter correlation 20-P1-087 grapefruit juice interaction analysis 竹内崇浩 1, 植沢芳広 1, Koichi Takeuchi 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

	20-P1-088 A study on the interaction of the Siberian ginseng extract and drug 高橋恒久1, 佐藤隆司1, 渡辺一弘2, 佐藤重一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

	About interaction with a constitution crude drug of the 20-P1-089 Chinese medicine and the Western medicine Muro Machiko, Chiaki Ogata, Shun Kanari Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

An example of patients with allogeneic hematopoietic stem cell transplantation that interaction of the josamycin was regarded as the tacrolimus in 20-P1-090 children
中村真依 1, Tatsuya Mori 1, Takao Sawai 1, Kazumi Atsuta 1, Junko Yamanaka 2, 大熊喜彰 2, Matsushita bamboo next 2, Jiro Mikami 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2008.

	A mechanism and application of the cytotoxic augmentation by a 20-P1-091 azole system antifungal agent and the zinc combination Yoshiro Okano 1, Shiro Ishida 1, Shinichi Yokota 1, 木奈崎昭男 1, Yasuo Koyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

One case of adult T cell leukemia guessed that diarrheal disease of the hydrochloric acid irinotecan induction became severe by combination of 20-P1-092 itraconazole
政賢悟 1, Ibara country charges 2, Wada greens cord child 3, Nosaka straight volost 3, Hiroaki Mitsuya 3, Junko Fujii 1, Yoshiteru Honda 1, Hideyuki Saito 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

	The change of blood valproic acid levels by the 20-P1-093 panipenem / betamipron combination Masaru Kurata life, 久木留涼子, Yoko Hara, Kazumi Hasegawa, Hiroshi Araki, Shigenobu Maruno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

	Investigation about the off-period when we change it from 20-P1-094 antidepressants to MAO-I 吉野達規, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

	The 20-P1-095 banana reduces titre of acetaminophen 植沢芳広 1, Naotaka Tsuji 1, 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

	Effect on hypoglycaemia effect of insulin by the 20-P1-096 antihypertensive drug celiprolol Yamase University male, Hiromi Kondo, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2008.

	About study on 20-P1-097 quinolone antibacterial and OTC Chinese medicine stomach and intestines drug interactions - inhibition of resorption remedy - Yasumasa Tsuda 1, Ryosuke Nakazawa 1, Takayuki Hanasaki 1, 赤瀬朋秀 2, Hisahiro Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	Incompatibility (the first report) of the 20-P1-098 OTC ophthalmic solution Hisao Matsumura, Yuka Ogawa, 水島紫芳, Lower garden Takuo, Masanori Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	It is one discussion ... about the saccadic sthenia of - SSRI communalization of the patients with 20-P1-099 mental disorder understanding and "the role" of the pharmacist (the 36th report) Satoru Ishida 1, Saso Akio 2, 3, Goro, Miura, Ayano Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	It is one discussion ... about sexual dysfunction by - SSRI communalization of the patients with 20-P1-100 mental disorder understanding and "the role" of the pharmacist (the 37th report) Saso Akio 1, Satoru Ishida 2, 3, Goro, Miura, Ayano Sasaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	20-P1-101 [Role] of sharing and pharmacist of mental illness patient understanding (Part 38) SSRI problems and herbicide injury Ombudsperson efforts 三浦五郎1, 石田悟2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	Syndrome of inapp ADH secretion (SIADH) case with the paroxetine that 20-P1-102 postoperative transfusion management, hospitalization food triggered it Tetsuro Koide 1, Keiko Watanabe 1, Toru Wakabayashi 2, Matsuda law of nature 2, Horiike Ichiro Sana 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2008.

	The symptom of depression that occurred at the interferon reuse to the patients who had 20-P1-103 anxiety symptoms as underlying disease Seiji Sato, 畠山盛良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

An example of the acute lymphocytic leukemia that presented with acute renal failure by 20-P1-104 methotrexate (R) high dose therapy, and required haemodialysis, blood adsorption
Kenji Miyazawa 1, Ryo Takagi 1, Akira Hagiwara person 2, Yokozawa Toshiya 2, Hirokazu Nagai 2, Kazue Sakano 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

	Examination for the potential operated calcium channel electric current in 20-P1-105 paclitaxel-induced peripheral neuropathy Yoshiko Okamoto 1, Nobuyuki Katagiri 2, Yoshiko Shibata 2, Run Zakoji; 2, Hideaki Ikeshima 2, Iku Utsunomiya 2, Keiko Hoshi 2, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

	We look at the rear of the side effect expression in the 20-P1-106 thalidomide therapy and analyze a mark 陶山登之, Ayako Nishimoto, Hiroki Tamaki, Nobuhiro Nishimura, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

	Stomatitis development situation survey after the 20-P1-107 TS-1 remedy 浜元孝 1, 山之内恒昭 2, Tomomi Fujita 2, Yasuhiko Mimura 2, Isao Adachi 2, Takashi Shimizu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

	20-P1-108 One case that expressed thrombocytopenia by Sorafenib 岡崎美代子1, 岩村正嗣2, 新井万理子1, 松原肇1, 馬場志郎2, 矢後和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2008.

	One case that overcame dose-dependent fever with 20-P1-109 imatinib Kentaro Ogata 1, 2, 内山将伸 2, Kenji Ishizuka 3, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

Investigation about the myelosuppression at the S-1/CDDP combination therapy for patients with 20-P1-110 progressive stomach cancer
Katsuya Tanizawa 1, Yoshiko Kiriyama 1, Keiko Taguchi 1, Tomoyuki Hirashita 1, Takehiko Kashiwa 1, Cedar wisteria good tree 1, Teramachi eyes 2, Teruo Tsuchiya 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

	1 case that showed hypercalcemia and cardiac function failed during treatment of 20-P1-111 acute promyelocytic leukemia (APL) Kano sheath or 1, Masako Oshige 1, 有木宏宗 1, Mieko Yokoyama 1, Yasuyuki Inoue 2, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

About association with fact-finding of the dysosmia in the hospital outpatient department chemotherapy room attached to 20-P1-112 Kanazawa University and the taste disturbance
春木一伸 1, 2, Kan Yukio 2, 5, Mieko Kishi 2, 3, Naoko Takada 2, 4, Masami Kawahara 2, Tadaaki Yamashita 1, Kenichi Miyamoto 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

	20-P1-113 Study of the anti-TNF drugs discontinuations in rheumatoid arthritis patients : And experienced 194 cases of infliximab and 157 cases of etanercept 寺西智子1, 岸本新作1, 福井利文1, 塩澤和子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

	Safe examination in the 20-P1-114 temozolomide radiation combination therapy Tomomi Kataoka 1, Sanae Miyano 1, Satoshi Motokawa 1, Michihiro Shino 1, Satoshi Horiguchi person 2, Koichi Mitsuya 2, Nakasu Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2008.

	Search of the pharmaceutical intervention point in 20-P1-115 temozolomide maintenance, recurrent protocol Sanae Miyano 1, Tomomi Kataoka 1, Satoshi Motokawa 1, Michihiro Shino 1, Satoshi Horiguchi person 2, Koichi Mitsuya 2, Nakasu Yoko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	20-P1-116 Investigation about thrombocytopenia by the linezolid 平下智之, 桐山佳子, 谷沢克弥, 新谷俊一, 柏毅彦, 杉藤善樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	20-P1-117 Factor analysis of thrombocytopenia expression by linezolid: Impact of renal function and administration dates 石原慎之, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	20-P1-118 Clinical examination of the background factor of the case that caused thrombocytopenia by the linezolid 松元加奈1, 石田茂伸2, 中井由佳2, 南野優子1, 中西由佳1, 森田邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	Safe investigation of the 20-P1-119 fondaparinux sodium Shuji Yamazaki, Samsung intellect, Kazuhiko Nagai, Rice month Yukinori, Hitoshi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	Fact-finding of the side effect of the 20-P1-120 fondaparinux sodium subcutaneous injection Mari Sakata 1, Kengo Matsumoto 1, Teruhiko Hoshino 1, Kazunori Shiozu 1, 2, Kyoshi, Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2008.

	Examination of gastrointestinal disturbance and the quality of life in the 20-P1-121 low-dose aspirin remedy patients Keiko Yajima 1, 保戸塚麻里 1, Kanako Takahashi 1, 冨ヶ Yuki Hara 1, Takao Akashi 2, Takashi Kawai 3, Akira Yamashina 4, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	Examination about the bone density decrease of the 20-P1-122 warfarin remedy patients 保戸塚麻里 1, Keiko Yajima 1, Takao Akashi 2, Kunihiro Sakoda 3, Akira Yamashina 3, Junko Kitsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	20-P1-123 An example of patients with severe renal failure that resulted in agranulocytosis by gatifloxacin administration 根来早紀子1, 古久保拓1, 松永千春1, 和泉智1, 前野芳史2, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	It is ... through an example of uniform management (collection of, analysis, reporting) - cholinergic crisis of the 20-P1-124 information on adverse drug reactions Motoko Funato, Akemasa Junko, Keiko Nitta, South Reiko, Oshino Valley fruit, Masaaki Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	20-P1-125 Pharmacoepidemiology (50) Examination for the purpose of cholinergic crisis avoidance by Ubretid tablet taking 大中博晶, 矢野良一, 塚本仁, 渡辺享平, 岩尾岳洋, 長谷川充, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	Side effect evaluation of pharmacist duties (72) clopidogrel as the 20-P1-126 medical care person Hisashi Yamashita Yoshie, Toshiaki Nakamura, Jin Tsukamoto, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2008.

	Impaired glucose tolerance and disorder of lipid metabolism in the 20-P1-127 cyclosporine administration rat Akira Sakata, Akira Suzuki person, Masami Hirai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	The present conditions of pulmonary artery-related pulmonary hypertension treatment and side effect of 20-P1-128 bosentan Junko Morihara 1, Eriko Kondo 1, Hanafusa Yukiyo 1, Yoko Ninomiya 1, Toshi Shibabe 1, Takahiro Kawamoto 2, Kiyoshi Yoshida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	Investigation about a side effect and the child born of the 20-P1-129 early or threatened labour therapeutic drug Kazuko Uematsu 1, 4, Masanobu Odaka 1, Mitsuhiro Sugimoto 2, Tadashi Kawakami 3, Junko Kitsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	About prednisolone doses in the 20-P1-130 idiopathic interstitial pneumonia and the correlation of the side effect Otsu good luck, The Tabuse course, Hidemi Isago, Misato Tsuji, 岡所扶美, Yoko Ogawa, Mika Miyazaki, Hitomi Kuroiwa, 宮部貴識 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	One case that caused hypoxemia after 20-P1-131 erlotinib 150 mg remedy Inside many protons 1, Tomonori Hirashima 2, Gilt bronze Yoko 1, Keiko Matsui 1, Court Security Office Mika 1, Teruhisa Ishikawa 1, Noriko Abe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	About the association between halfway awakening and fall accident after the 20-P1-132 sleeping drug remedy from inspection of - fall accident report - Toshihiko Takeno 1, Ai Sakuma 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2008.

	Background (respiratory disease) of 20-P1-133 mycotic stomatitis treatment Makoto Tanaka, Teruyuki Otsubo, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

	An example of the nephrotic syndrome with suspected rhabdomyolysis with 20-P1-134 cyclosporine Nishiyama rich person, Masayuki Tanaka, 打谷和記, Yukiko Inui, The Inoue pure white beauty, Furunaga Ikumi, Hisayo Kadoi, Yumiko Tsurumi, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

	One discussion about the side effect of 20-P1-135 miglitol Keiko Hirai, Misa Uehara, Yasuyuki Matsumura, Hajime Kagaya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

	Examination of the risk factor to be involved in the side effect expression of 20-P1-136 antituberculosis drug Yoshiaki Yamamoto 1, 2, Nobuyuki Mishima 1, Kenji Ogawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

	Side effect investigation after the use of 20-P1-137 influenza therapeutic drug Relation bowl Hideo, Yoshiyuki Miyasaka, Maho Miyake, Spring Mayuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

	About the infection situation of hepatitis C after the cardiovascular surgery surgery that combined transfusion with 20-P1-138 "fibrin glue" Masayoshi Takada, Eriko Yajima, Noriko Yamada, Makiko Kubota, The Yasuda early sum Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2008.

Relative investigation with the central nerve side effect onset and the immunosuppressive drug in the 20-P1-139 lung transplantation patients
Hiroki Fujiwara 1, Hidenori Sagara 2, Tomoaki Sato 3, It is still 3 Matsunaga, Sendo Toshiaki 3, 五味田裕 4, Fusako Takayama 5, Hiromi Kawasaki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	Action to information on adverse drug reactions collection of in the 20-P1-140 Fukuoka University Hospital Tomoko Yuda, Chika Yamamoto, 内山将伸, Kentaro Ogata, Yoshihiro Kawahara, Koji Washiyama, Kojiro Nikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	Examination about the TPN-related liver damage in the 20-P1-141 Toho University medical center Sakura Hospital Satoshi Sato 1, Member of Satoshi Doi 1, Ishii Toshihiro 1, Masaka Wataru 1, Yasuo Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	Study on 20-P1-142 chemical nephritis interstitial, patients background of the chemical urine cell damage and symptom Junichi Takeda, Fumiko Otsu, Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	Comparison evaluations such as the side effect incidence in 20-P1-143 Japan and the United States Miwa Yotsumoto, Chiaki Okamoto, Hiroshi Hori tree, Truth Naoyuki Eda, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	Bioequivalence of the itraconazole preparation which is available for 20-P1-144 suspension administration Takao Oshima, Ryoichi Sonoda, Morino Okuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2008.

	About a use of 20-P1-145 generic drug investigation and a future problem Koji Muto 1, Wataru Takizawa beauty 1, Yukiko Oshiki 1, Etsuko Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	Comparison - in approximately recognition investigation - fee-for-service revision for the generic drug of the 20-P1-146 outpatient Yamamoto lawn arrow incense 1, Naomi Takeda 1, 戒田文子 1, Yoshihiro Takaishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	Recognition comparison between non-medical person and pharmacist for the use of the 20-P1-147 generic drug The Inoue third son, Izumi Machida, Tomoyo Sato, Akio Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	Quality study of the 20-P1-148 metformin film coating 3 preparation Reiko Shimada, New shellfish Hiroaki, Takashi Sasaki, Yuichi Takahashi, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	Use pulse-taking of the generic medicine with the 20-P1-149 prescription style change Susumu Kudo, Comb mansion Yuko, 丹代恭太, Mai Kubo, Keita Umemura, 1, Sakae, Sasaki, Hirofumi Suzuki, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	Difference - between questionary survey - physician, the pharmacists for the 20-P1-150 generic drug Suzuki just argument 1, ウォーン pole 2, Junko Nagai 1, Tadanori Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2008.

	One discussion for the way of the 20-P1-151 generic drug medical supplies change Naoko Hayashi 1, Keiko Kishimoto 2, Yoshiko Kawamoto 1, Makiko Yoshimi 1, Two department Michiko 1, 2, Noriko Fukushima 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

	The change situation to the generic medicine of the out of the hospital prescription in the 20-P1-152 this hospital Miki Watanabe, Toshikazu Kawasaki, Eri Hino, Upper Tomomi Nakai, Shinichi Ishizuka, Hiroko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

	Examination of the quality of the 20-P1-153 theophylline timed-release tablet Kimie Imai, Mao Tomita, Rieko Hamada, Naoya Suzuki, Ayano Iwasaki, Kunio Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

	Clinical evaluation of the starting medical supplies and generic medicine of the 20-P1-154 pravastatin sodium 寺下朋江, Tega Eiji, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

	Use of drug evaluation of the generic medicine "re-duck (R)M lock" of the 20-P1-155 pravastatin preparation Takashi Nagata 1, Hiroaki Tsuchiya 1, Rina Kito 1, Naoki Hasegawa 2, White pine Takako 2, Akiyo Horie 2, Kazuo Nishimoto 2, Keiko Yamamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

Establishment - of the evaluation method to change evaluation - generic medicine of the preparation of the generic medicine of medical supplies "cyclosporine" requiring 20-P1-156 TDM, and to adopt it
Rina Kito 1, Takashi Nagata 1, Takahiro Hayashi 2, Katsuaki Ozeki 2, Kazuko Nakano 2, Keiko Yamamura 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2008.

	Comparison of laboratory values in the forerunner, the generic medicine of the 20-P1-157 sulbactam ampicillin injection Aspect shrine Koji 1, Keiko Miyakawa 1, Makoto Hayashi 1, Koichi Nagaoka 1, Koji Abe 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	Mainly on stability - generic drug of the gabexate mesylate in the dilute solution for the 20-P1-158 injection - Miyuki Sakurai 1, Kenji 2 who likes it in autumn, Yoko Saito 2, Junpei Inoue 3, Noboru Okamura 4, Kenji Matsuyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	About information about competitive review - generic medicine of the pharmaceutical literature database in 20-P1-159 Japan - Takumi Umemura 1, Nobuyuki Goto 1, Fumiko Otsu 1, Ukuru Watanabe flat 2, Toshiaki Nakamura 2, Mikio Masada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	Intelligence and utilization about 20-P1-160 generic drug Landowner Takafumi 1, 9, 五戸薫 2, 9, Yoko Kobayashi 3, 9, Makoto Takahashi 1, 9, Yumiko Noguchi 4, 9, Hiroaki Hoshino 5, 9, Yumiko Mikami 6, 9, Tooru Mori 7, 9, Yuki Yamashita 8, 9, Kenzo Nishino 4, 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	Interview form comparison between innovator drug and generic drug in the 20-P1-161 vancomycin note Tetsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	Prescription change after bringing medicine and the hospitalization in the 20-P1-162 medical treatment type hospital Hiromi Yamaguchi, Hiroko Koyama, Michi Ansaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2008.

	20-P1-163 Changes to the generics of the drug to be used for cancer chemotherapy: Impact on patients in levofolinate calcium introduced 敦見真由美, 藤原琴, 吉河絵美里, 藤本奈津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

	Comparison between safety and clinical response in the starting medical supplies and generic medicine of the 20-P1-164 paclitaxel preparation Kyoko Tadokoro 1, Tomohiro Miyake 1, Takashi Yamawaki fine weather 2, Hiroshi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

	Fact-finding with the change to 20-P1-165 risperidone generic drug Hitomi Horikawa, Golden Reiko, Takako Toi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

	Stability evaluation of the various nicorandil preparation when we saved it in a 20-P1-166 looseness and press through pack state Jin Miyamoto, Eri Mimura, Kanako Okazaki, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

	Bioequivalence in healthy adults of 2.5 mg of 20-P1-167 amlodipine tablets "Towa" and 5 mg of amlodipine tablets "Towa" Kuniko Nakamura, Hiroshi Morimoto, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

Comparison ... in the preparation of pharmaceutic equivalency evaluation (2) - BCS classification Class I of the generic medicine using the 20-P1-168 absorption prediction system and III
Yuko Watanabe 1, Chiaki Yamamoto 1, Descent from a mountain Tetsuya 1, Masanori Kobayashi 2, Shiro Itagaki 2, Mitsuru Sugawara 3, Tsuyoshi Hirano 2, Takeshi Iseki 2, 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2008.

	20-P1-169 Medicament evaluation of NSAIDs generic 田原雅子, 平昭圭介, 坪内知沙, 花田徳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

	Patients satisfaction investigation of the generic drug in the 20-P1-170 compounding of medicines juxtaposition type drugstore Tomoko Okumura 1, 3, Mikio Sakakibara 1, 3, Satoshi Okada 1, 3, Keiji Arai 1, 3, Toshitaka Nabeshima 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

	About drug costs reduction by the use of 20-P1-171 generic drug and self-burden reduction Keiji Totsuka, Naoko Kawaguchi, Ishiguro forest husband, 岡村正巧 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

	About the induction of the 20-P1-172 generic drug examination - to - evaluation and the systematization Abe going enthusiast 1, Yasuhiro Matsuzawa 1, Masaomi Tanaka 2, Masaru Fujii 3, Kazunori Yamada 4, Tadashi Maeda University 5, Hideki Sato 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

	A present conditions analysis and fact-finding of the multidirectional generic medicine in the 20-P1-173 medical supplies market Hiroshi Hori tree, Chiaki Okamoto, Truth Naoyuki Eda, Miwa Yotsumoto, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

The change situation to the generic medicine in the drugstore attached to 20-P1-174 Gifu College of Pharmacy and patients attitude survey
高島英滋 1, Tetsuo Adachi 2, Yosuke Miwa 3, Akira Higashi incense 1, Suguru Kubota sentence 1, Tadashi Horiuchi 1, Naoki Inagaki 3, Teruo Tsuchiya 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2008.

Fact-finding of the generic medicine in the 20-P1-175 Shinpo place hard to pass system enforcement
尾崎加職 1, Masaki Manda 1, Small bath Takako 1, Yasuko Takinami 1, Miyuki Miyake 1, Naoko Tsuji 1, Keiko Noguchi 1, Hitomi Kawaguchi 1, Takami Fujii 1, 野際俊希 1, Fuminori Matsubara 1, Shinnya Inaba 2, Tetsuji Sakai 2, Kazuhiro Izawa 2, Masayasu Matsumoto 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

	The change situation to the generic medicine with the 20-P1-176 fee-for-service revision Ashikari Saori, Hiroki Ito, Makoto Inoue, Fumihiko Katagiri, Sato male oneself, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

The actual situation after the style change about "the change to generic medicine" of the 20-P1-177 prescription and patients attitude survey
Koichi Otaki 1, 2, Toshio Awaya 1, Sayaka Fujimaru 1, Noriko Umezu 1, Katsuhisa Tahara 1, Hemp lower Tomoka 1, Kaori Koshiro 1, 安達知輝 1, Shinya Iida 1, Yuzuru Yamamoto 1, Yasushi Yamashita example 1, Toshiyuki Miyoshi 1, Yoshikazu Tazaki 1, Kazuo Matsubara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

A construction and use of the information standardization system of the out of the hospital prescription data between 20-P1-178 Hospital, the drugstore
Hidetoshi Honda 1, 4, Katsuyoshi Nakajima 1, 4, Toshiichi Seino 1, Hiroshi Suzuki 1, Eiji Shiozaki 2, Hiroki Watanabe 3, 4, Kazuhiko Oe 3, So Koike one 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

	Medicine medicine cooperation for use promotion of the 20-P1-179 generic medicine 戒田文子 1, Yamamoto lawn arrow incense 1, Naomi Takeda 1, Yoshihiro Takaishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

	Tendency of patients with acute poisoning in the 20-P2-181 Saitama Medical School comprehensive medical care center Naohiko Inoue 1, Katsunori Shinohara 1, Sawada mere beauty 1, Tomonori Oya 1, 原井賢秀 1, Motohiko Sano 1, Toru Kishino 1, Masayuki Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2008.

	Intervention of the pharmacist in 20-P2-182 ICU, the CCU Ayumu Nozaki 1, Ito greens wave 1, 茂木孝裕 1, Tomoko Fujita 1, Hirokazu Nakanishi 1, Masafumi Morita 3, Enjoji Yoshihisa 2, Shigeru Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

	Medical supplies proper use and safety management in the 20-P2-183 intensive care unit Emiko Kobayashi, 青山涼重, Fumio Okada, Kenichi Sagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

	Thorough injection management in the 20-P2-184 critical care center 畝本賜男, Kazuya Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

	Role of the 20-P2-185 critical care center support task - permanent residence pharmacist Mayu Komada, 橋本昌宜, Hamura Koichi, Marutani good period, Satoshi Ichikawa, Satoru Nagata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

	Injection management in the 20-P2-186 ICU Shigeki Nakane 1, Kaneji Miyahara 1, Yoshikatsu Mizutani 1, Tomohiro Kato ankle 2, Mitsuyo Kondo 2, Chiharu Kato 2, Izumi Uchiyama 2, Miyoko Kobayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

	Make use of role - pharmacy-like technical knowledge of the operation region exclusive duty pharmacist in the 20-P2-187 team approach in medical care; and - Yuka Shibata 1, Your Kodama A 1, Rieko Tanaka 1, Kernel Hiroshi Inouchi 2, Furrow well Hiroko 1, Tree flat Kenji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2008.

Drug control duties 1 in the 20-P2-188 operating room
Yoshizaki sheath incense 1, 濱野公俊 1, Top division Mari 1, Aya Sakurai 1, Moe Takeuchi 1, Yuko Matsuhashi 1, Otsuka having fun 1, Mieko Yokoyama 1, Kyoko Saito 2, 3, Sakamoto tree 3, Tachi field Takeshi 3, Tsuyoshi Otsubo person 4, Keiso Masuhara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

Drug control duties 2 in the 20-P2-189 operating room
Yuko Matsuhashi 1, 濱野公俊 1, Top division Mari 1, Aya Sakurai 1, Moe Takeuchi 1, Yoshizaki sheath incense 1, Otsuka having fun 1, Mieko Yokoyama 1, Kyoko Saito 2, 3, Sakamoto tree 3, Tachi field Takeshi 3, Tsuyoshi Otsubo person 4, Keiso Masuhara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

	Improvement of the medicine management method in the 20-P2-190 operating room Junichiro Kato, Harada University, Tamayo Takahashi, 奥津利晃, Noriko Ando, Eiko Kato, Masaki Kitamura, It is full of history of Kikuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

Intervention to the operating room drug control duties by the 20-P2-191 pharmacist
Yoshie Takeda 1, Kayoko Takada 1, Rie Komoda 1, Miyoko Tsunoda 4, Yoshiko Yamamoto 3, Fujisato beauty 2, Masumi Abe 1, Miyoko Kobayashi 1, Akiko Otake 1, Tazuko Shibata 1, Kyoko Tamai 1, Toshi Shibabe 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

	Induction and evaluation of the drug system of administration in conjunction with 20-P2-192 prescription order system Ai Aoki 1, Yasuyuki Kanbayashi 1, Hideaki Hiraga 1, Kosuke Toki 1, Shoji Miyamoto 1, 100 Kenji 1, 中尾滋久 1, Masato Honma 1, 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

	The present conditions and evaluation of the drug management that became 20-P2-193 electron Shinobu Yoshizawa, Yoshihisa Kawakami, Reiko Daita, 前島光廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2008.

	Drug system of administration using 20-P2-194 electronic chart The single Motoyoshi beauty, Satoe Yamaoka, Mari Kawano child, Fuminori Shibuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

	About the effective medical supplies management for long holidays in the 20-P2-195 emergency hospital Seiji Koga, Ryu Onizuka, Kamikubo love, Minoru Yasunaga sand, Hirokazu Tanaka, Masaaki Hirakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

	Evaluation of the resident pharmacist duties in the 20-P2-196 operation region Tomoaki Doi, Yoshie Isobe, Shigeko Tsuji, Masato Kachi, Tomomi Kubo, Masato Asakura, Shoko Fujita, Masaki Ninomiya, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

	Adoption means using 20-P2-197 antimicrobial susceptibility test Description of Nishimura existence 1, Maki Hanada 1, 河野博充 1, 風間義顕 2, Yoshiko Kato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

	20-P2-198 production lot and the construction of the medical supplies system of administration that enabled management on an expiration date and the use Hidenori Kitazawa 1, Koichi Tanabe 1, Satoko Takeuchi 1, Tomoaki Ikezaki 1, Goji Nakase 1, Masahiro Kawano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

Evaluation - about the efficiency of induction and duties of action -SPD to efficiency of the medical supplies administrative work in the 20-P2-199 Kochi medical center and the precision
The Tanaka immensity, Misako Takeda, Yasuyo Fujisawa, Land tax officer climb charges, Hiroo Sumida, 服部暁昌, Teruo Tanaka
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2008.

	Inflection of IC tag for the problem solving in the 20-P2-200 medical field Jin Matsumoto 1, Hiroyuki Sasagawa 2, Kunihiro Nitta 2, Ken Ogawa will 1, 3, Yasuo Watanabe 1, 3, Yoshinari Watanabe 1, 4, Daisuke Koide 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

Establishment of the 20-P2-201 Kitano Hospital heart center and relation of the pharmacy
1000, Aga Kyoko 1, Mami Shirakawa 1, Mariko Shirane 1, Hiroyuki Kawahara 1, Country original Junichi 1, Koji Ueyama 2, Harvest festival Akira Mori 2, Kunihiko Nagai 2, Takeshi Watanabe 2, Takashi Nohara 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

	20-P2-202 Efforts to a use situation investigation and proper use of the linezolid 白石貴寿1, 坂本晃世1, 村橋重樹2, 岩武資善1, 中村泰士1, 横山博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

	20-P2-203 Side effect of linezolid investigation of the myelosuppression 江口倫由, 小倉千奈, 河相景子, 藤川和大, 坪井菜野, 氏家澄絵, 堀田修次, 槙恒雄, 小川喜通, 中島弘光, 川上幹郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

Promotion of the proper use of antiMRSA medicine vancomycin in the 20-P2-204 Higashihiroshima medical center
Shuji Hotta, China Ogura, River aspect Keiko, Fujikawa sum size, 江口倫由, Tsuboi greens field, Kiyoshi Ujiie picture, Tsuneo Maki, Yoshimichi Ogawa, Hiromitsu Nakajima, Mikiro Kawakami
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

	Analysis of consumption change of the 20-P2-205 antiMRSA medicine and the affector Yuji Fukuchi 1, Sakiko Kurokawa 1, Eiji Tsutsumi 1, Nobuo Suzuki 1, Masahiro Sakamoto 2, Makoto Miki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2008.

	Spreading effect to a physician by the TDM enforcement of the 20-P2-206 antiMRSA medicine Maruoka eyes, Tetsuo Funamoto, Motomu Sumitani Yoshiko, Misae Takase, 飴谷太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	An action and result to TDM rate of use improvement of the 20-P2-207 antiMRSA medicine Momoko Horio 1, 3, Takafumi Omura 1, Matsushita sheath or 1, Yoshiteru Honda 1, 3, Juichi Miyakawa 2, 3, Nosaka straight volost 2, 3, Tatsuya Kawaguchi 2, 3, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	Action ... to proper use of activity ... antiMRSA medicine of the infection control team (ICT) in 20-P2-208 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Takeaki Nishibori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	The use situation of the antimicrobial agent in the 20-P2-209 Niigata Prefectural hospital 15 institution and pyocyanic meropenem susceptibility Taeko Higuchi 1, Katsuyuki Tanaka 2, Junko Takazawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	Problems and problem of the use of specific antimicrobial agent registration system in preventive measures against 20-P2-210 resistance Masayuki Kobayashi, Your family Norio, Kenji Yokochi, Kana Fukazawa, Person of moat Natsumi, Posterior Fujimitsu good Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	Chemical sensitivity of 20-P2-211 clinic isolation Pseudomonas aeruginosa and the use situation of the antimicrobial agent Koya third son 1, Kosuke Baba 2, Koji Narui 3, 野口雅久 3, Masanori Sasatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2008.

	About the use restrictions of the antimicrobial agent in the 20-P2-212 medical treatment type sickbed and a chemosensitive change Naoaki Shimizu 1, Masahiro Yasue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	Making and use of antimicrobial agent situation investigation of the anti-biogram for the 20-P2-213 antimicrobial agent proper use 滝波昇悟 1, Auditor Hideo 1, Keiji Nishiyama 1, Kawai thickness line 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	Utility of the specific antimicrobial agent registration system in a 20-P2-214 carbapenem system antimicrobial agent and the antiMRSA medicine Yui Yoichi Sono 1, 入江徳俊 1, Takeshi Shimomura 2, Mayumi Yokota 2, 槙林智子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	Multifaceted approach to a physician aiming at the proper use of the 20-P2-215 wide area antimicrobial agent Misato Mochizuki 1, Kamoto light person 3, Mizunuma Chihiro child 1, Koji Miwa 1, Kageno Takahiko 1, Yuji Ono 2, Masayuki Yamane 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	The designated antimicrobial agent registration system that the 20-P2-216 many types of job cooperated Tokuyama Kotomi 1, Noriko Kosaka 2, Yoshiyuki Ishii 1, Yoji Ogawa 1, Tomofumi Yano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	Action and fact-finding questionnaire - personnel participation hand-washing training ... to infiltrate 20-P2-217 hand-washing Saori Hashiguchi 1, Motomura two 1 in total, Ikeda ability interest 1, Yoko Sugimoto 2, Ryuji Morishita 2, Tsuyoshi Machida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2008.

	Use of primary irrigation, antiseptic turn of eventss by the primary antiseptic abolition of the 20-P2-218 medical device Masatoshi Saito 1, Morning wife Satomi 2, Hiroshi Nagoya 3, 渡邉彦 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

	An antimicrobial agent consumption investigation using 20-P2-219 ATC/DDD System and examination about the drug resistance of the in-hospital detected bacteria Hideji Takeshita 1, Matsuyama solstice 1-resistant, Haruyo Narishima 2, Nobuyuki Kawai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

	Questionary survey for the understanding degree of the standard precaution to 20-P2-220 pharmacy school trainee, the external staff Yoshiro Sakai, Chiyoko Arima, Yuko Kubo, Mieko Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

About the making of the 20-P2-221 "prevention of infection manual of the home health care"
Hakuno positive original 1, 2, Keiko Nagano 1, 3, Amagasaki path of righteousness 1, 4, Katsuhiro Yorioka 1, 5, Michiko Matsuda 1, 6, Hiroshi Yamazaki 1, 7, Mikiya Hayashi 1, 8, Tadao Kawaguchi 1, 9, Yoshiya Matsuo 1, 10, Shinya Sato 1, 11, Shigeharu Oie 1, 12, Noriko Hirata 1, 13, Akira Kamiya 1, 12
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

	Enforcement of the questionary survey about infection measures for 20-P2-222 inside the hospital personnels Michiko Adachi 1, 2, Asami Noda 1, Mari Kaneta 1, Infection measures committee committee 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

	Relation of the pharmacist as the ICT in the 20-P2-223 Masuda Red Cross Hospital Saza book Tomoyuki, Nishizono Kenro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2008.

	Effect of VRE infection prophylaxis measures on MRSA infection prophylaxis of the 20-P2-224 CCU Toshiyuki Irie 1, Hiromi Mizoguchi 2, 道越淳一 3, 永山眞紀 3, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

	Side reaction investigation (2007-2008 season) after the 20-P2-225 Nomi-shi staff influenza immunization Yumi Ota 1, High branch Masayoshi 2, Akemi Yamauchi 3, Yoko Nakajima 3, 成橋和正 4, Kiyotsugu Mizuno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

	Action to mupirocin ointment proper use in the 20-P2-226 Hiroshima City Hiroshima Municipal Hospital Nobue Uetake, Takafumi Sugawara, Toshiharu Matsumoto, Hiroshi Wada, Open Koichi, Yonezawa sing, Yasuki Tomota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

	20-P2-227 Bacterial contamination investigation of the amino acid sweetened electrolyte infusion and peripheral venous route three-way stopcock 堀川俊二1, 只佐宣子1, 成井浩二2, 野口雅久2, 笹津備規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

The examination that is safe efficacy of the levofloxacin once a day administration in the neutropenic phase after the pharmacist duties (73) cancer chemotherapy as the 20-P2-228 medical care person
Sana Hamazaki 1, Sakae, Toshiaki Igarashi 1, Jin Tsukamoto 1, Toshiaki Nakamura 1, Yoshimasa Urasaki 2, Takanori Ueda 2, Mikio Masada 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

	Discussion ... about blood mycophenolic acid concentrations change - trough value measurement significance in the 20-P2-229 liver transplantation patients Junko Fujii 1, Hideyuki Saito 1, Lake Aso Katsuhiro 2, 猪股裕紀洋 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2008.

	Examination of the utility of 20-P2-230 vancomycin initial administration guidelines Shigeyuki Miyamura, Aya Teramoto, Tomoko Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

About a utility of the monitoring of vancomycin levels out of the cerebrospinal fluid for 20-P2-231 MRSA meningitis
Naomi Hasegawa 1, Yukiko Narumi 1, 岩下佳敬 1, 中尾承司 1, Masako Fukumoto 1, Kimiyoshi Iwasaki 1, Chieko Kawahata 1, Yoshimi Yoshikawa 1, Yoshida Nanase 1, Kazuhisa Ishida 1, Osamu Miyanohara 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

	Association of a trough blood level of vancomycin in patients with 20-P2-232 advanced age malignant tumor and the pharmacokinetic parameter Shinnichi Sado 1, 2, Yasuhiro Tsuji 1, Akiko Mizoguchi 1, Sone book Emi 1, Masami Murakami 1, Ball Shiro Shima 1, Mound former Kazuhiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

	20-P2-233 Infusional pharmacokinetic examination of the linezolid in haemodialysis patients 辻泰弘1, 平木洋一2, 溝口晶子1, 佐道紳一1, 曽根本恵美1, 村上優美1, 神村英利3, 加留部善晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

Examination about the ring from blood cyclosporine levels and the side effect in the 20-P2-234 same kind hematopoietic stem cell transplantation
Hiromi Yoshida 1, Yutaka Nishikawa 1, Kanako Kawasaki 2, Takashi Kajita 1, Mutsumi Ueda light 1, Eitaro Nakatsuka 1, Fumihiko Nakamura 3, Satoru Koyanagi 2, 大戸茂弘 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

	Effect of the aging to give to the carbamazepine pharmacokinetics in patients with 20-P2-235 epilepsy Pond Masayuki Nishi, Masatoshi Sano, Eitaro Nakatsuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2008.

	The best case of the refractory ulcerative colitis that a drug blood trough value of the oral 20-P2-236 tacrolimus did not arrive at the appropriate value North Britain person 1, 永野俊玲 1, Tadahiko Kinoshita 2, Tetsuya Ishida 3, Toshiharu Asakura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	Examination about the initial warfarin potassium doses setting which assumed albumin concentrations out of the 20-P2-237 plasma an index Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	The effect that a system change of the 20-P2-238 blood drug concentration measurement business gives for a hospital income, medical safety management Fumihiko Katagiri, Makoto Inoue, Hiroki Ito, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	20-P2-239 Construction of cancer chemotherapy protocol creating and prescription audit system by commercial database software 山本優衣, 林仁子, 石崎真由美, 浅村梨沙, 中田久美, 角紀一郎, 後藤義之, 森戸敏志, 上田和雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	20-P2-240 electronic chart, safety management of the cancer chemotherapy in the order ring system non-induction institution Shuko Yuasa, Appearance tail Ayumi, The next treasure A is rare, Chiaki Taoka, Happiness and prosperity Hitoshi, Yoshiko Azuma, Hatsue Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	20-P2-241 Construction of a system oriented safety management (1) The introduction of departmental systems with the aim of streamlining and standardization of regimen check 椎木芳和, 佐久間悦子, 涌嶋伴之助, 秦英司, 林原正和, 大坪健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2008.

	Action to the in-hospital standardization of the correspondence procedure at shock, the extravasation with the 20-P2-242 anticancer drug Kishimoto truth 1, Kazuyuki Sunada 1, Long ヶ Takuma Hara 1, Yuko Nakamura 2, Fumiko Matsueda 2, Chiyoko Inomata 3, 三阪高春 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

	Action to safety management in the 20-P2-243 cancer chemotherapy Sakiko Kurokawa 1, Rina Tabata 2, Eiji Tsutsumi 1, Nobuo Suzuki 1, Yuji Fukuchi 1, Yukimasa Suzuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

	Action of the safe security in the 20-P2-244 cancer chemotherapy 井上梨恵, Kaori Tanaka, 岡冨亜紀, Noriko Iki, Hironobu Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

Combine a regimen management seat with action ... chemotherapy support system to safety management of the cancer chemotherapy in the 20-P2-245 this hospital pharmacy; and ...
Joji Mori 1, Kenichi Shimada 2, Ikuyo Toyota 1, Ryuma Sato 1, Kyoko Ohara 1, Keiko Ono 1, Naoko Tosa 1, Tadaaki Ogawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

	20-P2-246 pharmacist, attitude survey about the anticancer drug for nurses Maiko Koyama 1, 丘龍祥 3, Nobuyuki Saito 1, Naoki Soma 2, Absence Katsuyuki 2, Rei Oishi children 1, Tadashi Shiraishi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

	Action of anticancer drug preparation duties by the pharmacist in the 20-P2-247 pediatric ward 丘龍祥 1, Maiko Koyama 2, Mountain Masayuki Sawa 3, Mannen Takuya 4, Toshihiro Shida 1, Shinseki Masahiro 1, Shuji Takahashi 1, Tadashi Shiraishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2008.

	Completely conduct action - anticancer drug sterility preparation duties to the cancer chemotherapy systems construction that 20-P2-248 is safe; and - Ground field Mikiko, Nami Matsui, Sakuma Miyuki, 猿谷淳, Yuka Nakano, 向一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

	Development of the 20-P2-249 cancer chemotherapy enforcement confirmation system Yoshihisa Kawakami, 前島光廣, Tomoho Yamada child, Toshika Yoshizawa, Junko Kodaira, Shinobu Yoshizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

Evaluation - of the patients with action - cancer drug control instruction manual of the 20-P2-250 Aichi Hospital Pharmacist Association on koro Gee meeting for the study
Pine reason Koji 1, Hiroshi Okado 2, Saori Kato 3, Kushihara Hideyuki 4, 早見知浩 5, Kazuo Hotta 3, Kae Matsuoka 6, Watanabe eyes 7, Manabu Yokota 8, Itakura affinity 9, Kiyohide Takahashi 1, Hiroko Saito 10, Shin Hasegawa plan 11
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

	Induction of the protocol check system for 20-P2-251 anticancer drug proper use Naoko Tsuji, Hitomi Kawaguchi, Yasuko Takinami, Small bath Takako, Masaki Manda, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Takami Fujii, 野際俊希, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

Evaluation, examination - of the utility of the action - protocol check sheet for the communalization of the 20-P2-252 protocol information
Koji Kashimoto, Chinami Ueno, Yoko Sakai, Masako Imada, 岡冨大輔, Kenichi Sakamoto, Noriko Takaya, Kyoko Sekimoto, Tamotsu Harada virtue
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

	Construction of the section system in connection with 20-P2-253 electronic chart Kakinohana Makiko 1, Mikio Tomori 2, Virtue Keiko Mine 3, 勢理客成弘 1, Keiko Tomori 4, Takako Sunakawa 1, Yasuhiko Miyagi 1, Gushiken Koshin 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2008.

	It is ... about 20-P2-254 incident, evaluation - duties correspondence to chemotherapy duties judging from data change of the doubt inquiry and the role of the pharmacist Koji Moriya, Shinsuke Akagi, Kenji Nishimura, Ko Tokuda period, Takayanagi sum God Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	Evaluation of the cancer chemotherapy subtype regimen judging from the drug dose per the 20-P2-255 credit hour Hideaki Tokushima 1, Child 1 too rare Mochinaga, Egoe Masayoshi 1, Akiko Emoto 1, Masanobu Tazaki 1, Sawako Doi 2, Kazuhiro Hirano 1, 中野行孝 1, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	An effect of the pemetrexed + cisplatin chemotherapy on 20-P2-256 malignant pleural mesothelioma and adverse event Hiroyuki Kuwahara 1, Shizue Okubo 1, Mitsuru Tamura Expo 1, Yoshiyuki Yamauchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	1 case that effects of the warfarin were reinforced by 20-P2-257 paclitaxel Mountain Masayuki Sawa 1, Yutaka Hattori 1, Flat Hiroyuki 1, Mannen Takuya, 小嶋文良, 丘龍祥, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	Examination about patients with cancer and fall, the fall in the 20-P2-258 this hospital Junko Hirai 1, Masahiko Tsunoda 1, 熊岸敬晃 1, Kozo Suwa 1, Hideki Mori 1, Etsuko Honda 1, Manager former man 1, Tamie Ishida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	A change and peripheral neuropathy of the mean cell volume in the 20-P2-259 mFOLFOX6 therapy Yuka Isaka 1, Fumio Itagaki 1, Toshikazu Moriwaki 2, Akira Nakahara 2, 兵頭一之介 2, Masato Honma 1, 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2008.

	Use investigation of Oxaliplatin for patients with colorectal cancer at the 20-P2-260 renal function degeneracy Ikuko Fukumoto 1, 寺田智祐 2, Toru Hashida 2, Ikuko Yano 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

	Examination of a use investigation and the proper use of the portable chronofuser in the 20-P2-261 colorectal cancer chemotherapy Yoko Hamaguchi, Tomohiro Miyake, Kyoko Tadokoro, Hiroaki Nagata, Keiki Mori, Manabu Tanimura, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

	Fact-finding about the planned end time excess in the colorectal cancer chemotherapy (FOLFOX4, FOLFIRI) using the 20-P2-262 transfusion pump 澤柳直樹, Kenichi Nomura, Tomokazu Fujii, Haruhiko Nakamura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

	Examination of the factor affecting the flow of the 20-P2-263 in fuser pump Yoriko Wada, Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

	Comparison between 20-P2-264 metastasis, FOLFOX and administration order of FOLFIRI for recurrent colorectal cancer impossible of excision Aimi Goto 1, 2, Makoto Hosomi 1, 2, Masami Nishihara 1, 瀧内比呂也 2, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

Onset of side effect in patients with clinical validity and lung cancer of theoretical carboplatin doses based on a 20-P2-265 MDRD type and gynecologic cancer
Yuka Tanaka 1, Toshie Matsumoto 2, 吉村知哲 3, Toshiya Nakao 3, Michio Kimura 3, 宇佐美英績 3, Okada sum intellect 3, Tadashi Yasuda 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2008.

	Fact-finding of the carboplatin dosage in the 20-P2-266 this hospital Fujiko 1 between the fortune, Mari Takahashi 1, Jun Iwakawa 2, Toshi Yoneta 3, Terahara wise man 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Examination of the change of the dose by various calculating formulas of carboplatin (CBDCA) in the 20-P2-267 ovarian cancer TC therapy and the effect on hematotoxicity Tomohiro Miyake, Kyoko Tadokoro, Hiroshi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Discussion about neutropenia G3 in the 20-P2-268 CBDCA+WeeklyPTX therapy or more, onset of thrombocytopenia and administration criteria 高橋喜統 1, Yoshimasa Saito 1, Kayoko Yamaguchi 1, Takeo Shimazaki 2, Osamu Niwa 1, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Inspection of the initial dose setting method of the Carboplatin+weekly Paclitaxel combination therapy for the 20-P2-269 non-small cell lung cancer Yoshimasa Saito 1, 成橋和正 3, Yuka Ikeda village 1, Kayoko Yamaguchi 1, 高橋喜統 1, Hijiwara Kazuma 2, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Side effect investigation of the carboplatin +Weekly paclitaxel therapy in patients with 20-P2-270 non-small cell lung cancer Koji Nakao, 藤井広久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Fundamental researches for appropriate dosages of 20-P2-271 antitumor agents carboplatin 1 rare in Hamada summer, Koharu Fujikawa 1, Ai Inoue 1, 峠越崇範 1, Yasuhiro Kimura 1, Tree flat Kenji 1, Fidelity Takahiro 2, Hisaya Fujiwara 2, Miki Kudo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2008.

	Examination of the hematotoxicity with the platinum + gemcitabine combination therapy for the 20-P2-272 non-small cell lung cancer 計良貴之, Kyohei Mita, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

	Examination of the use of division of the 20-P2-273 anticancer drug vial preparation and the drug cost reduction effect 濱宏仁 1, Manabu Kurokawa 2, Wasaburo Kataoka 3, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

Economic effect by the adequacy of the injection standard choice in the 20-P2-274 outpatient department cancer chemotherapy
Koichi Fukushima, 濱宏仁, Yayoi Tatsumi, Public hilum Noriko, Rice corner Toshihiko, Great sound Mieko, Shozo Tamura, Hirofumi Akase, Flat field Masaki, Toru Hashida
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

Comparison ... of the onset of taste disturbance situation in each onset of taste disturbance situation first report ... regimen in patients who received 20-P2-275 outpatient department chemotherapy
Shiho Sugawara 1, Norio Takimoto 1, Akiko Iida 1, Takashi Sakakibara 1, Kenji Mori 1, Mitsuru Sugiura 1, Keiko Yamamura 2, 足立守 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

Effect on quality of life ... of onset of taste disturbance situation second report - taste disturbance in patients who received 20-P2-276 outpatient department chemotherapy
Norio Takimoto 1, Shiho Sugawara 1, Akiko Iida 1, Takashi Sakakibara 1, Kenji Mori 1, Mitsuru Sugiura 1, Keiko Yamamura 2, 足立守 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

	Safety assessment by the nutrition index using BMI and Alb of the S-1+CDDP therapy for inability to 20-P2-277 excision, recurrent gastric cancer Michio Kimura, 宇佐美英績, Mina Iwai, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2008.

	Examination (2) of the quantity of preparation extraction of the 20-P2-278 docetaxel preparation Tetsuya Sakamoto, 岩瀬利康, Yoshio Ito, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

	It is one patient receiving the tea S one for the 20-P2-279 gastric cancer surgery rejection patients Satoru Tamura 1, Hatakeyama chapter 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

The use situation with Mohs paste and the metronidazole ointment for breast cancer that 20-P2-280 skin infiltrated and difference of the effect
Kinuyo Matsuda 1, Yoshiyuki Tajima 1, Kaoru Shigeno 1, 閔貴善 1, Yukako Okude 2, Ikuko Abe 2, Kuniyoshi Sato 1, Mitsue Saito 2, Kazuhiro Sase 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

Environmental pollution investigation at the 20-P2-281 anticancer drug preparation
Yaeko Mishima, Naoko Hashiba, Taeko Saito, 銀杏麻維子, Kazuko Takahashi, Eri Isobe child, Fumi Mukoda, Eriko Hiruta, Naoko Kawashima, Homiki Ushigome, Keiko Sunakawa, Skilled miner Naomi, Aki Kuwahara, Keiko Takano
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

	About cancer chemotherapy regimen management every patients in the scale hospital out of 20-P2-282 Toshihiro Uenaka, Shuichi Kawashima, Sound Mai Kubo, Mt. Tadashi Maruyama, Hirase friendship, Hisashi Yagi Yoshiko, Oida chapter, Tadashi Doi reason Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

	The 20-P2-283 generic anticancer drug is premature; is the inspection of problems by the multicenter questionary survey Hiroshi Nomura British 1, 青山利人 2, Chie Mochizuki 3, Kiyoko Tanimura 4, Setsuko Anan 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2008.

Problems of the information about the stability after decomposition, the attenuation of the anticancer drug that the 20-P2-284 healthcare setting is available
Noriko Yamashita, Masami Tada, Reiko Muraoka, Mina Yanai, Kuniyoshi Tanaka, Mitsue Shindo, Tsuneo Hamaguchi, Hilum Muneo Hayashi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

	It is the action for anticancer drug preparations in 20-P2-285 this hospital Mihoko Yoshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

	Relation [the first report] of the present conditions and the pharmacist of the cancer chemotherapy in 20-P2-286 Akita Yoshikazu Koike 1, 5, Manabu Shoji 2, 5, Akiko Harada 3, 5, Higuchi meets; 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

Through an action to also accomplish 20-P2-287 cancer chemotherapy appropriately safely, making and the utilization of "the chemotherapy chart" in the digestive cancer treatment
Pupil-maru Emi 1, Koji Iwamura 1, Yoshiteru Honda 1, Honda will deferred 3, Naoko Hayashi 2, 3, Nobutomo, Miyanari, Masayuki Watanabe 2, Hiroshi Takamori 2, Hideo Baba 2, Hideyuki Saito 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

	Examination about the present conditions of the 20-P2-288 gemcitabine administration Goji Maeda, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

	Side effect investigation in the methotrexate, epirubicin, nedaplatin combination therapy for the 20-P2-289 progress urothelial carcinoma Hideko Kojima 1, Takashi Ogiwara 1, Katsumi Ishiwatari 1, Yutaka Yamamoto 1, Kazuki Kobayashi 2, Susumu Umemoto 2, Sumio Noguchi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2008.

	Pro-evaluation that paid its attention to an administration schedule of the 20-P2-290 breast cancer chemotherapy protocol establishment Eriko Hayashi 1, Tsuyoshi Hirano 2, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	Role of the pharmacist in the 20-P2-291 protocol screening committee Masayo Ueno 1, Kentaro Ogata 1, Natsuki Korenaga 3, Kenzo Hida 1, Masako Wakita 1, Yoshihiro Kawahara 1, Seiya Takahira 2, Koji Washiyama 1, Kojiro Nikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	Examination - of the weight loss ratio in action (the second report) - cancer chemotherapy of the 20-P2-292 cancer chemotherapy regimen authorization chapter Hiroaki Sakurada 1, Yumiko Oshima 1, Hiroshi Hashimoto 2, Kazuhiko Morita 1, Aoyama Kei daylight 1, Kunio Kitamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	Examination of the utility of the anti-androgenic agent alternating therapy for 20-P2-293 relapse prostate cancer Ikuko Ogata 1, Hiroyuki Yamazaki 1, Tomoko Ishizuka 2, Tsuzaki Shoichiro 2, Takashi Ishimatsu 2, Hideo Hirayama 2, Quantity of Seo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	It is a case with suspected interaction by combination of 20-P2-294 Warfarin and cancer chemotherapy including TS-1 Kazufumi Terui 1, Nao Odagiri 1, Kazuhiro Hosoi 1, Junya Sato 1, Takabata military exploit 2, Early hunting truth 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	An adverse event of the 20-P2-295 Bevacizumab combination therapy and examination of the expression time Boundary Saori, Kazufumi Iwata, Takako Baba, 合澤啓二, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2008.

	20-P2-296 Fact-finding of the hydrochloric acid amrubicin monotherapy in patients with lung cancer 安藤玲子1, 牧野好倫1, 山本昇2, 大江裕一郎2, 國頭英夫2, 関根郁夫2, 軒原浩2, 田村友秀2, 小井土啓一1, 村越功治1, 横手信昭1, 山本弘史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

	Behavioral evaluation for peripheral neuropathy in the rat induced by 20-P2-297 oxaliplatin single dose Takeshi Yamamoto 1, Kazunori Kawakami 3, Nobuyuki Katagiri 2, 篠原史憲 1, Iku Utsunomiya 2, Keiko Hoshi 2, Toshihiro Hama 3, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

	About relations with side effect expression and the BMI in the 20-P2-298 chemotherapy Chizuru Arakawa, Tadashi Watanabe, Naomi Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

	Action of the foreign patient compliance instruction for the patient with breast cancer in the 20-P2-299 this hospital Depths Yukiko 1, Hiroshi Arai person 1, 栗原康彰 1, Now Yoichiro 1, Mari Watanabe 1, Makiko Kamata 2, Hiroyuki Suzuki 3, 三村進 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

Examination of the alcohol levels (BRAC) change during the exhalation at the 20-P2-300 paclitaxel (PTX) administration
Akiko Ban 1, 2, Tatsuya Hisada 2, 牛膓沙織 2, Mayumi Takeuchi 2, Mio Soga 2, Motoaki Ishikawa 2, Hideko Noto 2, Hiroki Arakawa 2, Yumiko Oshima 2, Kan Minako 2, Aimi Oya 2, Shinobu Nakayama 2, Yoshihiro Matsushita 1, Hiroko Saito 2, 3, Shin Hasegawa plan 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

	Side effect investigation of postoperative adjuvant chemotherapy THP, C using the pirarubicin in 20-P2-301 breast cancer Tadashi Watanabe 1, Chizuru Arakawa 1, Naomi Sogabe 1, Yasuko Uchida 2, Hiroshi Honda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2008.

	The present conditions of the 20-P2-302 well cancer agent exposure and future problem (the second report) Manabu Tanimura, Kyoko Tadokoro, Hiroaki Nagata, Keiki Mori, Tomohiro Miyake, Yoko Hamaguchi, Noriko Oyake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

Reporting - for prevention of route management - incompatibility at the polypharmacy in patients with 20-P2-303 leukemia
Yasushi Aida, Naoko Shibata, Adachi texture to praise, Wakako Murata, Keiko Maruoka, Shiho Takamura, Hiroko Shibata, Yumiko Fukui, Fence tail Naomi, Junko Fujimoto, Kimiko Yasuda, Eiji Fukui
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

	Effect ... that standardization of the relation (2) - chemotherapy of the pharmacist in 20-P2-304 antineoplastic tumor injection mixed duties gives in doubt inquiry Kazuhisa Tsu Minoru, Tomohiro Otsuki, 佐蔭香織, Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

	Fact-finding about the operational management of the 20-P2-305 cancer chemotherapy regimen Keiko Nikaido, Ishimaru wide knowledge, Kazuhiro Watanabe, Shinji Takayama, Shinano Hiromi, Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

	Action to the cancer chemotherapy that utilized 20-P2-306 electronic chart Kenichi Nomura, Tomokazu Fujii, 澤柳直樹, Haruhiko Nakamura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

Making ... of the patients with 20-P2-307 Aichi on koro Gee meeting for the study brochure based on the side effect analysis of the action ... LEED therapy
森章哉 1, Yayoi Hiraishi 2, Kengo Kimura 3, Sekido Izumi 4, Yuka Tanaka 5, Feather Katsuhiko Oka 6, Satoru Kato next 7, Toru Maeda 8, Hiroyuki Niimi 9, Keiji Mizuno 9, Yoshiaki Ikeda 9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2008.

	For the safer preparation of the 20-P2-308 anticancer drug action - in - this hospital Noriko Okubo, Helmet slope Tomohiro, Osamu Nishida good luck, 尾之江剛樹, Seiichi Sawada, 舛重正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

Relation ... of the pharmacist in action ... inside the hospital chemotherapy authorization nurse of this hospital to provide 20-P2-309 chemotherapy safely
吉田昭昌 1, Emi Tokunaga 1, Aya Shinoda 1, Wakana Furuta 1, Emi Otani 1, Yoshihiro Murashige 1, Hiroko truth size 1, Kazuya Kimura 1, Kazushi Nakazawa beauty 1, Forestry 1, Kazuya Wada 1, Hiroshi Tachibana 1, Kazunobu Teratani 1, Yukio Motomura 3, Yano Izumi 4, Yukiko Kawazoe 4, Yoshiko Miyauchi 4, Morichika Toshiyuki 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

	Adoption strategy of the 20-P2-310 many standards anticancer drug Hisashi Ono 1, Toshio Awaya 1, Suno study 1, Hitomi Tsuzuki 1, Yasushi Yamashita example 1, Takehiro Yamada 1, Koichi Otaki 1, 2, Yoshikazu Tazaki 1, Kazuo Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

	Action to cancer chemotherapy regimen management using 20-P2-311 system Sanae Watanabe, Kana Okamura, Koichi Tamai, Mitsuyo Fujiwara, Junko Ono, Junko Deguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

	Relation of the pharmacist in the hospitalization chemotherapy of the 20-P2-312 this hospital Satoshi Shinoda, Masae Kubo, Natsuko Tajima, Kazuma Yano, Hiroshi Hashiguchi, Keiichi Goto, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

20-P2-313 Cancer chemotherapy support system using the ordering system is not introduced hospital, regimen by injection indication prescription and Microsoft Access
谷村紀代子, 荻野寿世, 菊井和伸, 高橋利江, 近本珠代, 高見美幸, 小林紀子, 須貝智子, 田中朋子, 高谷伸治, 市川雅美, 八木朝子, 臼井麻衣子, 恩田誠二
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2008.

	Case who had pemphigus and the CMV enterocolitis paraneoplastic after 20-P2-314 FN treatment Yoko Iwanaga 1, Kentaro Ogata 2, Kojiro Nikami 2, Makoto Takahashi 3, Yoshimi Sasaki 4, 川野昭 5, 清水裕彰 6, Masako Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

	Adverse event analysis of Erlotinib in patients with nonsmall cell lung cancer with a history of the use of 20-P2-315 Gefinib 大橋養賢 1, Kenichi Suzuki 1, Sakurai beauty 1, Kanako Sugimoto 1, Michihiro Shino 1, Toshiaki Takahashi 2, Nobuyuki Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

Chemotherapy - as the unionization team approach in medical care of the action 5-anticancer drug regimen for the cancer chemotherapy adequacy in the 20-P2-316 this hospital
Kimiko Nagata 1, Yuka Ito 1, Hiroko Shinoda 1, Lower volost Yumiko 1, Kunihiro Matsuzaki 1, 町島浩 1, Miho Nakamura 3, Koji Ando 4, Tatsuhiro Arai 2, Keiso Masuhara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

	Choice and side effect monitoring of the chemotherapy for patients with 20-P2-317 progressive stomach cancer Truth Rie Hara 1, Mio Takahashi 2, Junichiro Murayama 2, Akihiro Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

	The making of "the diary in the 20-P2-318 cancer chemotherapy of patients" and the use Yoshihiko Sugino 1, Eriko Takeo 1, Akiyo Morita 1, Kimura Kei and 1, 大圓修身 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

	About medical cooperation in the nutritional management of the 20-P2-319 cancer terminal patient Yumiko Sato 1, Akemi Kumazawa 2, Kanemitsu Shibata 3, Kazuhiro Ishikawa 4, Koichi Okamoto 4, Shuichi Noma 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2008.

	About preparation initiation of the hospitalization chemotherapy in the 20-P2-320 this hospital action - by the team approach in medical care for - smooth use Island Emi 1, 1, Kiyosumi, Hashimoto, Country east connection 1, Shuhei Yasufuku 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

Action ... which aimed at the improvement of the quality of the reporting as making of the 20-P2-321 gynecologic cancer chemotherapy brochure and establishment - team of the reporting method
Yoshiyuki Goto, The Azuchi greens beauty, Makoto Kurabayashi, Kurumazuka Chiho, 飛澤国広, Kimito Sato, Hiroshi Tamura, Descent from a mountain Koichi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

Effect of treatment prediction of platinum drugs in patients with 20-P2-322 hepatocellular carcinoma
Chisato Kitayama 1, Tamotsu Suzuki season 1, Osamu Ito greens 1, Daiya Sakurada 1, Masahiko Sunaga 2, Shoji Yoshikawa 3, 横須賀收 3, Fumio Nomura 4, Noboru Sato example 1, Shiro Ueda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

	Application to significance and cancer chemotherapy of the 20-P2-323 urinary Gurkha phosphoric acid measurement Shigeru Morimoto sentence 1, 好田稔規 4, Tomoki Suizu 4, 浦西龍之介 2, Yoshiharu Shono 3, Yoshiichi Fujita 4, Kenji Hasegawa 1, 田伏克惇 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

Effect evaluation of the L-asparaginase which assumed an ex vivo ammonia increase level in patients with 20-P2-324 infantile acute lymphocytic leukemia a parameter
Shizuka Watanabe 1, 4, Kumiko Miyake 2, 4, Matsumoto fine weather greens 4, Brook 1,000 up world 3, Daisuke Hasegawa 3, Jun Manabe 3, Junko Kitsu 4, Ryota Hosoya 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

	Example that gave TS-1 which dissolved by the 20-P2-325 simple suspension method than intestinal fistula, and showed effective blood level change Yukako Yasui 1, Yasuhiro Miyazaki 2, 岸本朋乃 2, Hiroshi Imamura 2, Hiroyuki Yasui 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2008.

	20-P2-326 Participation of the use situation and the pharmacist of the Erlotinib lock 大神正宏, 谷中敦美, 柳岡利一, 島田匡彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

	For the standardization of the procedure of drug intubation administration, the enteral nutrient infusion in our 20-P2-327 medical center Akira Nomura 1, Tomohito Kondo 1, Straight Suiko 2, Kaoruko Katsura 3, Miwako Nakanishi 4, Hikaru Katayama 5, Tatsuya Ueno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

	Making of the intravenous alimentation support map to conduct the nutritional management that 20-P2-328 is appropriate Kiyotaka Omori 1, Nishimoto enthusiast children 1, Yoko Tokuyama 1, Masaaki Hasegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

One case that intervened in the present conditions and patients of the 20-P2-329 NST activity with nontuberculous skin acid-fast bacterium disease
Mizuho Fukuhara 1, 2, Tomoko Teranishi 1, 2, Shinsaku Kishimoto 1, Toshifumi Fukui 1, Akiko Fujimoto 2, Chie Takagi 2, Akemi Onishi 2, Akishino Tatsuya 2, Kyosuke Ota 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

	Role <NST of the pharmacist in the cooperation of the 20-P2-330 team approach in medical care and cooperation> with the pressure sore measures team Ogata Miyuki 1, 2, 3, Kakazu Kayoko 1, 2, 4, Yoshiko Sugiyama 1, 2, 5, Kaori Izumi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

	20-P2-331 Involvement of the pharmacist to the NST : That I learned about nutrition 山岡聡江, 河野茉里子, 渋谷文則, 片本吉美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2008.

Relation of a nutrition improvement effect and the pharmacist by the 20-P2-332 NST intervention
Daisuke Ushijima 1, 2, Akiko Inoue 2, Kaori Shimizu 2, Kazuyo Sato 2, Yoshiaki Ogita 1, 2, Former house Kaori 2, Yoshiki Kawakita 2, Yuriko Miura 2, Tamiko Kotake 2, Reiko Kunisaki 2, Masanori Komatsu 2, Tadashi Yamakawa 2, Osamu Yamaguchi 2, Shinya Hashimoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	Study on weight fluctuation of 20-P2-333 psychoneurologist open ward inpatients 椎崇 1, Kuroda ちか江 1, Tobita evening period 1, Yoshinobu Sasaki 1, 高橋賢成 1, Hiroko Ishihara 2, Noguchi ball child 2, Yasuo Arai 3, Masaichi Kuroyama 1, Hitoshi Miyaoka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	20-P2-334 becomes calm, and the half solidity enteral nutrient by the use of agent does not have an influence on the rat growth Yuriko Nimura 1, Yui Ikeda 1, Miho Kawai 1, It is Mizuki 1 eight moves, 森茂彰 1, Yuki Ito 2, Kazunobu Kobayashi 2, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	Utility of aminoleban EN100g sleep premedication LES in patients with 20-P2-335 cirrhosis and patients with hepatocellular carcinoma Akira Nagayama 3, Masako Kondo 3, Kazumi Morishita 3, Hiroko Miyakawa 2, 天神尊範 1, Noge Ichiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	Through the case with the relation sacral region giant pressure sore of the pharmacist as the NST member in the 20-P2-336 Hekinan Municipal Hospital Megumi Suzuki, Hiroyuki Suzuki, Itakura affinity, Minoru Nagata, Masayasu Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	Examination of the 20-P2-337 NST intervention case Masahiro Maruyama 1, 尾藤弘昌 1, Ippei Nakamura 2, Takeshi Kaneko 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2008.

	2 cases that psychological care was the center with 20-P2-338 palliative care unit Junichi Isogai, Shinji Ito, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

	Intervention of the psychological care team to 20-P2-339 regular hospital Shinji Ito, Junichi Isogai, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

	Invention in the electronic chart use with the 20-P2-340 psychological care team establishment Satoko Takeuchi, 大浦冬裕, Koichi Tanabe, Hidenori Kitazawa, Tasuku Takarada oneself child, Shinobu Kuroda, 霜知浩, Yoshinari newly with floor, Yasuko Tanada, Murakami wish Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

	The manufacture of the preparation for 20-P2-341 xerostomia and the evaluation Yoshimi Otsuka 1, It is still 2 Matsunaga, Satoko Fujiwara 2, Hidenori Sagara 3, Kohei Kitagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

	As a member of the 20-P2-342 - eating, deglutition team the action to an eating function therapy by ... deglutition manual preparation Fumie Yamada 1, Tomoko Nakajo 2, Eriko Totsuka 3, Kenichi Osone 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

Relation of the pharmacist to the 20-P2-343 pressure sore measures team
Motoko Minemura 1, Hiroshi Kobayashi original 2, Eiji Suzuki 1, Noriko Machida 1, Yutaka Kubota 1, Yukiko Tsuchiya 1, Taeko Aoki 1, Takuya Furukawa 1, Takeshi Yamabe kernel 1, Kazuhiko Saito 1, Tokuko Shimizu 3, 斎木實 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2008.

Relation of the pharmacist to 20-P2-344 HIV infection treatment
Country book Yusuke 1, Job field Takashi 1, Keiichi Okahara 1, 片倉道啓 1, Hiroshi Nakata elegant 1, Rev. Noda original 1, Yuko Sasaki 2, There is the most top, and cross it; 2, Yanaka Miyuki 3, Yoshimura Maiko 3, Yutaka Yasui 4, Tei Ishida husband 4, Atsushi Miyamoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

Through patient compliance instruction in attitude survey and evaluation - mothers' class of the pregnant woman in the 20-P2-345 pharmacotherapy -
Sawako Hosono 1, Maki Sato 2, Yuko Hiraki 1, Hidaka sweetfish beauty 1, Murao south seas child 1, Masakazu Miyachi 1, Iida relationship 1, Tetsuro Yumoto 1, Small well 3, Tomo
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

Role ... as the pharmacist in action ... team approach in medical care to intravenous flow orchid constant infusion therapy induction in patients with 20-P2-346 pulmonary artery-related pulmonary hypertension
History of Sakuragi Kei 1, 杉浦宗敏 1, Miho Sano 2, Yumi Nakamura 2, Shie Ono 2, Hiromi Mori 2, Masaru Hatano 3, Hiroshi Suzuki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

	It is weighed HbA1c in a course and the two weeks course for 20-P2-347 diabetes education hospitalization one week Kato Yue Loong 1, Hiroaki Saito 1, Akira Murayama 1, Mitsuru Ota 1, 丹村敏則 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

Drug application preparations in anesthesiologist support task - operating room by the 20-P2-348 pharmacist
Toshio Awaya 1, Yasushi Yamashita example 1, Twig Masayoshi 1, Koichi Otaki 1, 2, Yuichi Itagaki 1, Kuniko Yamamoto 1, Chieko Hara 1, It is still 1 Masaru Takahashi, Satoshi Ogawa 1, Suno study 1, Hisashi Ono 1, Takehiro Yamada 1, Kaori Koshiro 1, Shinya Iida 1, Inoue Seicho 1, Noriko Umezu 1, 安達知輝 1, Rope river Tomoyuki 1, Hitomi Tsuzuki 1, Seven field Tomomi 1, Hemp lower Tomoka 1, Toshiyuki Miyoshi 1, Kazuo Matsubara 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

	Change - of the index of infection, the nutritional management in the result -10 year by 20-P2-349 infection measures team and a nutrient support team and the pressure sore measures team collaboration Yagi providential help 1, Hiroshi Ishii 2, Mie Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2008.

	Relation of the pharmacist in the 20-P2-350 breast cancer patients association Tomohito Nakazawa 1, 軽部真粧美 2, Mutsuko Kikuchi 2, Uki law 3, Mikio Shiozawa 4, Megumi Takehara 5, Omoto sum 5, Toshiaki Sudo 1, Yasuo Hozumi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

Analysis of the incident that a nurse in the 20-P2-351 Dokkyo medical college Hospital is involved in
早乙女聡良 1, Tomoaki Toyama 1, Soichiro Nakata 1, 長岡匠 1, Miyoko Horie 1, Satoru Usui 1, Keiko Osodo 1, Yuko Yashiro 2, Kimie Okusa 2, Emi Ueno 2, Junko Oyama 2, Mika Suzuki 2, 後藤浩恵 2, Mitsuharu Omori 1, Yukinori Usui 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

Analysis - of the drug information offer contents in action - ICU, the CCU ward to the risk management of the pharmacist in the 20-P2-352 acute phase medical care
Takahiro Amemiya, Kazuo Takayama, Chopped burdock root cooked in soy and sesame oil hemp Tamako, Yukari Sankaku, Yuko Nakajima, History of Sakuragi Kei, Katsuyoshi Nakajima, Hiroshi Suzuki
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

	Examination such as drug for household delivery products of the 20-P2-353 emergency cart (emergency cart) Masami Honda 1, 岩瀬利康 1, Chiaki Koshikawa 1, Hisao Matsushima 2, Kazuyuki Ono 2, Hideaki Sakio 2, Kayoko Suzuki 3, Michiko Yoshida 3, Sanae Toyota 3, Shizue Sayama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

	20-P2-354 pharmacist, action to the consciousness improvement for the error of the physician Shuichi Aoyagi, Hiromi Otomo, Jiro Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

Improvement of drug control, instruction business processes for the safe reinforcement of the 20-P2-355 pharmacotherapy
Masayuki Nishihara 1, Yasuko Harada 1, Masako Yoshikawa 1, Masahiro Yasuhara 1, Akiko Taniguchi 1, Yoshimura eyes 2, Encounter wish person 3, Five disciplines Yukihiko 4, Nobuyoshi Okudaira 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2008.

	Present conditions investigation about the 20-P2-356 medical care security Yutaka Fukaya 1, Kenichi Sagawa 1, 4, Toru Hirashima 2, Ryu Kawai beauty 2, 4, Tomiko Katsumura 3, Toshi Shibabe 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

	Analysis of background and the applied medicine of the 20-P2-357 fall fall patients Kyoko Obayashi 1, 2, Etsuko Nomoto 1, 3, 廣村佳樹 1, 4, 中嶌広美 1, 3, Yayoi Nagai 1, 5, Masahiko Kurabayashi 1, 7, Yasushi Yamamoto Jiro 2, 6, 野島美久 1, 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

	Revision - of relation - "fall risk reporting book of the pharmacist in the fall accident prevention of 20-P2-358 elderly patients of the drug" Yuko Ishikura, Nao Katayama incense, Foot Hideki Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

Action ... of the pharmacy about ward supervision of development of the administration support task by the 20-P2-359 ward pharmacist and evaluation - hospitalization prescribed drug
Yuki Kobayashi 1, Wakako Nagao 1, Tsuyoshi Katagiri 1, Yasuko Kuriki 1, Akiko Kitano 1, Plum shrine Yumi 1, 平田司 1, Sum Chie Kita 1, Chiho Iwaki 1, Straight Katsumi Shiroyama 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

	Analysis of the bringing medicine information for 20-P2-360 medical care security Akiko Emoto, Kazuhiro Hirano, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

	Examination about the risk by the misconception of the bringing medicine divided into a half lock in the 20-P2-361 medical care security Kazuhiro Hirano, Akiko Emoto, Masanobu Tazaki, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2008.

	Relation to the risk management of the 20-P2-362 pharmacist Chie Kiryu, Ryohei Suga, Sho Momoi system, Makoto Katsuta, Tomoko Okawa, Person from Kurokawa High School Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

	Questionary survey and examination about the medical supplies safety management workshop in the hospital attached to the 20-P2-363 Nippon University Matsudo school of dentistry Yasufumi Komatsuzaki 1, Field point Expo 1, Junko Kitsu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

	20-P2-364 Attempt of sharing of cooperation facilities, including Medicament allergies and side effects printed information 牛島智子, 宮村重幸, 上田奈穂, 森山かおり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

The situation for the evaluation of the disaster manual for patients with 20-P2-365 diabetes and the disaster in medical facilities under Ehime
Takeichi Yoshiji 1, Well hilum Keiko 1, Risako Yamashita 1, 末丸克矢 1, Fujiko Ikeda 2, Manabu Amano 3, Jin Machida 3, Hiroaki Miyaoka 4, Haruhiko Osawa 5, Hiroshi Araki positive 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

	The activity of medical safety management - medical supplies safety management person in charge in the 20-P2-366 Kochi medical center and future problem Teruo Tanaka 1, Yuki Okazaki 1, 服部暁昌 1, Rieko Matsumoto 2, Akio Takeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

	Analysis of the factor structure about the safe climate of the 20-P2-367 drugstore Akiko Nakagawa 1, Tokiko Okuda 2, Downhill path static Kei 2, Nobuaki Takahashi 2, Motoyashiki Kayoko 2, Mitsuko Onda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2008.

To ward duties expansion in the 20-P2-368 Aichi Medical University Hospital wrestle; questionnaire findings - to a nurse before and after the (1)-pharmacist permanent residence
Makoto Nakamura Tsu child, Nozomi Nishida Kushiro, Masanari Hagiwara, Maki Arakawa, Iku Kawamura person, Yukio Toyama, Hiroko Saito, Takaaki Hasegawa
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

To ward duties expansion in the 20-P2-369 Aichi Medical University Hospital wrestle; pharmacist duties - in the (2)-operating room satellite pharmacy
Masafumi Onishi 1, Tomoyuki Nonogaki 1, Noriko Sakaida 2, Hiroshi Ito 3, Toru Komatsu 3, Shunsuke Kurono 1, Hiroko Saito 1, Takaaki Hasegawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

	To ward duties expansion in the 20-P2-370 Aichi Medical University Hospital wrestle; relation - to the ICU of the (3)-pharmacist Masanari Hagiwara 1, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Hiroshi Noguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

To ward duties expansion in the 20-P2-371 Aichi Medical University Hospital wrestle; about administration and TDM of phenobarbital in the (4)-NICU -
Saori Kato 1, Tadao Kimura 1, Umaki Kato 1, Kana Ichihashi 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Daisuke Muto 2, Atsuko Shibata 2, Masahide Nimura 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

To ward duties expansion in the 20-P2-372 Aichi Medical University Hospital wrestle; blood 5-FU level of (5)-sigmoid colon cancer 1 case - at bevacizumab combination
Kazuo Hotta 1, Fumie Abe 1, Masanari Hagiwara 1, Masayuki Ejiri 1, Maki Arakawa 1, Iku Kawamura person 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Field wave Toshiaki 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

To ward duties expansion in the 20-P2-373 Aichi Medical University Hospital wrestle, and is associated with use of the chemotherapy by the permanent residence pharmacist in the (6)-this hospital urology department ward; -
Maki Arakawa 1, Kazuo Hotta 1, Saori Kato 1, Iku Kawamura person 1, Nozomi Nishida 1, Kushiro, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Yoshiaki Yamada 2, Yasuaki Honda 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2008.

One - that we wrestled, and a local insulin allergy symptom developed in patients with (7)-type I diabetes mellitus to ward duties expansion in the 20-P2-374 Aichi Medical University Hospital
Masayo Tanahashi 1, Tatsuya Muto 1, Yukio Toyama 1, Hiroko Saito 1, Takaaki Hasegawa 1, Koichi Kato 2, Chisato Inagaki 2, Otake cluster 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

Medication actual situation - of the children who wrestled, and became clear by a use of (8)-drug situation investigation to ward duties expansion in the 20-P2-375 Aichi Medical University Hospital
Sekido Izumi 1, Atsumi Sato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Megumi Aoyama 2, 堀壽成 3, Crane Seiji Sawa 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

Example - of patients with extensive burns that wrestled, and suffered from administration plan of the (9)-teicoplanin to ward duties expansion in the 20-P2-376 Aichi Medical University Hospital
Kato Takahiro 1, Masanari Hagiwara 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 3, Hiroshi Noguchi 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

1 case - that we wrestled and performed the headache monitoring with the (10)-Beraprost Na timed-release tablet to ward duties expansion in the 20-P2-377 Aichi Medical University Hospital
Tomoe Sato 1, There is Nagase, and cross it; 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Rika Hasegawa 2, Koji Wakita 2, Takaaki Hasegawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

To ward duties expansion in the 20-P2-378 Aichi Medical University Hospital wrestle; (11)-warfarin and enteral feeding and interaction - of the intravenous hyperalimentation
There is Nagase, and cross it; 1, Tomoe Sato 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Fumitaka Isobe 2, Takaaki Hasegawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

To ward duties expansion in the 20-P2-379 Aichi Medical University Hospital wrestle; present conditions investigation - of the painful rate and desensitization rate of patients with (12)-cancer
Nozomi Nishida Kushiro, Yukio Toyama, Maki Arakawa, Saori Kato, Moat appearance Kazuo, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2008.

One - that we wrestled and produced amenorrhea by (13)-docetaxel administration to ward duties expansion in the 20-P2-380 Aichi Medical University Hospital
Yumiko Goto 1, Tomomi Funahashi 1, Hino black beauty 1, Hiroaki Kato 1, Forest pre-1, Shibi, Shoko Kinoshita 2, Takaaki Hasegawa 1, Eiji Mihara 3, Masakazu Nita 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

To ward duties expansion in the 20-P2-381 Aichi Medical University Hospital wrestle; contribution - of the use situation and the pharmacist of the (14)-fondaparinux Na subcutaneous injection
Masayuki Ejiri 1, Makoto Nakamura Tsu child 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Morishima farsighted view 2, Shiro Hirose 2, Takaaki Hasegawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

It is examination ... from ... laboratory values for the effective medication counseling for 20-P3-401 diabetes and patients with hypercholesterolemia
Maki Egawa 1, Yui Ishimaru 1, Maho Doi 2, 石田茂 3, 村川公央 4, Kazuaki Shinomiya 1, 2, Hiromi Kawasaki 3, Sendo Toshiaki 4, Yoshihisa Kitamura 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

For the effective medication counseling for 20-P3-402 diabetes and patients with hypercholesterolemia examination - from - disease degree of improvement
Yui Ishimaru 1, Maki Egawa 1, Maho Doi 2, 石田茂 3, 村川公央 4, Kazuaki Shinomiya 1, 2, Hiromi Kawasaki 3, Sendo Toshiaki 4, Yoshihisa Kitamura 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

	Examination - second report - of the drug which has an influence on the glycemic control of patients with 20-P3-403 diabetes Emiko Asakura 1, 久英男 1, 土屋辰司 2, Kazuko Otsuka 3, 横山道江 4, Yuko Fujiwara 5, Tsukahara sky 5, Tomomi Yoshida 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

	Examination tertiary report of the drug which has an influence on the glycemic control of patients with 20-P3-404 diabetes 久英男 1, Emiko Asakura 1, 土屋辰司 2, 横山道江 3, Kazuko Otsuka 4, Yuko Fujiwara 5, Tsukahara sky 5, Tomomi Yoshida 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2008.

Examination 1 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-405 family drugstore about the physical condition changes of subjects of the smoking cessation instruction:
Satoyo Miyata 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Asami Matsumoto 1, Murakami truth road 1, Ryuichi Ogawa 2, Makoto Watanabe 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

Examination 2 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-406 family drugstore about exhalation carbon monoxide densitometry:
Asami Matsumoto 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Satoyo Miyata 1, Murakami truth road 1, Ryuichi Ogawa 2, Makoto Watanabe 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

Follow-up questionary survey of the subjects who received smoking cessation instruction examination 3 of the smoking cessation instruction using "the standard manual for smoking cessation treatment" in the 20-P3-407 family drugstore
Murakami truth road 1, Asami Matsumoto 1, Kozue Shinozaki 1, Shinohara Keisuke 1, 高倉浩臣 1, Satoyo Miyata 1, Ryuichi Ogawa 2, Makoto Watanabe 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

	Patients questionary survey about 20-P3-408 hypoglycemia Makiko Ogawa, 葛葉守, Reiko Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

Effect of the macrolide drugs which gives it to the hydrogen peroxide instruction cell death of 20-P3-409 Calu-3 cells
Kusakabe young of sweetfish 1, Rocky mountain books for admonition 2, Keisuke Otsu 2, Yasushi Takahashi soldier 2, Design of turbulent waves Ryosuke 2, Yoshiko Tanbo 2, Eriko Murakami 1, 早勢伸正 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

	Examination of the factor which has an influence on the clinical response of 20-P3-410 VCM Junko Ogura, Yasuhiro Nakano, 藤本希久加, Akira Kato example, Rie Kobayashi, Ayumi Ishioka, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2008.

	Utility examination of miglitol in patients with 20-P3-411 type II diabetes mellitus Satsuki Azuma 1, Miwako Watanabe 1, 福井宗憲 1, 弘世貴久 2, Noriyuki Sano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

	Examination of doxazosin for congestive heart failure patients with hypertension of the 20-P3-412 early morning Ayaka Shiozawa 1, Junko Narikawa 2, Hiroshi Tanaka period 2, 小林靖奈 1, Masashi Saito 2, Junichiro Murayama 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

	20-P3-413 Compare on the usefulness of Insulin detemir and Insulin glargine intended for the type 1 diabetes patients 大谷寧次郎, 後藤昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

	Examination of the fondaparinux administration after the 20-P3-414 total hip replacement enforcement Kazuko Yamanaka 1, Yasuyuki Saeki 1, Ryoko Mori 2, Takuma Yamazaki 3, Furrow well Hiroko 1, Kazumi Kitamura 2, Yuji Yasunaga 3, Yasuhiro Kimura 1, Tree flat Kenji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

	An effect of 20-P3-415 pioglitazone and fact-finding of the side effect expression Akiko Mizoguchi 1, Yukihiro Tsuji 1, Shinnichi Sado 1, Sone book Emi 1, Masami Murakami 1, Naoyuki Hirakata 1, Kazunari Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

	Action of the pharmacist in the 20-P3-416 ITB treatment (intrathecal baclofen therapy) Yumi Yoshida 1, Kyoko Sato 1, Hidekazu Takamatsu 1, Akiji Arikawa 2, Shiro Miyata 2, Shinji Yamashita 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2008.

Examination of the simple suspension method application for the 20-P3-417 theophylline controlled release-related tablet
Every field Chieko 1, Rika Sasaki 1, Michiko Sakai 1, Taniguchi lawn intellect 1, Haruka Tomita 1, Koji Muto 2, Wataru Takizawa beauty 2, Yukiko Oshiki 2, Kazuyuki Saito 1, Side shop Yoshibumi 1, Etsuko Miyamoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

Examination about the proper use of the antimicrobial agent with the 20-P3-418 laparoscope lower cholecystectomy pass
Your Ishikawa friend 1, Makoto Hayashi 2, Chiaki Okamoto 1, Hiroshi Hori tree 1, Truth Naoyuki Eda 1, Miwa Yotsumoto 1, Katsuhiko Takano 1, Sanae Fujiko 1, Koji Abe 2, Aspect shrine Koji 2, 黒阪慶幸 3, Teruaki Nakagawa 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

	Genetic factor to influence efficacy of methotrexate in patients with 20-P3-419 articular rheumatism Hideki Hayashi 1, Chihiro Fujimaki 1, 坪井声示 2, 4, Kishi, Daimon, Matsuyama solstice 3-resistant, Kazuyuki Inoue 1, Kunihiko Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

Study on symptom after the inhalational instruction of the 20-P3-420 antiasthmatic drug and patients satisfaction
Rina Kishi 1, Yoko Kurata 1, 4, 山田真之亮 1, Masaya Hasegawa 2, Kiyobumi Yamada 2, Toshitaka Nabeshima 5, Yoshinori Hasegawa 3, Hiroaki Kume 3, Yukihiro Noda 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

	Utility of the lecture about the pharmacotherapy by the pharmacist for the nurse concerned with 20-P3-421 diabetes practice Aki Kubota 1, Eitaro Nakajima 2, 3, Aki Ito male 1, Jiro Nakamura 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

Effect expression of 20-P3-422 warfarin investigation
Ito greens wave 1, Ayumu Nozaki 1, 茂木孝裕 1, Tomoko Fujita 1, Satoru Miyamoto seedling 2, Yutaka Muranishi true 2, Makoto Utsunomiya 2, Ryuji Yamamoto 2, Yutaka Mizobuchi 2, Atsushi Funatsu 2, Tsunemi Kotaro 3, 吉井康欣 3, Tomoko Kobayashi 2, Hirokazu Nakanishi 1, Masafumi Morita 3, Enjoji Yoshihisa 2, Shigeru Nakamura 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2008.

The effect of the proton pump inhibitor on serum phosphorus level in the 20-P3-423 calcium carbonate remedy hemodialysis patient and relations of the genetic polymorphism
Kanai A Kei 1, Mt. Hisagi Atsuko 2, Noboru Tazoe 3, 中山眞人 4, Nobuhiko Ikezaki 5, Motoko Tanaka 6, Hideo Hirayama 7, Hirofumi Kai 8, Tsuyoshi Shuto 8, Toru Irie beauty 9, Esaki hsiang tsai child 1, Daisuke Kadowaki 1, Sumio Hirata 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	Heart squama lesion investigation in the 20-P3-424 ergot system dopamine agonist preparation remedy patients Kazunori Yamada 1, Mai Onishi 1, Tomori Mizuguchi 1, Mami Shimakawa 1, Woodcut former 1, Nobuhito Murakami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	Investigation - of a pain, the itching after spinal anesthesia - cesarean section using 20-P3-425 morphine hydrochloride Yoshie Nomura 1, Akira Takahashi 1, Shuichi Matsumoto 1, Yuichiro Takahashi 2, River fin Ichiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	Efficacy for haemodynamic unstable ventricular tachycardia of the preparation for the 20-P3-426 amiodarone hydrochloride IV infusion and the ventricular fibrillation and safe evaluation Jun Hirano, Eri Kinoshita, Morihiro Okada, Kazuhiro Ito, Kazue Sakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	Patient compliance instruction in relation - proteinuria-positive patients of the pharmacist for the 20-P3-427 CKD prevention and importance - Kana Okumura 1, Toru Maeda 1, Chigusa Kikuchi 1, Atsushi Yoshida Expo 2, 木村和哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	Examination about the initial therapy for 20-P3-428 Clostoridium difficile-related diarrhea Mika Kusanagi, Naoko Isoda, Tomomi Mori, Takeshi Morimoto trunk, Upper ability Yuki, Yasushi Osato chapter, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2008.

	The combination of drugs in the HIV treatment in the 20-P3-429 this hospital and investigation examination of the drug change Mariko Arai 1, 斉京明子 1, Hiroyuki Tanaka 1, Ayako Wada 1, Mika Suguro 1, Hajime Matsubara 1, Yoko Takayama 3, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	Meta analysis about an effect and the safe comparison between oral bisphosphonate and raloxifene for patients with 20-P3-430 postmenopausal osteoporosis 高地恵市 1, 2, Ryuichi Ogawa 1, Harumi Takahashi 1, Kazumi Goto 2, Hirotoshi Echizen 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	20-P3-431 benzodiazepine system, analysis using effect on postoperative delirium investigation ;Propensity Score of non-benzodiazepine drugs Yoko Ishiguro, Yasuhiro Miyakawa, Atsumi Nitta, Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	As relation - hospital pharmacist, diabetes medical treatment instruction person to the use of 20-P3-432 insulin patients - Miho Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	20-P3-433 Study of the usefulness of as neuronal differentiation-inducing agent of acute promyelocytic acute leukemia treatment Tamibarotene (Am80) 潮平英郎, 北岡明, 遠城寺宗近, 中島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	Quantity of Warfarin stability to predict from an INR rate of change in 20-P3-434 early stage 蝦名範嗣 1, Naoko Fujita 1, Yuki Kimura 1, Metoki Norifumi 2, 齊藤元太 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2008.

	Examination about the evaluation of the glycemic control in the treatment with 20-P3-435 oral hypoglycemics Kazuo Hattori 1, Takahashi greens child 2, Akihiko Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	20-P3-436 Examination of the clinical response of the darbepoetin alpha 渡部達也, 石崎文子, 中村聡, 鈴木邦弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	20-P3-437 Comparison of the effect of treatment in epoetin alfa and the darbepoetin alpha 渡部優, 石谷麻里子, 関根有貴, 神田侑子, 松井七奈, 久保悠, 小財弘己, 今田深雪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	The present conditions of 20-P3-438 myocardial infarction secondary prevention guidelines and the prescribed drug Hiromi Nagai, Hiroko Enota, Emi Momiyama, Yoshie Nishiyama, Yoshie Araki, Tomoko Shibata, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	20-P3-439 Efficacy evaluation after Insulin detemir injection introduced in our hospital 船間みさ1, 小幡恵美1, 後藤啓之1, 工藤琢也1, 松田大輔2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	20-P3-440 Study by Basal Insulin change in Basal-Bolus therapy enforcement patient: From NPH Insulin to Insulin detemir 中島啓二1, 西脇加代1, 宇佐美英績1, 安田忠司1, 傍島裕司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2008.

	Investigation about the blood test in patients with 20-P3-441 end stage renal failure and the use drug Tadashi Kitagawa, Takeshi Morimoto trunk, The Yasushi Yokoyama method, Kamiyoshi Noriko, Mika Kusanagi, Chika Sakano, Upper ability Yuki, Yasushi Osato chapter, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

	Glycemic control after the insulin induction when a 20-P3-442 diabetes medical treatment instruction person licensed pharmacist (CDE pharmacist) was concerned Tiger shallows Kazuko 1, Mitsui sincerity fine weather 1, Sumie Fujii 2, Takashi Seta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

	Examination of the effect that 20-P3-443 benidipine hydrochloride gives to various kinds of protein urine excretion of the essential hypertension patients Tetsuya Fujimoto 1, Yoko Matsushita 1, Maiko Machida 1, 武智茂 2, Shigeo Kakigi 3, Koichi Kanda 4, Norikazu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

	The change of the drug choice of the antiHIV therapy in the 20-P3-444 this hospital (ART) Small house Yoshiko 1, Tomomi Sato 1, Maki Sato 1, Tatsuya Goto 1, 諏江裕 1, Toshihiro Ito 3, Isao Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

	20-P3-445 A study on the effects of β-Lactglobulin for food allergic gastrointestinal symptoms induced model mouse 大島新司, 小熊良裕, 石井達也, 指田達也, 細谷治, 從二和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

Comparison between complications and lipids management target achievement quotient - secondary prevention case and high-risk primary prevention case - of 20-P3-446 dyslipidemia
Ryu Nishiwaki wide 1, Mitsutoshi Sato 1, Fumihiko Yoshie 2, Daisuke Kishi 2, Koji Hamada 2, Keiko Fukuda 2, 雪吹周生 3, Kiyohiko Seino 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2008.

	Utility of darbepoetin alfa in anemia in renal disease treatment of the 20-P3-447 hemodialysis patient Chihiro Takatsu 1, 2, Old Taku Kubo 2, Satoshi Izumi 2, Chiharu Matsunaga 2, Negoro early Noriko 2, Maekawa Kiyoshi 3, Tomoyuki Yamakawa 3, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

Collaboration system - with clinical trials -SMO (trial site support organization) of a cancer region in the 20-P3-448 Kochi medical center and the emergency region
Katsuya Yoshitani 1, Natsuko Kozaki 1, Okada indigo plant 1, Matsuki sand Wakako 1, Kayoko Okada 1, 服部暁昌 2, Teruo Tanaka 2, Junichi Fukada 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

Investigation about examination results at new trial examination in 20-P3-449 many institutions
Shinnichi Yokota 1, Yumiko Saito 1, 2, Kioroshi flourishing endlessly 3, Yoshinobu Sasaki 1, 2, Tomomi Nakamura 1, 2, Mizue Shida 1, 2, Mika Maeda 1, 2, Naoko Kamimiya 1, 2, Yukio Ogawa 1, 2, Masaichi Kuroyama 1, 2, Yuji Kumagai 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

The present conditions of the trial secretariat duties in the 20-P3-450 clinical trials department and future problem
Hajime Yamazaki, Mutsuko Tamura, Naomi Yamamoto, Megumi Harada, Natsumi Matsuda, Hideyuki Hayashi, Hiroko Shigematsu, Tomoyuki Iwasaki, Yoichi Yamamoto, Kazunori Asano, Sako field Saburo
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

From experience of correspondence - voluntary clinical trials support of the CRC for the 20-P3-451 ethic guideline revision -
Mieko Hagiwara 1, Akiko Ito 1, Hiroyasu Sasahara 1, Seiichi Maruyama 1, Atsuko Nagasawa 1, Kumi Yamanaka 1, Yayoi Koyanagi 1, 鈴木由加利 1, Kazuhisa Sasahara 1, 吉澤弘久 1, Hiroshi Sato 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

	Support of pharmacist TRC in 20-P3-452 alveolar bone reproduction clinical studies Minako Kawano 1, 2, Nakajima Ikue 1, 3, Kumiko Sumino 1, Kazushi Matsumoto 1, Yosuke Kurokawa 2, Hideaki Kakumu 4, 東條有伸 5, Fumitaka Nagamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2008.

	Safety of medicine evaluation - chemotherapeutic agent - that we saw it from 20-P3-453 clinic dose, an exposure level and a nothing toxic level, an exposure level Arumi Hideto 1, Kazuyuki Saito 2, Shunsuke Ono 3, Hironobu Kodama 4, 中出進 5, Tsuneo Kodama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

	The present conditions of the large-scale clinical trials enforcement about the 20-P3-454 circulatory system disease Chiaki Okamoto, Hiroshi Hori tree, Truth Naoyuki Eda, Miwa Yotsumoto, 石川友貴, Katsuhiko Takano, Sanae Fujiko, Teruaki Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

	About the use corresponding to the clinical record seal in the 20-P3-455 electronic chart Keiko Fujita, Noriko Oyama, Yoshihiro Sakagami, Emiko Tanaka, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

The medical communication training using the simulated subjects for the staff engaging in 20-P3-456 trial
Mitsuko Morita 1, 川村之則 1, Takashi Suzuki charges 1, Kayoko Uehara 1, Kurita beauty 1, Nae, 1000, Keta Emi 1, Shun Morita 1, Hajime Iijima 2, Kuniaki Fukushima 2, Kenji Chiyoda 2, Southern part sincerity 2, Toshihiko Hiraoka 2, Hiroshi Yamada 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

It is a pharmaceutical evaluation by the clinical judgment analytical procedure an optimal evaluation of the adjuvant endocrine therapy in patients with breast cancer after 20-P3-457 menopause
Yoshiko Miyazaki 1, Hisashi Shimizu example 2, 野村久祥 3, Ichiro Arakawa 4, Tadao Inoue 5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

	Examination about antimicrobial agent costs by the pneumococcal pneumonia clinical path induction in the 20-P3-458 this hospital Mieko Suzuki 1, Upper ability Yuki 1, Yasushi Yokoyama method 1, Yasushi Osato chapter 1, Yoshihiko Kida 1, Yasushi Uryu chapter 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2008.

	Examination of the use actual situation of OTC medical supplies during 20-P3-459 pregnancy and the safe information science Bamboo blind Takashi 1, Kudo sheath or 1, Small Asami Noguchi 2, Trimming off Expo 3, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	Seasonal examination of the INR target value control of the 20-P3-460 Warfarin remedy patients and the bleeding risk Eiji Hatakeyama 1, Yoshiko Kadota 2, Takashi Fukazawa 2, Yoichi Oe 2, Hajime Kagaya 2, Saruwatari power 4, Toru Sato 1, Tomoji Osawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	Research about the switching of the selective serotonin reuptake inhibitor (SSRI) using 20-P3-461 medication history data Kazumi Nagai 1, 2, Kunihiko Hayashi 2, Katsunori Nakamura 3, Tatsuya Horiuchi 1, 3, Yasushi Yamamoto Jiro 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	Use fact-finding (4) of antihypertensive medications using the medication history data of the 20-P3-462 wish star drugstore Takeshi Honma, Three fossa Kazuo, Toshimi Iizuka, Upper Yamawa road, Masami Horiguchi, Hideo Ishizuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	Analysis of the returned goods medicine in the 20-P3-463 hospitalization prescription Tomoko Nagata, Hiroko Akasaka, Tajima Keiko, Kenzo Senzaki, Iku Tamura, Kayoko Ihara, Seki Kyoko, Takayuki Mizoguchi, 鹿間良弥, Takashi Inoue solstice, Fukuda Yasuaki, Yukinari Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	Comparison ... with investigation - medical institution consultation time about the economy of the self-medication with 20-P3-464 OTC medical supplies Shigeru Umeno intellect 1, Mikiro Nakajima 1, Michiko Ueda 2, Nobuya Ueda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2008.

	20-P3-465 type II diabetes mellitus association drug costs and patients background, relations with the control situation Mihoko Tesaki 1, Aya Fujinami 2, Koji Hasegawa 1, 向誠一郎 1, Hitoshi Okugawa 4, Michiko Hayakawa 3, Kenzo Ishihara 5, Mitsuhiro Ota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

	Establishment of the assay with the liquid chromatography tandem mass spectrometer of 20-P3-466 pyrrole - imidazole polyamide Tomoyuki Watanabe 1, Takashi Nagashima 1, Akiko Fukazawa 1, Takahiko Aoyama 1, 上野高浩 2, Noboru Fukuda 3, Hiroki Nagase 3, Yoshiaki Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

Establishment of the rat biliary level of 20-P3-467 pyrrole - imidazole polyamide assay by the high performance liquid chromatography
Akemi Shiotani 1, Takashi Nagashima 1, Akiko Fukazawa 1, Takahiko Aoyama 1, 上野高浩 2, Noboru Fukuda 3, Hiroki Nagase 3, Yoshiaki Matsumoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

	Pharmacokinetics of fat-soluble model drug menatetrenone in the 20-P3-468 dyslipidemia rat Kumiko Ueda, Mayumi Yoshida, Maiko Ueda, 吉村善榮, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

	Effect of the phenytoin dosing period on instruction of CYP3A and P glycoprotein in 20-P3-469 rat liver and the small intestine 大鳥徹, Asami Oka, Atsushi Kawase, Mitsutaka Takada, Masahiro Iwaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

Expression of drug transporter change in the liver of the 20-P3-470 endomorph diabetes model TSOD mouse
Toshiyuki Kudo 1, Iori Igarashi 1, Abe Rieko 1, Mariko Yoshizawa 1, Yudai Toda 1, Tsutomu Shimada 2, Wataru Suzuki 2, Igarashi sincerity intellect 1, Kiyomi Ito 1, Oil field Masaki 2, Kiyoshi Sugiyama 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2008.

	Enterobacterial effect to give to the expression of drug transporter in the 20-P3-471 liver Yudai Toda, Ooi plane, Double cross Shintaro, Tetsuya Ono, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

	Effect of sex differences on change of the cerebrospinal fluid transitivity of lithium with 20-P3-472 acute renal failure 坂江利恵, Atsuko Ishikawa, Koji Kobayashi, Two sect Tomoko, 合葉哲也, Hiromi Kawasaki, Yuji Kurosaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

	The specific transportation promotion phenomenon that was observed in transport property analysis of ribavirin using the 20-P3-473 human erythrocyte membrane vesicle Eri Kimura, Hanada existence Utako, Junya Nagai, Positive former Yoshiko, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

	20-P3-474 Establish an evaluation system by differentiation single layer membrane model of human choriocarcinoma cell line JEG-3 with the aim of indicators of placental barrier drug permeation 池田賢二, 名徳倫明, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

	Contribution of the oxidative stress that a plasma protein binding rate of the drug decreases under 20-P3-475 cancer clinical condition Ryo Matsushita 1, Yuya Kondo 2, Shino Hatta 2, Kenichi Miyamoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

	Pharmacokinetics of Co-enzyme Q10 included in 20-P3-476 new combination software capsules Kunihiro Nitta 1, Hiroyuki Sasagawa 1, Yoko Kubota 2, Koji Kashima 3, Relation next fortune 4, Akihiko Isobe 5, Jin Matsumoto 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2008.

Effect of the digestive tract function in the acetaminophen desensitization effect by the 20-P3-477 PK/PD analysis
Igarashi sentence 1, Takahiko Aoyama 1, Yumi Koyama 1, Hiroshi Kobayashi 1, Akira Mori 1, Hisashi Oshima 1, Takashi Suzuki 1, Takeshi Kikutani 2, Yoko Oe 3, Yoshiaki Matsumoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

Efficacy change - of the pravastatin in consideration of pharmacometrics - circadian rhythm of the dyslipidemia therapeutic drug by the 20-P3-478 PK/PD analysis
Takafumi Nagashima 1, Takahiko Aoyama 1, Tomoyuki Watanabe 1, Akemi Shiotani 1, 上野高浩 2, Noboru Fukuda 3, Yoshiaki Matsumoto 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

	Effect to give efficacy and sleep of the 20-P3-479 statin Naoki Okamoto 1, Kazuo Hattori 1, Miyako Azuma 2, Akihiko Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

	Absorption change of cyclosporine with the 20-P3-480 digestive symptom Charcoal Masaki 1, Masaru Ota kernel 1, Hiroshi Konishi oneself 1, 2, Nobuo Hoshino 1, 蓑内徳蔵 1, Akira Yamaji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

Relations with a PK parameter and the clinical outcome of 20-P3-481 cyclosporine and the tacrolimus
Hiroki Takeuchi 1, Hiroyuki Uchida 1, 5, Tiger stone Riyusuke 3, Kiyoshi Okuyama 3, Konno law of nature 2, Yuki Nakamura 2, Koichiro Hama 2, Hitoshi Iwamoto 2, 葦澤龍人 2, Tadashi Matsuno mischief 2, Toshihiko Hirano 4, 長尾桓 2, 畝崎榮 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

	The evaluation of the teicoplanin free drug concentrations in patients with 20-P3-482 hypoalbuminemia and examination of the effect of treatment Hiromi Yanamoto 1, 寺松剛 1, Takeshi Moriguchi 2, Kenichi Matsuda 2, Masahiko Suzuki 1, 花輪剛久 1, Toshio Oguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2008.

Combination therapy - pharmacokinetics and clinical response - of tacrolimus and mycophenolic acid in 20-P3-483 renal-transplant recipients
Valley Kumiko 1, Hiroaki Tanaka 1, Takashi Motoki University 1, Sumio Kimura 1, Kazuko Higuchi 1, Masaki Ninomiya 1, 福岡憲泰 1, Masashi Inui 2, Water pipe 2, Zengyo, 芳地一 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

	Effect of the Byakko-ka-ninjin-to which gives it to pharmacokinetics of 20-P3-484 tetracycline and the ciprofloxacin Equal Kotaro 1, Masafumi Onishi 2, Shunsuke Kurono 2, Hiroko Saito 2, Miki Kato 1, Rough sea well Masayuki 1, Takaaki Hasegawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

Micafungin pharmacokinetics in the febrile neutropenia of patients with 20-P3-485 hematopoietic organ malignant tumor
City residence proton 1, Michiyoshi Kumi 1, Yasushi Nakagawa chapter 2, Kenji Suzuki 2, Nobuo Mochizuki 3, Keiko Ono 3, Satoshi Kishino 3, Yasuhiro Saeki 1, Masanobu Odaka 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

	Effect to give serum urate concentration of the antiandrogen therapy in 20-P3-486 prostate cancer Kayo Yamashita 1, 川奈部英洋 1, Hatsue Nagakura 1, 山下与企彦 2, Akihiro Oka 2, Maki Kimura 3, Hosoyamada truth 3, Toshiaki Shibazaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

PK/PD analysis - of action - progress, recurrent colorectal cancer chemotherapy of the 20-P3-487 Aichi Hospital Pharmacist Association on koro Gee meeting for the study
Akiko Tsukada 1, 2, Masayuki Ejiri 2, Saza Hideya 2, Atsushi Suzuki 2, Masanari Hagiwara 2, Kazuo Hotta 2, Eiji Yoneyama 2, Hiroko Saito 1, 3, Takaaki Hasegawa 1, Shin Hasegawa plan 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

	Comparison between construction and overseas data of the blood level trough value of the blood 20-P3-488 antiHIV medicine levels measurement support system Takeshi Kuwahara 1, 矢倉裕輝 2, 吉野宗宏 2, Katsuya Komori 2, Takuma Shirasaka 3, Sugiura Wataru 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2008.

	It is a 1 case of the methyl bromide poisoning by the exposure of the defectiveness cylinder empty can the role of the pharmacist in the 20-P3-489 acute poisoning Hiroko Nomura 1, Kanbara Eicho 2, Noboru Okamura 3, Takahiro Uchida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

	One case of the chronic hemodialysis patients who caused QT prolonged with the 20-P3-490 pilsicainide hydrochloride Katsuji Shimizu 1, Nakano sentence kernel 1, Upper ability Yuki 1, Kanbara Eicho 1, Yasushi Osato chapter 1, Yoshihiko Kida 1, Sumio Hirata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

Bleeding event investigation by the combination of the proton pump inhibitor in the 20-P3-491 warfarin remedy patients
Slope sum Sonoko 1, Hideki Hayashi 1, Misa Yoshizawa 1, Eri Sato 1, Masato Horino 1, Kazuyuki Inoue 1, Tashiro Kei straight 2, Midori Kimura 2, 河原崎貴伯 2, Hideaki Moriwaki 4, 秋本剛秀 3, Osamu Doi 4, Kunihiko Ito 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

EGFR, K-ras mutation in the gene detection using the SMAP method for 20-P3-492 personalized medicine
Yasumasa Mitani 1, 2, 清水公裕 3, 懸川誠一 3, Takuya Araki 4, Yasushi Yamamoto Jiro 4, Nako Hoshika 5, Hideki Takakura 5, Kenji Tatsumi 5, Jun Watanabe 5, Hiroshi Shimada 5, Lezhava Alexander1, Stone Takefumi Tao 1, 2, Taiji Kogo 1, 2, Yoshihide Hayashizaki 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

	Examination about the association between change and CYP2C19 genetic polymorphism of blood desmethyl clobazam levels by the 20-P3-493 stiripentol combination Sho Noguchi period, Yoshiaki Yamamoto, Nobuyuki Mishima, Yukitoshi Takahashi, Yushi Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

	*Case with the genotype of UGT1A16/28 which developed Serious ADR with 20-P3-494 irinotecan and SLCO1B115/15* Hiroshi Takane 1, Katsuyuki Kawamoto 2, 佐々木智啓 3, Kuniaki Moriki 1, Kazuyo Moriki 1, Hiromi Takeuchi 2, Shun Higuchi 3, Ichiro Ieiri 3, Kenji Otsubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2008.

	Promotion and present conditions ... of role - medicine notebook of the hospital pharmacist in the 20-P3-495 medicine - medicine cooperation Hirokazu Yamashiro, Yusuke Taki, Yoko Osawa, Kusaka Toyoshi, 揚張真利子, Kozue Kurihara, Toshiaki Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

Examination ... of the utility by the induction of the patients with further action ... on admission information communication list of on admission pharmacist duties using 20-P3-496 medicine, medicine cooperation
Yusuke Taki, Hirokazu Yamashiro, Yoko Osawa, Kusaka Toyoshi, 揚張真利子, Kozue Kurihara, Toshiaki Kitagawa
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

	Pressure from the 20-P3-497 nation to the "medicine medicine cooperation" practice that we can get trust from and future problem Kimio Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

Fact-finding ... which we turned to problem - medicine, the medicine cooperation of the patient compliance instruction of the ethical pharmacy in the 20-P3-498 warfarin outpatient department induction
Akiko Horikawa 1, Yoshino name Suiko 1, Masao Oguro 1, Fumiko Mochizuki 2, Iwade Kazunori 3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

Action aiming at acquisition rate improvement of the medicine notebook in 20-P3-499 medicine, the medicine cooperation
Tomoaki Katayama 1, Kyoji Terasawa 1, Jun Okamoto 1, Jun Ota 2, Masami Tanaka 2, Tokuko Matsumoto 3, Beam Seiji 4, Hiroyuki Yuge 5, Kenichi Miyata 2, Tomoko Yamashita 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

	Fact-finding of the 20-P3-500 medicine notebook utilization Mikako Senoo, Furrow well Hiroko, Yasuyuki Saeki, Yuka Shibata, Usui Kazuko Sana, We praise snipe Tae law of nature, Ai Inoue, Kajioka Kayo, 児玉優貴, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2008.

	Relation of the pharmacist to temporary correspondence at the 20-P3-501 food allergy onset Shinichiro Fukushima 1, Komada indigo plant 1, Yuki Yamamoto 1, Motonori Ito 1, Takeshi Iritani 1, Mizuho Nagao 2, Takao Fujisawa 2, Mitsumasa Iguchi 2, Ihara Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

About medicine medicine cooperation in the treatment with internal use anticancer drug of 20-P3-502 these days
Nomoto incense, 田中政康, Kazuo Komatsubara, It is still a person Tagashira, Yumiko Yamagiwa, Naruoka success, 小暮友毅, Katsuko Mabuchi, Kyoko Miyoshi, Matsuhisa Noriaki, Hisae Eguchi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

	Public - of the pharmacist lecture training specialized in role - cancer of the 20-P3-503 metropolis and districts cancer practice base Hospital Rieko Miyashita, Fumiko Kawahara, Takako Nakano, Haruki Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

	20-P3-504 Okayama Hospital Pharmacist Association group method hospital business training trial Takako Oda 1, Hama Yu Tani line 2, Shinji Yamamoto 3, Takashi Hamasaki 4, Chie Miyamoto 5, Daisuke Teshima 6, 増田憲俊 7, Sendo Toshiaki 8, Yoshiyuki Ishii 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

	About a long-term business training trial in the 20-P3-505 Okayama Hospital Pharmacist Association Muroyama Hideki 1, 7, Yoji Nakajima 2, Morimoto Katsu child 3, 坪井昭 4, Teruko Izawa 5, 増田憲俊 6, 7, Daisuke Teshima 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

	Action of the early on-site training (hospital) in the 20-P3-506 this school Taiko Masao, Katsuyuki Murakami, Ukyo Rieko, Kaori Kido, Takeshi Katsuyama, 齋田哲也, 前田共秀, Keiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2008.

	Action of the 20-P3-507 early stage on-site training "associated welfare university and inconvenient experience that cooperated" Keiko Morita, Taiko Masao, Katsuyuki Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

	Action of early on-site training - lifesaving first aid treatment in 20-P3-508 Kyoto Pharmaceutical University and future problem - Tsushima oneself good luck, 深田守, Tetsuo Nakata, Eiju Suzuki, Kazuki Nagasawa, Hiroshi Hamasaki, Masayuki Yamashita, Haruo Kanazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

From the questionary survey before and after the visit to evaluation (the second report) - hospital, drugstore of the early on-site training in 20-P3-509 Kyoto Pharmaceutical University -
Eri Yasuda 1, Akira Takayama 1, 2, Tsutomu Hashizume 1, 2, Tsushima oneself good luck 1, 2, Nobuhiko Nakamura 1, Kazuo Kuroda 1, Masahiko Shibakawa 1, Haruo Kanazawa 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

	20-P3-510 Analysis of evaluation of PBL Tutorial of implementation and product announcement [pharmaceutically use the medicine] first year 足立哲夫, 寺町ひとみ, 原宏和, 臼井茂之, 神谷哲朗, 葛谷有美, 土屋照雄, 平野和行, 永井博弌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

	The practice of the business training model core curriculum in the 20-P3-511 this hospital and the problems Now Yoshiko Takada, Shinichi Tamiya, Tomohiro Umemura, Tree Masaji, Saza Yaeko, Masashi Nakamura, Ikuro Suzuki, Tomohiko Aoyama, Kenji Tokui, Kazunobu Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

	- to use correspondence - information to 20-P3-512 business training model core curriculum definitely Fumiko Nakahara 1, 今田愛也 1, Kaori Honma 1, Mayuko Soma 1, Yoichi Sasaki 1, Akiko Iwakawa 2, Masashi Tomita 2, Mitsuhiro Okazaki 2, Tooru Hayakawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2008.

20-P3-513 Aiming to promote PBL Tutorial education to increase the motivation of pharmacy students to be the leaders of the medical
飯田耕太郎, 半谷眞七子, 大津史子, 亀井浩行, 野田幸裕, 後藤伸之, 岡本光美, 森健, 吉田勉, 伊藤達雄, 松葉和久
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

	Action to "patient compliance instruction" training of the 20-P3-514 business training model core curriculum Hisano Kitayama 1, 2, Hiromi Ogasawara 1, 長堀司 1, Yudai Miyamoto 1, Fumio Nakajima 1, Hisashi Nakajima 1, County 2, Shuutoku Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

	Four weeks training - that we adopted action - model core curriculum for the hospital business training for 20-P3-515 long term Miyoko Kurihara, Takayuki Ishimaru, Shinichiro Ando, Kazuaki Yonezawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

Grasp - of problems of the curriculum achievement in inspection - training period 2.5 months to achieve 20-P3-516 Hospital business training model core curriculum
Osamu Imakiire 1, Yukiko Inoue 2, Hama place Yuko 2, Mari Shuto 2, 安藝敬生 1, Yasushi Kataoka sentence 1, Masaaki Hirakawa 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

	Practice of PDCA when we adopt 20-P3-517 model core curriculum for normal business routine Small Hill Akiko to congratulate, Asako Shinozaki, Nagayoshi eyes, Yukie Muroya, Forest 1,000 rice, Kinuyo Matsuda, Yoshiko Harada, Kuniyoshi Sato, Kazuhiro Sase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

	Mental attitude of the pharmacy student for the 20-P3-518 first aid treatment enforcement Takeo Nakamura, Eiji Ito, Tadashi Miyake is elegant, Hiroshi Kuwajima, Etsuko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2008.

Induction of the confirmation of vital signs in the 20-P3-519 bedside training and the pharmaceutical clinical skill
Takamura rich person 1, Jin Tokunaga 1, Kenji Ogata 1, Hiroki Yoshida 1, Masashi Nagata 1, 2, Muneaki Hidaka 1, 2, Toshikazu Matsuoka 1, Seiji Ono 1, Ryuichi Yamamoto 1, Kazuhiko Arimori 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

As a trial of the communication education to qualitative examination - pharmacy student of the role playing training about the 20-P3-520 informed consent scene -
Etsuko Arita 1, 2, Jun Ujihara 2, Akiko Omori 2, Satoko Kamata 2, 東慧子 2, Nishijima incense 2, Masaharu Taga 2, Tatsuya Watanabe 2, Atsushi Yokoyama 1, Kanji Tsuchimoto 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

	Construction of the communication education for lower grades pharmacy students to make the 20-P3-521 patients understood 半谷眞七子, Hiroyuki Kamei, Kotaro Iida, Kazuhisa Matsuba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

	Upbringing of the base of the medical person by the participation, practice type communication education in the 20-P3-522 lower grades Yuko Tomita 1, Kato Noriaki 1, Is Kurata; see it; 2, Miwako Kamei 2, Yuji Kiuchi 3, 戸部敞 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

Investigation about enforcement of the patient compliance instruction training for 3 annual students in 20-P3-523 Kobe College of Pharmacy and the education effect
Yuko Matsuda 1, Yagi Keiko 1, Chikako Numata 2, Yukiyo Nakao 3, Takashi Michigami 4, 長野恭久 4, Akeda Takeshi 5, Mihoko Taniguchi 1, Hiroe Mizutani 1, Toshiko Kiguchi 1, Kensho Emoto 1, Hirai green 6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

	Consciousness structure analysis of the student to worth doing for the 20-P3-524 patient compliance instruction Yukari Shibata, Akio Kochi, Toshiro Motoya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2008.

Evaluation of the quality of activity report - simulated patient (SP) of the 20-P3-525 west area of a castle international university pharmacy school simulation patients association
Takashi Tomizawa 1, 2, Mika Ozawa 1, Chika Nakamura 1, 2, Takehira Rieko 1, 2, Hiroshi Kawai 1, 2, Yoshihisa Tomioka 1, 2, Shigeo Yamamura 1, Shinichiro Nakajima 1, 2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	It is ... for the medical healthcare worker who learns, and is better than one ... necessary for 20-P3-526 pharmacy student Maki Yamamoto 1, 2, Yokoi fathom sum 1, 2, Masaru Yuguchi 2, Kida sand sound village 2, Yoshihiro Nagai 2, Hiromi Okazaki 3, 名倉弘哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	Evaluation for the communication training by the Eiji mixing method in the learning before 20-P3-527 business true taking lessons Teramachi eyes 1, Yumi Kuzutani 1, Tetsuo Adachi 2, Teruo Tsuchiya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	The on-site training raises motivation for the pharmacy in 20-P3-528 early stage, and help a future course design; or from results of the questionary survey: Toshitaka Nabeshima, Tadashi Taguchi cord, Mitsuyoshi Okamoto, Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	Development and practice of the effective method of education in the great lesson type lecture of the 20-P3-529 pharmacy school Tadashi Taguchi cord, Ichitomo Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	Effect of the 1.2 annual on-site training in the 20-P3-530 pharmacist education Noriko Kobayashi, Junko Kitsu, Tadashi Kasahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2008.

	The pharmacy student early stage on-site training that 20-P3-531 Haneshima Municipal Hospital aimed at Keiichi Goto, Suguru Nishimura still, Kazuhiro Asai, Watanabe method man, Eiji Yamamoto, Tadako Ohashi, Kimio Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

Based on the questionary survey of the present conditions and the evaluation -1 annual life, institution leader of the early on-site training in 20-P3-532 Tokushima Bunri University -
Miki Iguchi, Shono sentence, Masami Tanaka, Shinya Suzuki, Hiroto Kaku, Yoichi Matsunaga, Toshihiro Hashimoto, Masao Toyota, Takashi Kuzuhara, Akemi Umeyama, Yasuyuki Yagi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

	Questionary survey to an enforcement system and the student of the early on-site training in the 20-P3-533 Kyushu University pharmacy school Daisuke Kobayashi 1, Tomoko Okada 2, Takao Shimazoe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

	Accept an on-site training in 20-P3-534 early stage; and as a pharmacist of - care health center for the elderly and the general hospital - Rika Tomita 1, Reiko Nakamura 2, Chieko Murayama 2, Katsuhiko Okumura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

	Attitude survey of 2 annual students for the realistic problems in the 20-P3-535 healthcare setting 久岡清子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

	Problem solving type education in the 20-P3-536 Arizona University pharmacy school Jin Nakamura 1, Michael Katz2, Michinao Mizugaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2008.

	The present conditions and expectation second report of the pharmacist function in the 20-P3-537 psychiatrist medical care Akio Fujii, Izumi Machida, Tomoyo Sato, The Inoue third son Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

The evaluation by induction and the questionary survey of the voluntary learning support institution "training laboratory" in the 20-P3-538 Showa University pharmacy school
The Takahashi Italy Tsu beauty, Mari Kogo, Koji Negoro, Eri Sugiyama flower, Tatsuya Kurihara, Yoshihiro Sano, Kenichi Saguchi, Junichi Mashita, 戸部敞, 山元俊憲
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

	Attitude survey for the Sino-Japanese traditional medicine of the 20-P3-539 Yokohama pharmacology university student It is the best among Komatsu, Miwako Saito, Toru Iizuka, Narita deferred good luck, Akio Nanba, Masahiro Washimi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

	Attitude survey - of the study student for new dietetics - action to unfold for 20-P3-540 pharmacy six years system advanced education 豊田行康 1, Tadashi Takeda kernel 2, South Aki 3, Akira Tamura 3, Yukihiro Noda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

Enforcement of regional alliances program - summer vacation children color color experience school - in 20-P3-541 Kobe College of Pharmacy and evaluation
Ikuko Yokoyama 1, Yukiko Nagamine 2, Naoko Tomita 1, Seigo Iwakawa 3, Isao Sugimoto 4, 辰見明俊 1, Takeshi Kotake 1, Masatoshi Sugiyama 1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

	Outlook on ethic found by the pharmacist whom 20-P3-542 pharmacy student recognizes Yokoi fathom sum 1, Maki Yamamoto 1, Hidenori Sagara 2, Takashi Egawa 3, Kazuaki Shinomiya 4, Yoshihisa Kitamura 4, 名倉弘哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2008.

	Clinic by the active visit of the practice settings for students of 20-P3-543 small number of people Akira Suzuki person 1, Seiji Ono 1, Akira Sakata 1, Shinji Kawamura 2, Nagamachi Shigeki 3, Purple fence Seiya 2, Shozo Tamura 3, Masami Hirai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

	Attitude survey about the harmful effect of the 20-P3-544 pharmacy student Yuka Watanabe, Mountain volost Mayumi, Keiji Kuramoto, Toru Shoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

An action and result of the medical care person GP "participation type learning of Showa University which kept the characteristic of the 20-P3-545 medical care system university alive to realize a utility of the team approach in medical care"
Yuji Kiuchi, 戸部敞, Akihiro Nakamura, Takashi Ito, Miwako Kamei, Is Kurata; see it, 山元俊憲
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

	About the need of the 20-P3-546 hospital pharmacy briefing session through - opening hospital automation pharmacy - Shinji Soeda, Hidemasa Koitabashi, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

20-P3-547 Hokkaido College of Pharmacy medical care person GP "local experience-based type learning and support to bring up clinical competence"
Hiroaki Ono, Design of turbulent waves Ryosuke, Tanaka three Eiko, Endo chrysanthemum Taro, Shimamori beauty light, Kenichi Komatsu, Tokumi Mizukami, Hiroshi Yamashita, Jun Takahashi, Koichi Sakurai, Sanae Muraoka, Yoshiko Tanbo, Koji Wada, Hidehiko Sakurai, Kazuhiro Watanabe
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

	The trial that "we learn about humanism" through 20-P3-548 art Kenichi Tanaka, Akiko Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2008.

	Practice of the practical pharmacy training that we did on the basis of preparations for lessons by e-learning on the 20-P3-549 Internet Takahiro Nishida 1, Foot Shintaro 1, Junzo Nakamura 1, Hidenori Maruta 2, Hitoshi Suzuki 2, Fujio Kurokawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	Conduct the injection compounding of medicines training of the 20-P3-550 pharmacy student Narita deferred good luck, Akio Nanba, Kyoko Sonoda, It is the best among Komatsu, Toru Iizuka, Mayu Araki, Masahiro Washimi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	About - combination impossibility, incompatibility to perform chemistry of 20-P3-551 compounding of medicines - Toshiaki Saito 1, Junichiro Murayama 2, Satoshi Toyama 3, 榛澤雄二 1, Kazuki Kushida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	Investigation of consciousness and the vaccination history about the vaccination of the 20-P3-552 pharmacy school student Yumiko Komori 1, Mitsuyoshi Okamoto 2, Tatsuo Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	Effect of the pharmacist duties visit by the 20-P3-553 pharmacy teacher Yukio Kishikawa 1, Nobuaki Miyagi 2, Yumiko Konno 1, Jin Nakamura 1, Fuminori Matsubara 2, Setsuo Tsuchiya 2, Michinao Mizugaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	The penetrance of the company idea judging from consciousness for the lifetime education of the 20-P3-554 new employee and the importance Hideaki Kawanishi, Kazumi Kawamura, Mikio Sakakibara, Satoshi Okada, Keiji Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2008.

	20-P3-555 we are ... through the instruction (TDM training) to one or the pharmacist by ... pharmacy student who can grow up to where Osaki good luck, 猪川和朗, Kayo Ikeda, Keiko Kameda, Norifumi Morikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

	It is ... for the penetrance to hospital pharmacist duties publicity work - citizen using the 20-P3-556 commercial radio broadcast Hideyuki Nishida 1, Keiji 2 Kim, Yukiko Kawamoto 3, Yoshiro Suzuki 4, Hirai green 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

Survey about the duties situation of the drug section under 20-P3-557 Kanagawa
Tetsuro Yumoto, Yukino Ayabe, Junichi Iida, Large root Izumi, 岡田樹彦, Tatsuya Kato, Akitoku Kojima, Yoji Shimizu, Tamura harmony, reverence, purity and tranquility, The Hisashi Fujiwara up, Takuya Maeda, Hajime Matsubara, Takeshi Yamaya, Yoshiko Miyazaki, Masahisa Saito, Hajime Kagaya, Masayuki Morita
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

	Recognition comparison of a pharmacist, the non-medical person about the 20-P3-558 pharmacist function Tomoyo Sato, Izumi Machida, The Inoue third son, Akio Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

	The construction of the personnel evaluation system that aimed at the nature improvement of the 20-P3-559 hospital pharmacist and evaluation one year after the induction Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

	About the upbringing of the pharmacist who can be active at 20-P3-560 disaster than the experience from <Japan Team for Disaster Relief medical care team workshop> 渡邉暁洋 1, Keiko Fukuda 1, Ayumi Kato 2, Kenji Nishizawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2008.

	Stare at the activity from the viewpoint of the 20-P3-561 TMAT disaster support activity [Union of Myanmar cyclone disaster] - pharmacist; and ... Haruhiko Sato 1, 2, Kazuyoshi Harano 2, 4, History of Hayata stand 2, 5, Hiromi Sekiguchi 2, Hirotsugu Kita 1, 伊波潔 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

	About the setup of the lifesaving first aid support task of the pharmacist in the 20-P3-562 Shimane Prefectural center Hospital 寺西正充, Emiko Takano, Maki Nitta, Sachiyo Nagaoka, Makiko Ishida, Asozu Yuko, Kyohei Yamamoto, Mikiko Imaoka, Katsuki Yokote, Sumiko Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

What kind of effect did the arts and sciences support task give the practice duties of the physician the new action first report called the 20-P3-563 arts and sciences support pharmacist?
Tomoya Asada, Yosuke Oka, Emi Nagao, Mayumi Okazaki, Mitsugu Saegusa, 眞鍋伸次, 森由弘, Thickness well Bunichi
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

	The new action second report called the 20-P3-564 arts and sciences support pharmacist from the questionary survey for the arts and sciences support task: Mayumi Okazaki 1, Emi Nagao 2, Mitsugu Saegusa 2, Tomoya Asada 1, Shinji Manabe 1, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

	Joint ownership and professional ability appeal ... of action ... fur Matthew tical care practice contents to 20-P3-565 pre-Abo id report system 豊濱隆, 延藤勇, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

	The present conditions and problem of the simple suspension method in our 20-P3-566 corporation 2 institution Makoto Kyono 1, Madoka Ito incense 2, Kikuchi light 2, Teruko Komatsu 2, Yuichi Yoshida 2, Yoshikazu Koike 2, Nobuyuki Sugawara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2008.

	Hypoglycemic action with the 20-P3-567 de novo synthesis thienyl alanine derivative 奥貞佳奈子 1, Rie Murakami 1, Mitsuru Nishida Kyoko 1, 濱邊和歌子 1, Makoto Asada 2, Toku Kitagawa Jiro 2, It is still I 1 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

	About an action to 20-P3-568 medical supplies safety management Kazuaki Yonezawa, Seiji Fujita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

	Quality evaluation about the insoluble particulate matter of 20-P3-569 transfusion line, the injector Yasushi Suenaga 1, Maiko Nakao 2, Hideki Shuto 2, Yasushi Kataoka sentence 2, Osamu Imakiire 2, Masaaki Hirakawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

	Inspection - of the drugstore duties efficiency by action - simple SPD induction to drugstore duties efficiency in the cottage-hospital in the 20-P3-570 area 和田匡央, Satoshi Hirota University, Maiko Higuchi, Hiromi Fujimoto, Yumiko Yamashita, Pornographic book Ayumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

	20-P3-571 Medication teaching of anti-epileptic drugs (Depakene (R) R Tablets 200mg) against minnow shifts workers 寺澤知彦1, 加藤隆寛2, 吉田勉1, 伊藤里奈1, 江崎秀樹1, 金田僚子1, 笹野央1, 灘井雅行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.

Education, the training is necessary for the maintenance improvement of the information security information security of the 20-P3-572 drug department; or -
Mitsuru Kaneta Expo 1, Sanae Ida 1, Yasunori Nagano 1, Kazutoshi Terayama 1, 藍澤牧美 1, Satoshi Yamazaki 1, Kaori Saito 1, Tomoko Yamazaki 1, Akio Uchida 2, Junko Kitsu 3, Seko mouth studies 4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2008.